Free Papers by unknown
FP001 SURGICAL TREATMENT OF PANCREATIC
NECROSIS
J E Monteiro da Cunha, M C C Machado,
S Penteado, T Bacchella and J Jukemura
S’o Paulo University Medical School, Department
of Gastroenterology., Surgical Division,
So Paulo, Brazil
Despite progress achieved in the medical treatment of patients with acute
pancreatic necrosis (APN) and the role of surgery is no longer in dispute,
controversy still exists regarding the ideal time of surgery. We have reviewed
our experience at SPUMS between 1980 and 1991 with 68 patients undergoing
surgery for APN. Patients with pancreatic abscess were not included. The
most common etiologies were biliary(n--25), alcohol (n= 16) and postoperative
pancreatitis (n=9). Proportion of males to females was 3.8:1 and the average
age was 46 years. The APACHE II score was calculated in all patients and it
was higher than 9 in 48% (n=33).
Thirty-three patients were operated before 14 days of illness onset and 35 were
operated after the second week onset at the appearance of evidence of infected
necrosis. The APACHE II scores for both groups were not different. The
surgical predure consisted of necrosectmy plus extended drainage. Re-
operation for persistent sepsis occurred in 87.8% (n=29) in the early surgery
group patients and in 34.3% (n= 12) in the delayed treated patients. Infection
of the necrotic tissue investigated in 61 patients was present in 83.6% (n=51),
72.5% of which were monomierobial and was related to early laparotomy in
57% (n=29). The overall mortality rate was 26.4%. In patients with severe
pancreatitis (APACHE II> 9) undergoing delayed neerosectmy mortality rate
was 18.7% compared to 76.5% mortality associated with early laparotomy.
Necrosectomy delayed until the second week is a suitable procedure and may
achieve a low mortality rate in patients with severe pancreatitis with pancreatic
necrosis.FP002 HEMODYNAMIC CHANGES IN
PANCREONECROSIS
V A Koubishldn, V D Fedorov
A V Vishnevsky Institute of Surgery,
Moscow, Russia
We investigated 36 patients with pancreonecrosis, using mdionuclear techniques,
catheterising the celiac trunk and portal vein. The changes we observed do not
correlate with the degree of hypovolemia, but strongly correlates with the fall
in cardiac output. In patients with group II severity pancreonecrosis (L.F.
Hollcnder, 1) we observed a mean decrease in total blood flow to the liver of
20%. In group III patients we observed a mean decrease in total blood flow to
the liver of 53% in comparison with normal individuals. After 3 days of
treatment there was only a mean decrease of41% in total blood flow to the liver
in group III patients. While in group II patients the results, were close to the
control group. After 6-7 days of treatment the results were very close to those
in patients with group I disease. From our data the main reason for decrease
in total blood flow to the liver were portal hypertension with increase in
pressures of 2,39+_.0,42 kPa (in group II patients) and 3,05_.+0,38 kPa (in group
HI patients). The signs of portal hypertension as well as thrombosis of splenic
vein and migration of the thrombus were observed at angiography. In our
o_pinion hypoxemic damage to the liver played a bigger role than enzymatic
aggression, in causing hepatocellular failure, according to biochemical
parameters we notice in all patients. We used local fluid infusion through
celiac trunk and portal vein for treatment and prophylaxis. This method has
improved the outcome of hepatocellular damage and reduce the incidence of
paralytic ileus. But there was no reduction in suppurative complications and
mortality in patients without operative drainage.
Ref: Hollender L.F. et al. Aku Pankreatitis.Mtinchen, Baltimor, 1983.FP003 TOTAL COLECTOMY FOR THE MANAGEMENT
OF NECROTIZING PANCREATITIS
S Smyrnis, T Gyomisis, A Babos, A Koutsikou
M Pappa, B Nikolis, N Mamoulakis
Surgical Department, Hippokration Hospital
Athens, Greece
The clinical course of necrotizing pancreatitis and cndotoxaemia show
similarities, and, as it is known, the gut contains large amounts of Gram
negative bacteria that continuously shed cndotoxins. Using the Limulus Lysatc
Test in 1976 we found endotoxin in the ascitic fluid in cases of this pathology.
On the other hand enteric micro-organisms arc frequently isolated from different
tissues in pancreatitis. All these have raised the hypothesis that the intestinal
tract may play a major role in the pathogcncsis of ovcr-whclming septic
complications which have been recognised as a primary cause of morbidity and
mortality in necrotizing pancreatitis. So, on the basis of this in a session of the
Hellenic Surgical Society in 19861 stated: I wonder whether a total colectomy
has a therapeutic place in necrotizing pancreatitis.
In November 1990 1 performed the first total colectomy in a lady 82 years old
with pancreatitis and in a situation of multiple organ failure. She had a very
smooth postoperative course and left the hospital in good condition after three
weeks. Since then six more patients have been operated on and a ttal
colectomy done. Our own policy is:
cholystectomy and decompression ofa dilatedmmon bile duct if stones are
present; total olectomy with an ileostomy and a mucus fistula of the sigmoid
colon; scholastic removal of the great omentum and also of the mesxlon from
its root. We leave the pancreas alone because the problem is the enzymatic
secretion from the "sound" pancreatic tissue and note necrotic pancreas.
In all seven patients the operative evidence of necrotizing pancreatitis was clear-
cut. They recovered very soon and five left the hospital earlier than one month.
One died from pulmonary embolism 17 days after operation. Another
developed an iatrogenic enteric fistula at the time of drainage of a subhepatic
abscess and, during the conservative management, a metabolic disorder which
had been overlooked also developed and the patient died the 50th postoperative
day. Independently of these two deaths, both the results and also that of the
origin of endotoxin and bacteria in the gut, strongly support an indication to
total colectomy in cases of necrotizing paucreatitis until some effective measures
against endotoxin are discovered.FP004 PERCUTANEOUS DRAINAGE OF
PANCREATIC ABSCESSES
E Bloom, C H Julio, P Maquin
B Pradere, J L Gouzi
CHU Purpag, Place du Dr Baylac,Chirurgie Digestive
31059 Toulouse Cdex, France
This retrospective study was aimed to assess the efficiency of percutaneous
drainage of infecte pancreatic necrosis.
From 1987 to 1992, 43 consecutive patients were treate for unequivocal severe
acute pancreatitis with documented necrosis on CT with dynamic
pancreatography. Ranson’s bioclinical criteria were available in 29 patients,
with an average score. Six patients died by multiple organ failure within
the first 48 hours in the I.C.U.
In the remaining 37 patients, CT scans were graded according to
BALTHAZAR’s classification. Sixteen patients were grade E, 13 were grade
D, and 8 were grade C.
All patients underwent transcutaneous fine needle aspiration (FNA) for bacterial
Culture.
Eight patients demonstrated a nonseptic clinical course with negative FNA
cultures. All of these patients with non infected necrosis survived with
supportive treatment alone.
Among the 29 patients with positive FNA, 11 underwent surgical exploration
and drainage 5 of these patients died. Eighteen patients were treated by
percutaneous drainage. From 1987 to 1990, we used the Van Sonnenberg 12-
14 F sump drains in 7 patients, 3 ofwhom were subsequently operated on, with
three deaths in this subgroup.
Since July 1990, 11 patients were treated by 24-F bore lavage catheters
providing an immediate evacuation of large debris. All of ese patients
recovered without complementary surgery despite 3 colonic fistulas and one
biliary fistula at the time of Nrcutaneus drainage.FP005 ENDOSCOPIC SPHINCTEROTOMY LEAVING THE
GALLBLADDER ’IN SITU’ AS A DEFINITIVE TREATMENT
FOR ACUTE GALLSTONE PANCREATITIS IN THE HIGH
RISK PATIENT.
EM Targarona, I Pros, MJ Pons, J Martinez, C Balagu6, RM Perez
Ayuso, E Ros, JM Bordas, J Teres, M Trias.
Service of Surgery and Gastroenterology and Endoscopy Unit.
Hospital Clinic, University of Barcelona, Barcelona, Spain.
Cholecystectomy is the best stablished treatment for acute biliary
pancreatitis (ABP). Morbidity and mortality after cholecystectomy
increases with age and associated diseases. In recent years,
endoscopic sphincterotomy leaving the gallbladder ’in situ’ (
EE-GiS) has been considered as an useful option in high risk
patients with choledocholithiasis. Nevertheless, is not known the
efectiveness of EE-GiS in ABP. EE may facilitate the passage of
stones and papillary obstruction could be prevented. AIM. To study
the eficacy of the EE-GiS as a definitive treatment of ABP in high
risk patients. MATERIAL AND METHODS. 23 patients were treated
with EE-GiS between 1988 and 1992. Mean age was 78+/-8 years. All
patients presented a mild pancreatitis (Glasgow score <3), and ABP
was dignosed by biological and sonographic studies. Risk factors
were age> 70 y (80% patients), or associated medical diseases (20%).
EE-GiS was performed 15-9 days (3-25 d) afetr the onset of ABP.
RESULTS. ERCP demonstrated a dilated bile duct in 70% of cases,
and bile duct lithiasis in 9 patients (39%). EE could be done in 21
patients (91%). Morbidity was 8% and mortality 4%. 3 patients were
operated, 2 for technical failure (billroth II, residual stone after EE).
A third patient was operated because a gallbladder cancer was
found. All patients remain asymptomatic with a follow up of 23+15
(2-51) months, without relapsing of ABP or symptoms secondary
to gallbladder stones. 1 patient died for a non related biliary disease.
CONCLUSION: EE-GiS may be considered as an useful alternative
to conventional surgery for definitive treatment of ABP in the
aged or high risk patient.FPO06 LONGITUDINAL PANCREATICOJEJUNOSTOMY
IN THE TREATMENT OF CHRONIC
PANCREATITIS
F Callejas Neto, J C Pareja, L S Leonardi
U
Department of Gastroenterolggy Surgery
niversity of Campinas, Campinas-SP, Brazil
From July 1982 to July 1992, 80 patients underwent longitudinal
pancreaticojejunostomy for surgical treatment ofchronic pancreatitis. Therewas
a predominance of male (94%) and alcohol-abusers (96%). Clinical findings
were intractable pain by medical treatment (100%), Steatorrhoea (23,7%) and
diabetes (12,5%). The surgery was indicated due to pain symptoms (100%),
pancreatic cysts (63,7%) common bile duct obstruction (28,7%), pancreatic
fistulas (8,7%), haemorrhage (7,5%) and duodenal obstruction (3,7%).
The postoperative complications were anastomosis fistulas (6,2%), wound
infection (3,7%), pneumonia (3,7%), intra-abdominal abscess (2,5 %). Thirty-
day mortality was 2,5%. Follow up of 60 months showed persistence of pain
(13,7%), exocrine insufficiency (31,2%), endrine insufficiency (20%) and
mortality (7,1%).FP007 SURGICALMANAGEMENT OF PSEUDOCYSTS
IN CHRONIC PANCREATITIS.
R.C.N. Williamson
Department of Surgery, Royal Postgraduate Medical
School and Hammersmith Hospital, London
Most pseudocysts in chronic pancreatitis are intrapancreatic and associated
with parenchymal destruction; treatment is controversial. A personal series
of 169 patients with chronic pancreatitis undergoing operation between
1978-1992 included 72 with recurrent pseudocyst (42%). There were 55
men (76%) and 17 women, age 15-75 yr (mean 41 yr). Aetiological agents
were alcoholism in 50 (69%), recurrent acute pancreatitis (9) and unknown
(13). Cysts arose insidiously (57) or followed an acute exacerbation of
pancreatitis (post-necrotic) in 15. Multiple in 16 (22%), cysts were sited in
the head (27), neck (17) and body/tail (44) and contained between 20-1600
cc fluid. Complications in 24 patients (33%) were bleeding (6), infection
(5), persistent fistula following percutaneous drainage (5), jaundice (4),
gastric outlet obstruction (2) and pancr
eatic ascites (2). Drainage procedures were performed in 28 patients
(Roux-Y cyst-jejunostomy 25) with concomitant drainage of the pancreatic
duct in 12; there were two re-operations but no deaths. Resection of the
cyst was carded out in 44 patients by distal (29), proximal (9) or total (6)
pancreatectomy; there were three re-operations and one death (overall
mortality 1.3%). Recorded blood loss varied from 300 ml to 12 L and was
generally greater after resection. Larger, multiple and post-necrotic cysts are
mostly selected for internal drainage, whereas those replacing the body and
tail are treated by distal pancreatectomy.FP008 HAEMORRHAGIC COMPLICATIONS IN CHRONIC
PANCREATITIS
F Callejas Nero, J C Pareja, E A Chaim,
S C P Lego, V F Pilla, L S Leonardi
D.epartment of Gastroenterology Surgery,
University of Campinas, Campmas-SP, Brazil
We present our experience in the management of a group of 10 patients who
developed haemorrhagic complications due to pseudo-aneurysms secondary to
alcoholic chronic pancreatitis. The bleexting was located in pancreatic cysts in
four patients, in the digestive tract in four patients and in the peritoneal cavity
in two patients. The surgery was on an elective basis in six cases and
emergency in four cases. Surgical procedures performed were distal
pancreatectomy (50%) and ligation of the artery with pseudo-aneurysm
associated with longitudinal pancreaticojejunostomy (50%). There was no
operative mortality and no haemorrhage recidive in the follow-up at 36 months.
In selected cases the combination of ligation and pancreatic drainage could be
performed at the same time to manage the pain and the haemorrhagic
complication of chronic pancreatitis.FP009 SURGICAL TREATMENT OF HEPATIC
HYDATID DISEASE
P Chervenkov, R Madjov, R Radev and N Tzolov
Department of Surge_ry, Med University,
Varna, Bulgaria
Hepatic echinococcosis is a widespread zoo-anthroponous disease in the Balkans
and our country. For the last two years there is a tendency towards increasing
an incidence, especially those with complicated cysts. For the last 5 years, 101
patients with hepatic echinococcosis were hospitalised in our Clinic, 43 male and
58 female (mean age- 50,1). Most common localisation of hydatid cysts was
right hepatic lobe (72 patients) left hepatic lobe (14 patients). In 6 patients both
lobes were affected. In 7 cases hydatid cysts were diagnosed simultaneously in
patient’s liver and lungs. Solitary cysts were found in 74 patients, two cysts in
18 and 6 patients were with numerous cysts.
Most common signs were: heaviness and discomfort in the fight
hyphondrium (57,4%) pain (31,6%) dyspepsia (40,6%), palpable mass
(15,6%), fever (14,6%), jaundice (12,7%) asymptomati (16,9%).
Complications in our patients were: suppuration (11) rupture into biliary tree or
peritoneal cavity (10) jaundice (13), biliopleural fistulas (3).
US and CT scan were most useful diagnostic methods. The following operative
predures were rformed: echincectmy (63), echincetomy and
cholecystectomy (9), liver resection (6), pericystectomy (3), echinococcectomy
and cholecystectomy and T-tube drainage (5), echincectomy and
cholecystectomy and choledochoduodenostomy (6), thoracotomy and
diaphragmotomy and echinoccectomy and Mbectmy (5).
Post operative mortality one patient (diffuse peritonitis, causeA by rupture of
purulent cysO.
The results suggest that surgical treatment of hepatic hydatid disease should be
governed by the size, lation, number and complications of the cysts.FPOIO THE SURGICAL MANAGEMENT OF
THE HYDATID DISEASE OF THE LIVER,
OUR EXPERIENCE OF 50 CASES
P. At faras, S. Baratsis, K. T. De is,
S Drakopou Ios, H. Stoooos,
A. Papaonstantinou, E. J.Had iyannakis.
A’Surgical Department of the GH
"The Evange lzsmos of Athens".
Hydatid disease, caused by the tapewarm Echinococcus
Granulosus, is characterized by worldwide distribut-
ion and multilocular involvement,showin a prevaillin
occurrence in the liver.n this paper we am at pre-
sentin our experience from the surgical treatment of
50 patients with Hydatid disease of the liver,who have
been managed in our department through the years 986-
-1991.
males er ages ranging from 15 to 81 years old (mean
52,8).Solitary cysts were encountered in 25 cases,
multiple cysts in 14,whereas multilooular abdominal
disseination, includin the liver, in 11 subjects. Mana-
gement of the uncomplicated liver cysts (17),was pro-
vided as follows.ln 5 cases the cysts were totally
excised, with relative ease, but in another 5 patients
atypioa! hepatectomy was inevitable. The residual cyst
space in the remaining 7 was managed by removal of all
living cyst elements, llgation of the leaking bile ra-
dicles,sterilization of the cavity and drainage by tu-
be placement. 13 of the 33 complicated csts had ruptu-
red into the bile ducts necessltatlng,geyond the aro-
rementloned treatment,as for slmpe oss,choleoyste
otomy, bi|e duct exploration and T tuoe insertion. In
all patients with ihfeoted oysts(20),the cavities were
treated as it is mentioned above,but we proceeded with
omentoplas.ty and drained both the ,residual
space,by
lacing a three way Folley catheter at the subhepatio ouoh, y fixin an elastic tube (pen-rose).
Our re,ult, have been most
uninoidental postoperati- vely demanding no reoer
ion in all oases t one,
where further drainage ad to be instituted. We experi-
enced only 1 (2%) casualty. Presentation of our
teohnlque and results are elaborated, alon with a
brief review of the updated literature.
lOFPOI HEPATIC HYDATIDOSIS.
ARE DRAINAGE OPERATION JUSTIFIED?
C Vagianos, E Tzorakoleftherakis, J Petrochilos,
C Panagopoulos, S Kakkos, J Androulakis
Department of Surgery, Rion Hospital,
University of Patras, Patras, GREECE
Surgery offers the only possibility for cure in hepatic
hydatidosis (HH). Proposed operations are divided in
"radical", including removal of the pericyst (pericystectomies,
hepatectomies) and "conservative", including drainage
operations. Conservative operations are criticized for inferior
results as for early (sepsis, biliary fistulas) and late
(recurrence) postoperative complications.
From 1985 to 1991 we treated 83 consecutive patients with
HH, exclusively by drainage operations. (Isolation of the
peritoneal cavity, wide unroofing of the cyst, careful
evacuation of the cyst contents, sterilization with hypertonic
saline, interlocking haemostatic suturing of the cyst edges
and postoperative drainage with closed drainage systems).
Omentoplasty was added in 27 patients. Cholecystectomy
was performed in 33 (40%), when biliary pathology coexisted.
Intraoperative cholangiogram, performed in all
cholecystectomized patients, yielded true, choledochal
pathology, of 12%, treated by common duct exploration.
There was postoperative mortality of 1% (cerebrovascular
accident) and morbidity of 12% (two abscesses, eight biliary
fistulas). One abscess was treated by surgical and one by
percutaneous drainage. Three fistulas were treated
expectantly (healing required three to 12 months) and five by
endoscopic sphincterotomy and nasobiliary tube drainage
(healing required 7 to 14 days). No statistical improrement
was shown by adding an omentoplasty. There was a
recurrence rate of 8% (follow up from one to seven years,
achieved in 50 patients).
Conclusion: Drainage operations, when carefully performed,
achieve very satisfactory results with minimum perioperative
risks. Omentoplasty does not further improve these results,
while biliary complications can be successfully treated
endoscopically.
11FP012 TACHOCOMB, A NOVEL COMBINATION OF A
COLLAGEN FLEECE WITH FIBRIN GLUE: A
NEW APPROACH IN LIVER SURGERY.
Dr. E. Samhaber
HAFSLUND NYCOMED PHARMA AG
International Medical Affairs
Triesterstr. 50, A-1100 Vienna / Austria
A combined application of sheets of collagen covered with freshly prepared
fibrin glue improved local haemostasis to a great extent. Large areas of capillary
bleedings can be treated successfully. But due to the relatively complicated
preparation required at the operation site, this method has not been used on a
large scale. These drawbacks have been overcome with the latest development
in this field a sheet of collagen covered with a fixed layer of the solid
components of fibrin glue (fibrinogen, thrombin and aprotinin).
In a prospective study, 225 cases of liver resections due to metastases
(43 %), primary liver carcinomas (16 %), intraoperational injuries of Glisson’s
capsule (10 %), liver ruptures, benign tumours, bleeding subsequent to punch
biopsies, echinococcus cysts and others were included. The assessment of the
haemostyptic properties of TachoComb was "very good" and "good" in 95 %,
"satisfactory" in 4 % and unsatisfactory in 1% of the cases.
In several cases, particularly difficult bleeding situations could be controlled,
e.g. those with massive coagulation disturbances or hepatic stasis. No
complications attributable to TachoComb occurred.
So far, more than 280 patients with liver resections have been treated
successfully with TachoComb in clincal trials. In a liver transplantation study
with 27 patients, haemostasis with TachoComb was assessed as "very good" and
"good" in 96 % of the cases.
12FP013 PREDICTION OF BLOOD TRANSFUSION
DURING LIVER RESECTION
G Borgonovo, N Bourokba, C Vons, D Mariette,
C Smadja, D Franco
Service de Chirurgie, H6pital Antoine B6cl6re,
Clamart, France
Liver resection are often associated with operative bleeding and blood
transfusion. The purpose of this work was to determine which patients
were particularly at risk of intraoperative blood transfusion. Between
October 1990 and July 1992, 100 patients had liver resection for a liver
tumor hepatocellular carcinoma in cirrhosis (37 patients), primary liver
cancer in normal liver (14 patients), liver metastases without previous
chemotherapy (16 patients) or following chemotherapy (3 patients) and
benign liver tumor (30 patients). There were 12 atypical resections, 39
segmentectomies, 25 major hepatectomies, 15 extended hepatectomies
and 9 liver resections associated with portal, IVC or biliary
reconstruction. Clamping of the portal triad was used in all patients and
hepatic vascular exclusion in one patient with IVC replacement. Twenty
two (22 %) patients required blood transfusion. It was significantly (p <
0.01) more frequent in patients with cirrhosis (41%) or following
chemotherapy (66 %) than in patients with a normal liver (4.5 %). The
rate of blood transfusion was almost similar during atypical (17 %),
segmental (5 %) or major (16 %) liver resection. It was slightly higher
after extended (40 %) and significantly higher during resection with
associated procedures (89 % p < O.O1). The mean volume of blood
transfusion per transfused patient was around 5 units of blood whichever
tumor was resected and whichever resection was performed. These
results suggest that blood transfusion is not frequent in patients will a
normal liver undergoing liver resection when no associated procedure is
performed. Autotransfusion, hemodilution, hepatic vascular exclusion
(HVE) are not required in such cases. Blood transfusion is frequent and
abundant in cirrhotic patients and patients with chemotherapy
undergoing an extended liver resection or a liver resection associated
with reconstruction of the portal vein, IVC or bile duct. Only in such
patients a combination of HVE, hemodilution and autotransfusion might
decrease transfusional needs.
13FPO14 3-D DISPLAY OF INDIVIDUALIZED LIVER ANATOMY
MS van LeeuenI, MA Fernandez I, HW van ES.
RS Stokkig, HG van Meus.
H Obertop, AH Henniman,
ThJMV van Vroonhoven.
Department of Radiology1, Computervision2
Department of Surgery. University Hospital
Utrecht, Netherlands.
MATERIAL and METHODS
In anatomical liver resections the intrahepatic vascular
anatomy and tumors have to be related to the external
landmarks on the liversurface in order to define the precise
extent of the planned resection.
The relation between internal anatomy and external landmarks
on the liversurface was studied in 10 voluneers using 3-D
reconstructions of MRI acquisitions.
RESULTS
Two out of 10 subjects showed a normal pattern of 3 hepatic
veins, middle and left vein sharing a common runk. The
remaining 8 subjects had 9 accesory hepatic veins, 4 right, 2
middle and 3 left. Additionally, I subjec had a separate
origen of he left hepatic vein and righ hepatic vein.
Two out of I0 subjects showed a conventional portal branching
pattern with a separate righ anterior and posterior trunk.
Two subjects had a separate branch to the right liver which
originated from the main portal vein before it’s division in
right and left portal trunk. subjects showed a common trunk
to segment 5 and 6 and 4 ohers showed a trunk to segment 7
and 8.
On average the gallbladder was located 6 degrees to he right
of the middle hepatic vein (range 1-18). The righ hepatic
vein was allways located in the coronal plane or slightly
posterior ro i. The transverse fissure could not be assigned
in 3 our of 10 patients due to the presence of more than one
right portal trunk.
CONCLUSION
Marked individual variations in hepatic and portal vein
anatomy, known from in vivo and in vitro studies, can be
shown with 3-D liver imaging thus providing the possibility
of an individualized preoperative planning procedure.
14FPOI5 REMOTE RESULTS OF SHUNTING EFFLUENT
PANCREATIC BLOOD OPERATION IN INSULIN-
DEPENDENT DIABETIC PATIENTS
E I Galperin, T G Diuzheva, P F Pctrovskyi,
S E Rabmovich, A U Tchevokin, L V Platonova
Moscow Medical I M Sechcnov Academy, Russia
In 409 patients with insulin-dependent diabetes mellitus, distal splenorenal
venous shunt was made to divert pancreatic blood rich with hormone glucagon
into the general circulation to meet injected insulin (ins) in the peripheral
tissues. After the operation the ratio of exogenous insulin and endogenous
glucagon in the tissues (hepatic and pcriphcric) seems to bc more optimal for
their interaction. Angiographic control was made in 137 of them at a period of
8 months after surgery and included renal vcnography, selective splenic
venography. In 114 patients (83%) splcnorenal shunt proved to be permeable
and in 23 patients (17%) opacification of the splenic vein was not achieved after
using all the above methods.
After the shunting operation, the patients with permeable anastomosis showed
disappearance of, or diminishing complaints of leg pains, general weakness,
clinical manifestation of hypo- or hyperglycaemia. The dose of injected
exogenous ins. reduced from 0,95 + 0,05 Un/kg to 0,76+ 0,04 On/kg
(P< 0,05) without changing the preparation and schedule of injections. In 16
patients improvement took place without changing the dose of exogenous ins.
The level of glycosilated haemoglobin (HbAc) was 9,3+ 0,3% against 13,3+
0,3 prior to surgery (P < 0,05). At the same period of time after the operation
patients with non permeable anastomosis had the same complaints and the same
dose of ins. as before surgery. The level of HBAc remained high"
12,8+_.0,3%. It was proved that development of splenorenal collaterals in
patients with permeable anastomosis reduced the efficiency of the shunting
procexiure, therefore we now perform additional ligation of vv. gastrica sin. and
gastro-epiploica sin. Hepatic function did not suffer after surgery.
Stabilization of clinical state and metabolism after the operation and dependence
of remote results on permeability of applied anastomosis wimcss efficiency of
the new approach to treatment of insulin-dependent diabetes mcllitus.
15FP016 HUMORAL FACTOR(S) ASSOCIATED WITHACUTE
PANCREATITIS INDUCELEUKOAGGREGATION
KS Guico, KT Oldham
Divisions ofGeneral Surgery and Pediatric Surgey
Depamnent of Surgery
Duke University Medical Center, Durham, NC 2/710
Local and remote tissue injury results from the development of acute
pancreatitis, in particular, the sequestration of neutrophils (PMNs) occurs at
sites of capillary endothelial cell injury in the lung and pancreas. Other data
from our laboratory indicate a pathogenic role for these PMNs. It is not known
whether this PMN sequestration results from specific humoral factor(s), or
from alterations in the target endothelial cells, or both. This study was
designed to assess whether circulating plasma in animals with acute
pancreatitis contains humoral factor(s) which enhance PMN adhesion.
METHODS: Secretagogue-induced acute pancreatitis was generated in 200
gram Sprage Dawley rats by continuous intravenous infusion of supra-
physiologic doses (5tg/kg/min) of caerulein, a CCK analog. Blood was
obtained after 3 hours by venipuncture from the inferior vena cava and plasma
PMN aggregation potential was quantitatively determined electronically with
a CoulterTM Counter by a method previously developed and described.
GROUP MEAN+ SE
$ 30 xrn .0 + 1.2
C 60 rain 43.9 + 13.7 *
NS 60 rain 8.50 + 7.5
RESULTS
*p<0.05 compared to time matched NS control
(C = Caerulein infused; NS = Normal Saline infused)
Conclusions:
Plasma from rats with caerulin-induced acute pancreatitis has significantly
greater leukoaggregafion potential than plasma derived from saline infused
control animals. These data offer compelling evidence for the presence of
humoral factor(s) which enhance PMN adhesion following acute pancreatitis.
The nature of these factors is the subject of ongoing investigation.
16FP017 THE INFLUENCE
THE PROGNOSIS
PANCREATITIS
OF SERUM-ENDOTOXIN ON
OF ACUTE EXPERIMENTAL
U. Sulkowski, C. Boin, J. Brockmann,
A. Holzgreve
Department of General Surgery, MOn-
ster University Hospitals, Germany
In a controlled prospective randomized trial serum-
endotoxin levels were measured after induction of
acute experimental pancreatitis and synchronous
colonic irrigation or creation of a cecostomy.
Thus, after inducing acute pancreatitis in male
wistar rats by injecting a 2% taurocholate-solution
into a temporarily closed duodenal loop according
to a technique first described by Orda and co-
workers (Arch. Surg. 1980) 40 animals underwent
cecostomy (group B), in 36 the colon was irrigated
with normal saline (group C) and 36 served as
controls (group A). Altogether, twelve animals
succumbed intra- or immediately postoperatively. As
a consequence 31 remained in group A, 36 in group
B, and 33 in group C. Before the end of scheduled
follow-up (15 days) the mortality rate in the
control group was 22.6%, 16.7% in group B and 9.1%
in group C, with the difference between group A and
C being statistically significant at p < 0.05. This
difference was parallelled by a significant
difference of serum endotoxin levels between the
groups (219 ng/l in group A, 79.2 ng/l in group B,
and 71.7 ng/l in group C). Also the number of serum
endotoxin positive animals was significantly higher
in group A than in group B and C (7 in group A vs.
2 in group B and C). Our results suggest that
endotoxin might play an important role in the
pathophysiology of acute pancreatitis and that
endotoxin absorption might be reduced by cecostomy
or colonic irrigation.
17FP018 EFFECT OF L-GLUTAMINE ON ESSENTIAL FATTY ACID-
INDUCED DESENSITIZATION OF PANCREATIC BETA
CELLS
EC Opara, M Garfinkel, SK Lee, OE Akwari
Department of Surgery, Duke University Medical
Center, Durham, NC 27710, USA
The essential fatty acid, linoleic acid, constitutes about 60-70% of the clinically
available lipid emulsions, which are now routinely provided to patients receiving
parenteral nutrition to avoid the development of essential fatty deficiency. However,
it has been shown in experimental models, that the infusion of polyunsaturated fatty
acids (PUFA) into rats and isolated perifused islets, will stimulate insulin secretion,
but will render the beta cells unresponsive to glucose. The mechanism of both the
stimulatory and desensitization effects of PUFA was shown to be linked to fatty acid
oxidation. The AIM of the present study was to explore the possibility of restoring
the glucose effect by the provision of L-glutamine, a major fuel soume and a
precursor for the biosynthesis of the antioxidant, glutathione (GSH) to the PUFA
perifusate of isolated islets. METHOD: In each experiment, a batch of six islets
microdissected from three female CD-1 mice were preperifused for 1 hour at 37C
at the rate of l ml/min with a Krebs-Ringer bicarbonate buffer, containing 5.SmM
glucose (basal), 2% bovine albumin, 100 KIU/ml trasylol and maintained at pH 7.4
by continuous gassing with 95%/5% Oz/COz. Basal effluent samples were then
taken before the glucose concentration was raised to 27.7mM for 20 minutes;
immediately followed by 20 mins basal glucose ’washout’ in the absence or
presence of 20raM glutamine (GLN) or 3raM glutathione (GSH). Linoleate (10raM)
was then added to the basal perifusate without or with GLN or GSH. Effluent
perifusate samples were collected on ice at 2 rain-intervals and stored frozen until
radioimmunoassay for insulin. RESULTS: The stimulatory effect of 27.7mM glucose
on insulin secretion assessed as the incremental area under the curve were 1552.8
_+ 276.3 and 220.4 +_ 163.9 pg/20 mins (p<0.001, n=6) respectively, before and
after linoleic acid treatment alone. In experiments, in which islets were treated with
the fatty acid in the presence of L-glutamine, there was no difference in the insulin
response to 27.7mM glucose before and after linoleate treatment (2051.8 +_. 420.5 vs
2159.2 pg/20 rains respectively, n=6). When GSH was substituted for L-glutamine,
qualitatively similar results were observed. CONCLUSION" The presence of
glutamine or GSH completely blocked the linoleate-induced desensitization of beta
cell secretory response to glucose, suggesting similar a mechanism between their
actions. These data support an efficacious role for L-glutamine during hyper-
alimentation.
18FP019 SURVIVAL FOLLOW UP OF A RAT PANCREATIC CANCER
TREATED BY PHOTODYNAMIC THERAPY
S Evrard1, P KllCr1, G Balboni2, C Damg62,
M. Aprahamian3 & J. Marescaux1
1" Department of Surgery A, University Louis Pasteur, Htpital
Civil, BP 426, F 67091 Strasbourg Cedex; 2: INSERM, Unit 61,
3 avenue Molire, F 67200 Strasbourg
At the present time surgical resection is the sole chance of cure in pancreatic cancer
but only for 5-10% of the patients. Efficiency of surgical resection could be
perhaps enhanced by an adjunctive intraoperative photodynamic treatment. The aim
of this work was to study the survival of a model of rat pancreatic cancer treated by
Pheophorbide A (PPA) photodynamic therapy (PDT).
The tumoral model was an acinar pancreatic cancer induced by azasedne and
transplanted in the pancreatic tail ofLewis rat. The survival time of this model do
not exceed 33 days. The.photosensitizer used (PPA) was a chlorophyll derivative
at a dosage of 9 mg. kg- 1.intravenously administered 24 hours before illumination
and achieving a ratio of 12:1 between tumor vs surrounding normal pancreas. A
DCM laserpumped by a copper vapor laser was used to deliver a fluence of 100
J.cm-2 at 660 nm. The spot size of laser light was 3 cm-2. The tails of the pancreas
(bearing a tumor of 1 cm in diameter) of 18 rats (9 with PPA and 9 without) were
exposed under a midline laparotomy. The surface temperature of the tumor was
monitored throughout the illumination. The maximum tumor tenperature rise was
less than 2 C. This elevation was not considered in favour of thermal effects. Rats
follow up was established according with Kaplan Meier method. Autopsies were
performed on dead rats. Rats surviving more than 4 months were sacrificed for
histological examinations.
Control rats (9 illuminations without PPA, 9 PPA without illumination and 9
without any kind of treatment) did not survive more than 33 days with evidence of
metastatic spread and carcinomatosis. At this time, the rate of survival in the PDT
group was 89% (log rank test, p < 0,001). Six animals (66%) were still alive 4
months after PDT. Histological examination of the survivals showed evidence of
pancreatic tail necrosis without metastatic spread.
Further experiments were conducted histologically in order to determine the
threshold ofPDT damage. 33 and 75 J. cm-2induced a surrounding edema of
pancreatic acini but failed to destroy tumor cells. Tumor destruction was achieved
only at a fluence of 100 J. cm-2. It should be observed that normal pancreas was
immune to PDT damage even at a fluence of 100 J. cm-2.
The efficiency ofphotodynamic therapy using pheophorbide A was assessed not
only by histological selective necrosis of pancreatic tumor but also by 2/3 survival
ofPDT rats. This work suggests that intraoperative adjunctive PDT may improve
therapeutic results of pancreatic carcinoma surgery.
19FP020 CHLOROQUINE ATTENUATES THE INTENSITY
OF EDEMATOUS ACUTE PANCREATITIS IN RATS
A L Montagnini, M S Kubrusly R Yamauchi, A M M
Coelho, ABonizzia, $ N Sampetri, M C C Machado
Department of Gastroenterology, Hospital das
Climcas, S[o Paulo University, S[o Pa-ulo,Brazil
Trypsinogen activation by cathepsin B in acinar cell zymogen occurs only at low
pH (3-4) and is an important step in the initiation of acute pancreatitis.
Aim: Determine ifchloroquine, a lysosomotropic agent that rises intra zymogen
pH, can alter the intensity of edematous acute pancreatitis induced by
supramaximal doses of cerulein.
Method: During 3 days 25 male Wistar rats (220 250 g) received by gastric
tube diphosphate chloroquine 50mg/kg body weight/day (Group I) or saline
solution 2ml (Group II) and stayed under overnight fasting between days 2 and
3. At day 3, two hours after the last dose Group I and Group II rats were given
a subcutaneous injection of cerulein (20ttgr/kg body weight) and one hour later
an intravenous injection of eerulein (201gr/kg) and Evan’s blue (20ttgr/kg).
Rats were sacrificed after one hour and the pancreas isolated for water and
Evan’s blue determination. The amount of dye in pancreatic tissue correlated
with pancreatic edema. A control group (III) was included in the study. Group
III rats received saline solution instead of cerulein.
Results: mean 5: SEM
Group I Group H Group III
n=ll n=14 n=19
Water 78,5+ 1,5 84,0+ 1,0#
Evan’s Blue 197,5+30,0
Igr/gr dried tissue (*)P< 0,05 vs GI
(#)P< 0,01 vs GI (o)p< 0,01 vs GII
302,1 :t:30,1
(**)P<0,01 vs GII
()P< 0,05 vs GI
72,4+0,7***
0
69,3+7,3*
Conclusion: Chloroquine attenuates the intensity of edematous acute
pancreatitis induce by cerulein in rats. The alkalinization ofzymogen granule
and lower activity of cathepsin B may play a role in this protective effect.
20FP021 PHOTODYNAMIC IMAGING (PDI) OFARATPANCREATIC
CARCINOMA USING PHEOPHORBIDE A (PPA)
P. Keller1, F. Heisel2, S. Evrard1, C. Damzd3,
M. Aprahamian3 & J. MarescauxI
1- Department of Surgery A, Htpital Civil, BP 426, F-67091
Strasbourg Cedex. 2: GOA, CNRS, 3: INSERM, Unit 61.
The use of optical spectroscopy is a potential new approach for the diagnosis of
pancreatic malignant mmours. We will report the use of laser induced fluorescence
of a new photosensitizer (PPA) which presents tumour-localising properties.
The tumoral model used in this experiment was an acinar pancreatic cancer induced
by azaserine and transplanted in the pancreatic tail ofLewis rat. The PPA is a
chlorophyll derivative used in our experiment at a dosage of9 mg. kg-1 IV 24
hours before illumination.
Fluorescence emission spectra of 5 tumours and their surrounding pancreas
obtained under 400 nm excitation showed a broad double peak with a maximum at
678 nm. Autofluorescence from tissue was also observed at 463 nm. A reduction
ofPPA fluorescence intensity was found at the surface of the tumours because of
their heavy blood staining. Consequently, PPA fluorescence signal alone was
unable to provide a photodynamic ,image of pancreatic carcinoma.
In order to avoid problems related to variations in distance, surface topography,
drifts in laser intensity, detection efficiency and overall cancer blood staining, we
have developed a concept based on a dimensionless function. This function was
established by dividing the intensity fluorescence signal ofPPA by
autofluorescence. We called it Rt for the mmour andRp for the surrounding
pancreas. The fluorescence contrast C = Rt IRp should be greater than one to allow
obtaining ofPDI of a tumour.
To determine the best excitation we have tested the previously established excitation
wavelengths ofPPA (355, 400, 510, 530 and 610 nm) on 5 tumours and
surrounding pancreas. Obviously, 355 nm gave the best fluorescence contrast (C =
1_) and was used to perform.our preliminary imaging of an intrapancreatic tumour
and its intraperitoneal metastasis.
We used a Nd" YAG laser at 355 nm as excitation source. Fluorescence was
recorded by a CCD camera through 2 interferential filters: in the red forPPA signal
and in the green for autofluorescence. A dimensionless contrast function has been
calculated for each spatial location using the values in corresponding pixels in the
two images. A resulting artificial image was formed with false colours coding.
High contrast images have been obtained from the tumour and peritoneal
metastasis.
PDI of pancreatic carcinoma using PPA as a dye seems to be effective. Such an
imaging process may perhaps allow in the future to detect and cure the metastatic
spread in the time course of debulking surgery of a pancreatic carcinoma.
21FP022 PROTECTIVE EFFECT OF REDUCTION OF PANCREATIC
ENZYME CONTENT IN EXPERIMENTAL ACUTE
PANCREATITIS IN RATS
A M D M Coelho, M S Kubrusly, A Bonizzia,
M C C Machado
Department of .Gastroenterology Hospital_
das Clinicas, So Paulo University, Brazil
We have shown previously that under nutrition reduces the mortality of acute
experimental pancreatitis by decreasing the pancreatic enzyme content.
Cerulein in physiologic doses reduces the enzyme content of the pancreas
without any harmful effect t the pancreas.
The aim of this study was to assess the effect of acute reduction of pancreatic
enzyme content by using inframaximal doses of cerulein in the outcome of acute
pancreatitis (AP).
Method: Two groups of rats were studied: Group Io con.trol animals fasting 12
hours and Group II- animals receiving cerulein in inframamal dses
(0,2g/kg/h) with free access to water and food. Enzymatic content of the
pancreas was studied in both groups. Acute pancreatitis was induced by
retrograde injections of 0,5 ml of 2,5% Na-tauroclate into the pancreatic duct.
Results: Cerulein administration resulted in 71%, 55%, 60%, 62% and 41%
decreases in pancreatic content of chymotrypsin, trypsin, proelastase, amylase
and cathepsin B respectively (p < 0,01). Mortality was 56% in the control
group and 23% in the cerulein group (p < 0,05).
Conclusions: These results indicate that decreasing enzymatic content of the
pancreas reduces the severity and gives a protective effect in acute pancreatitis
in rats.
22FP023 LIVER TRANSPLANTATION WITH OR WITHOUT
OCCLUSION OF THE INFERIOR VENA CAVA
COMPARISON OF TVVO TECHNIQUES
D. Cherqui, N. Rotman, J.L. Hingot, J.Y. Lauzet,
D. Dhumeaux, M. Julien, P.L. Fagniez
H6pital Henri Mondor 94010 Crteil, France
Regular orthotopic liver transplantation (OLT) technique includes occlusion of the
inferior vena cava (WC) and portal vein with or without use of venous bypass. A new
technique was recently described permitting to avoid WC occlusion (1). It includes (a)
recipient hepatectomy with preservation of the IVC, (b) closure of the graft IVC at its
upper and lower ends, (c) side partial clamping of the recipient IVC, and (d) side-to-
side anastomosis between the graft and recipient IVCs. The aim of this study is to
compare the results of the regular and the modified techniques used successively at the
same center.
From 1989 to 1992, 89 OLTs were performed in 88 patients. Five patients with a major
technical variant were excluded (2 clusters and 3 reduced-sized grafts from a split
procedure). Until September 1991, the regular technique was used in 41 patients (42
OLTs) using venous bypass in cases of hemodynamic intolerance to clamping (group 1).
Since that date 42 consecutive patients were operated on with the modified technique
associated to a temporary end-to-side portacaval anastomosis (group 2).
Results
group I 8roup 2
numberOLTs 42 42
operative time * 9.3+1.9 7.5+1.7
red-cell units 20.3+14.4 12.4+6.5
transfused **
venous bypass 69% 0
hospital 2.4%
mortality.. *** (1/41 pts)
* p<0,01 ** p<0,005 *** NS
12%
(5/42)
The use of the modified technique was
possible in all cases. Early portacaval
anastomosis was very useful for
recipient hepatectomy. In 2 cases, the
WC had to be occluded for a 5-minute
period because of hemorrhage during
hepatic vein dissection. There were no
deaths due to the technique used.
The modified technique allows to avoid venous bypass in all cases and to reduce
significantly operative time and intraoperative blood loss. This technique has proved
to be simpler and as safe as the regular one and, therefore, can be recommended.
1. Belghiti et al. Surg Gynecol Obstet 1992;175:271-2
23FP024 INCIDENCE, MANAGEMENT AND OUTCOME
OF PORTAL VEIN ABNORMALITIES AT
ORTHOTOPIC LIVER TRANSPTATION
B Davidson, A Burroughs, K Rolles
Hepatobiliary and Liver Transplantation Unit, Royal
Free Hospital and Medical School, London
Partial or complete occlusion of the portal vein (PV) is considered a
relative or complete contra-indication to orthotopic liver transplantation
(OLT). We have analysed the incidence, management and outcome of this
group of patients.
Of 140 consecutive patients undergoing OLT during the period October
1988 to October 1992 14 patients had either partial (n=7) or complete
(n=7) occlusion of the PV at surgery. In 13 of the 14 portal inflow was re-
established by flushing, Fogarty balloon embolectomy or passage of a
graduated dilator. In one patient complete fibrous obliteration necessitated
a PV to right gastro-epiploic vein anastomosis.
On follow up there have been 6 deaths in this group (6/14 = 43%) from
recurrent cancer (n= 1), sepsis (n=4) and cardiac and renal failure (n= 1).
Four of these 6 patients had confirmation of PV patency on imaging. The
remaining 8 patients are alive and well (median follow up 28 months, range
1-44 months)
Further PV thrombosis (PVT) occurred in 3 of the 14 patients (21%) with
PV abnormalities. At the time of surgery in one and at 7 and 12 days post
op. This was successfully treated by thrombectomy in two and required re-
transplantation in one with associated arterial occlusion. Of the 126
patients with a normal PV at surgery post op PVT occurred in two (2/126
= 1.6%) at 24 hours and 14 days post op and was again successfully
treated by thrombectomy.
Portal vein abnormalities found at the time of OLT are common (10%)
and these patients are high risk (43% mortality). Further thrombosis ofPV
is significantly increased in this patient group (3 of 14 vs 2 of 126. X =
14.4, p<0.001)FP025 USE OF T-TUBE STENT IN BILIARY RECONSTRUCTION
DURING ORTHOTOPIC LIVER TRANSPLANTATION
A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
V Vougas, N D Heaton, M Rela, E Gane,
R Williams, K C Tan.
Department of Liver transplant surgery and the
Institute of Liver studies, King’s College Hos.
Different surgical techniques have been used for biliary tract
reconstruction following orthotoplc liver transplantation (OLT).
These techniques include the Roux-en-Y choledocho-jejunostomy,
gallbladder conduit and direct ductal anastomosis.
Biliary complications range from 12%-50% depending on the
technique utilized and the presence of vascular insufficiency.
Over a full year period (1992), 127 patients underwent 145 liver,
transplantations in King’s College Hospital. From these, 58
patients have been randomized in a prospective study of their
billary reconstruction. Excluded from this study were patients
with previous Roux-en-Y anastomosis and retransplants. In 28
patients (age range of 13-64 years) a T-tube was used (T-T),
whereas in 30 patients (age range of 19-66 years) no stent or
T-tube (NT-T) was used during a direct end to end bile duct
anastomosis.
Compcions occurred in 8 patients (28.5%) from the T-T group
and in 4 patients (13.3%) from the NT-T group. In the T-T group
7 had early (<3 months) complications including: accidental
dlslodgement (2), bile leakage (3), cholangltls from bile stasis
(I) and T-tube blockage (I). There was a late complication (>3
months): localized peritonitis after T-tube removal.
In the NT-T group 4 patients experienced bile duct stricture: one
early and 3 in the late postoperative period. All patients were
treated with endoscopic baloon dilatation but 2 required surgical
reconstruction and one was retransplanted because of hepatic
artery thrombosis. Fifty two patients survive a mean follow up
of 5.7 months. Six patients died (10%) from causes unrelated to
billary complications.
In biliary anastomosis during OLT there was significant increase
in morbidity with the use of a T-tube, when compared to those
without a T-tube stent (28.5% vs 13.3%).
25FP026 BILIARY COMPLICATIONS AFTER ORTHOTOPIC
LIVER TRANSPLANTATION.
D Mirza, G Batignani, B Gunson, S Olliff,
AD Mayer, JAC Buckels, P McMaster.
The Liver and Hepatobiliary Unit, Queen
Elizabeth Hospital, Birmingham, U.K.
Despite improvements in survival after orthotopic
liver transplantation (OLT), biliary complications
continue to cause significant morbidity. In April
1988, we changed our technique from a gall bladder
conduit to a direct donor bile duct anastomosis to
either the recipient bile duct (DD), or to a Roux
1oop (DR). Up to August 1992, 487 OLTs were
performed, of which 383 were in 339 adults (median
age 48). Biliary reconstruction was in the form of
DD (326), DR (56), and choledochoduodenostomy(CD)
(I). Biliary complications occurred in 86/383 OLTs
(22%), 12 following DR (21%), 73 following DD
(22%), 1 following CD (100%).
Bile leaks occurred in 38 cases due to anastomotic
leaks ( 17 ), 9 of whom subsequently developed
strictures, asymptomatic leak diagnosed on protocol
T tube cholangiography (9), leak following hepatic
artery thrombosis (4) leak following T-tube
removal ( 5 ), cystic duct leak ( 2 ), segmental
hepatic duct leak (i). Biliary obstruction occurred
in 48 cases due to anastomotic stricture (7),
intrahepatic stricture ( 9), papillary stenosis/
recipient duct obstruction (8), sludge syndrome
(14), hepatic artery thrombosis with stricture (3),
retained T-tube/ stent (3), recipient duct calculi
(2), cystic duct stump granuloma (2). Bile duct
complications were not related to prolonged
preservation.
Surgical treatment in the form of biliary
reconstruction, was carried out in 27 patients, and
one patient required retransplantation. There were
4 deaths related to biliary complications, and one
graft loss. In conclusion, biliary complications
continue to be a significant cause of patient
morbidity.FP027 RISK FACTORS OF LATE BILIARY COMPLI-
CATIONS IN LIVER TRANSPLANTATION
S. Landen, J.F. Desjardins,
F. Siriser, E. Bardaxoglou,
C. Stasik, B. Meunier, B. Launois
Department of Digestive Surgery and
Transplantation Unit
Pontchaillou Hospital, Rennes, France
Improval in survival following liver transplantation
has brought to light late complications, particularly
those concerning the biliary tract. The aim of this stu-
dy is to determine the risk factors of these late bilia-
ry complications.
Between April 1978 and June 1992, 135 orthotopic liver
transplantations were performed. During the harvesting
procedure (rapid technique as of 1978) the bile ducts
were rinsed by injection of saline via the gallbladder.
The anastomosis was choledoco-choledochal, choledoco-
jejunal and cholecysto-jejunal in 102, 27 and 3 cases
respectively. Three patients died intraoperatively,
prior to biliary anastomosis.
Among ll0 functional grafts at 1 month, 12 late biliary
complications were observed (10.9%). Six of these late
biliary complications consisted of an association of
strictures and dilatations of the intrahepatic bile
ducts. Among the group (n=12) with late biliary compli-
cations, 4 showed stenoses of the hepatic artery or one
of its branches, whereas only one of the patients in
the group (n=98) without late biliary complications
showed arterial lesions (p<0.001). Excluding patients
with hepatic artery stenosis or thrombosis, mean cold
ischemia time of liver grafts that developed late bi-
liary complications was 859+259 minutes versus 583+283
minutes for those having not developed biliary lesions
(p<0.01). Late biliary complications were not correla-
ted with the type of biliary anastomosis or the presen-
ce of a positive cross-match. Seven reoperations and 1
retransplantation was performed for late biliary com-
plications.
These results suggest that prolonged cold ischemia
times and reduced arterial inflow increase the inci-
dence of late biliary complications.
27FP028 Combined Heart-Lver transplantation:
refinement in surgcal technque.
KC Tan, ND Heaton, A Khagani*, M Pepys+,
R Wlliams and sir Magd Yacoub*
King’ s College Hospital, Harefield Hospital*
and Hammersmith Hospital, London.
Combined heart-liver transplantation had been performed
sporadically with mixed success. Since the first case was
performed in 1984, the procedure has met with severe intra-
operative difficulties such as haemorrhage and cardiac dysfunct-
ion. The main reason for these had been the simultaneous
implantation of the two organs under cardio-pulmonary bypass. In
order to circumvent this a staged procedure was described where
the liver was grafted 2 weeks after the heart. The obvious
disadvantages are that the organs were from different donors and
two major surgical procedures were required.
We described a modification of the technique whereby the organs
were grafted sequentially in a single operation. This was
performed in two patients with great success. The first patient
was a 33 year old woman with familial hypercholesterolaemia and
severe coronary artery disease, the other was a 60 year old man
with familial amyloidotic polyneuropathy in moderate heart
failure. The latter was the first time such an opeation was
performed for this condition. We encountered no intraoperative
problem and except for a mild rejection in the first patient
their postoperative recovery was uneventful.
28FP029 OCTREOTIDE IN THE CONTROL OF POST-
INJECTION SCLEROTHERAPY HAEMORRHAGE
S.A. Jenkins, R. Shields, A.N. Kingsnorth,
R. Sutton, S. Ellenbogen
Department of Surgery, Royal Liverpool
University Hospital, Liverpool, U.K.
Bleeding from oesophageal ulcers, oesophagitis or from the varices
themselves after injection sclerotherapy is occasionally massive and
difficult to control. Since our current experience with octreotide suggest
that it is a safe and effective treatment for the control of the acute variceal
bleed, we have examined its efficacy in these post-sclerotherapy problems.
Seventy-seven patients experienced a significant gastrointestinal bleed
(blood pressure < 100mm Hg, pulse > 100 b.p.m, or the need to transfuse
2 or more units of blood to restore the haemoglobin levels). The source
of bleeding was varices in 42 patients (Child’s Group A = 1, B = 9, C =
32), oesophageal ulcers in 31 (Child’s A 3, B --
3, C --
25) and
oesophagitis in 4 (Child’s A = 2, B = 2). All patients received a
continuous intravenous infusion of octreotide (50 tg/h) for between 40
and 140h.
Haemorrhage was successfully controlled by an infusion of octreotide in
all patients with oesophagitis, in 30 of 31 patients with oesophageal
ulceration and in 38 of 42 patients with bleeding from varices. In the 1
patient with persistent haemorrhage from ulcers and in 2 of the 4 with
continued bleeding from varices, haemostasis was achieved by hourly
boluses of 50 /g octreotide for 24h. No complications were associated
with octreotide administration.
The results of this study clearly indicate that octreotide is a safe and
effective treatment for the control of the severe haemorrhage after
technically successful injection sclerotherapy.
29FP030 ENDOSCOPIC SCLEROTHERAPY IS MORE COST
EFFECTIVE THAN OESOPHAGOGASTRIC
DEVASCULARIZATION AND TRANSECTION IN THE LONG-
TERM MANAGEMENT OF BLEEDING OESOPHAGEAL
VARICES: INTERIM ANALYSIS OF A PROSPECTIVE
RANDOMIZED CONTROLLED TRIAL.
JEJ Krige, PA Goldberg, PC Bornman, J Terblanche.
Department of Surgery and MRC Liver Research Centre, University of Cape
Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Fifty-two patients (35 male, mean age 45.8 years, range 18 65
years) with variceal bleeding were randomised after emergency
endoscopic sclerotherapy to continued endoscopic sclerotherapy (ES)
using 5% ethanolamine until variceal obliteration followed by regular
check endoscopy (n--27) or to oesophagogastric devascularization
with transection (OGDT;n =25). Childs C score > 11, those over 65
yrs and high risk operative patients were excluded. Thirty-seven pts
had alcoholic cirrhosis; 7 were Childs A, 26 Childs B and 19 Childs
C. Mean follow-up was 19 months (range 6- 58 months).
All data were analyzed on an intention to treat basis. Mortality during
the first month after randomization was higher in the surgical group
(2/25 v 0/27) but late deaths in the OGDT pts were fewer than
among the ES group (5 vs 9). Varices were eradicated in 24 of 27
patients in the ES group after a mean of 5 injections (range 2-10).
Three patients in the ES group died before eradication at a mean of
96 days. One patient in each group required dilatation for an
oesophageal stricture. No patient died from rebleeding.
During follow-up there were no significant differences between the
ES and OGDT groups with regard to number of patients rebleeding
from varices (6 vs 7), number of bleeding episodes (8 vs 6) number
of units of blood transfused per patient (0.7 vs 0.4), total number of
hospital admissions (79 vs 70), mean number of days in hospital per
pt (52 vs 45) or mean days per admission (15 vs 16). The mean cost
per patient was however significantly more in the group undergoing
operation (OGDT-- $12,475; ES = $7,542). We conclude that while
ES and OGDT are equally effective in eradicating varices and
preventing rebleeding, sclerotherapy is significantly more cost
effective than operation.
30FP031 SUGIURA PROCEDURE VS. PORTACAVAL
SHUNT RESULTS OF A PROSPECTIVE
RANDOMIZED STUDY
G Borgonovo, D Mariette, C Vons, C. Smadja,
D Grange, D Franco.
Services de Chirurgie, H6pital Louise Michel,
Evry, et HSpital Antoine Bclre, Clamart, France.
The purpose of this work was to compare the results of Sugiura
procedure (SP) and portacaval shunt (PCS)in the elective treatment of
cirrhotic patients with previous variceal bleeding. Fifty-four patients were
included in the study between January 1986 and April 1989. Twenty-
seven patients were randomized into the PCS group and underwent a
direct side-to-side portacaval shunt (22 patients), an interposed
portacaval shunt (1 patient), or a mesocaval shunt (4 patients). Twenty-
seven patients were randomized into the SP group and had a Sugiura
procedure (26 patients) or a mesocaval shunt (1 patient). The intention to
treat principle was applied to this study. The two groups were
comparable according to etiology of cirrhosis, liver function tests, number
and severity of bleeding episodes and size of varices. Total and variceal
recurrent bleeding episodes were more frequent after SP (33 % and
22 %) than after PCS (11% and 4 %). The difference however was not
significant. In each group, one patient died from recurrent variceal
bleeding. Encephalopathy occurred in 8 patients after SP and in 15
patients after PCS. The rate of chronic encephalopathy was significantly
higher after PCS (40 %) than after SP (7 %, p < 0.05). One-, 2- and 3-
year survival (Kaplan-Meier) were respectively 93 %, 81% and 67 %
after SP and 78 %, 66 % and 39 % after PCS. The difference between
survival curves (Log-Rank) was significant (p < 0.01). These results
suggest that, although it is slightly less efficient in preventing recurrent
bleeding, the Sugiura procedure is better tolerated and associated with
longer survival than portacaval shunt. The Sugiura procedure is an
operation of choice when surgical prevention of recurrent variceal
bleeding is contemplated.
31FP032 PORTAL PUMPING: A NEW PERSPECTIVE FOR
TREATMENT OF VARiCEAL HEMORRHAGE AND
LIVER FAILURE IN END-STAGE CIRRHOSIS?
Jorge E. CARDOSO, Mahmud EL METEINI, Yvon CALMUS,
Michel VAUBOURDOLLE, Didier HOUSSIN.
Laboratory for Surgical Research and Department of
Surgery, Cochin Hospital, Paris, France.
In end-stage cirrhosis complicated by variceal hemorrhage, treatments such as
portosystemic shunts which aim to reduce portal pressure decrease sinusoidal
perfusion at the same time, with the risk of impairment of liver function. A new
concept was put forward that encouraging portal flow to pass through the cirrhotic
liver by mechanical action could result in a decrease of distal (splanchnic) portal
pressure on one side, and improvement of liver function on the other side. The aim
of this work was to evaluate the hemodynamic and functional effects of a short
term pump driven increase of portal blood flow through the liver of 13 patients
with end-stage cirrhosis before the anhepatic phase of liver transplantation. In 10
of them, portal flow was increased peroperatively during 30 minutes, using a
pump-driven venovenous bypass in a portoportal closed circulation. Basal portal
flow (800 + 270 ml.min-1) was increased two-fold (n--lO) or four-fold (n--9). When
flow was doubled, splanchnic portal pressure decreased 18% (from 31.8 + 5.7 to
26.0 + 5.8 mmHg, p<O.001); when flow was increased four fold, splanchnic portal
pressure decreased 39.2 + 15.4% (from 32.8 +/- 5.0 to 19.9 + 6.0 mmHg, p<0.001).
Comparison of indocyanine green clearance between basal and doubled portal flow
demonstrated an increase of 32.1 +/- 26.9% (n--S; p-0.OS3). Histological analysis
demonstrated sinusoidal dilatation in 3 out of 10 livers. According to these
results, and with previous studies using isolated perfused cirrhotic rat or human
livers, we suggest that portal pumping should be explored as a new perspective of
treatment for some cirrhotic patients, sclerotherapy-reststant, with variceal
hemorrhage and liver failure.
32FP033 A 19 YEAR EXPERIENCE WITH SELECTIVE
SHUNTS FOR PORTAL HYPERTENSION
H Orozco, MA Mercado & J Hernndez
Portal Hypertension Clinic
Instituto Nacional de la Nutrici6n
Selective shunts were described in 1967 and were
initially performed in our hospital in 1973. Herein we
report our experience with this kind of operation.
Material and Methods: In a 19 year period, 192 patients
were operated in an elective function. In 170 cases,
liver cirrhosis was demonstrated and in 85 alcohol was
the etiology. Mean age was 50 (range 11-76). Most of
them were low risk patients (132 Child A patients, 45
Child B and 15 Child C). The postoperative results,
regarding operative mortality, re-bleeding,
encephalopathy, and long term survival were analyzed.
Results: 140 distal splenorenal shunts were done and 52
splenocaval shunts (30 direct, 22 indirect). Operative
mortality was 16% for the whole group, and 12% for the
Child A group. Postoperative encephalopathy was 16%, but
only 7% was incapacitating. Shunt thrombosis was
demonstrated in 4% of the cases. Survival for the whole
group (Kaplan-Meier) was 67%% at 1 year, and 56% at 5
years. Survival for Child A group was 75% at 1 year and
65% at 15 years. In 72% of the surviving patients, a
good quality of life was recorded.FP034 NEW COMBINED OPERATION FOR LIVER
CIRRHOSIS IN CHILD C GROUP PATIENTS
A V Shaposhnikov, S A Shaposhnikov
Department o_f Surgery, Rostov Medical
Institute, Rostov-on-Don, Russia
34 patients with Child C grade liver cirrhosis underwent combined operation
that included:
Marginal resection of 150-200g of liver tissue and intra-operative application of
He-Ne laser radiation (670rim) for 10 min; ligation of splenic artery and
omentohepatopexy; resection of 300cm of peritoneum on both sides of the
abdominal wall peritoneal-muscular shunt.
The main purpose of the first procedure was stimulation of liver regeneration;
the second decreasing portal hypertension. The last part of the operation was
made for the reduction of ascitic liquid in the peritone cavity. The mortality
rate at the first month after operation was 8.8%. Follow-up results were
investigated for 1-5 years after operation (31 patients, group A) in comparison
with non-operated patients with Child C liver cirrhosis (35 patients, group B).
Number of survivors present in the table:
Years after operation
1 2 3 4 5
Group A (31)
N 22 20 17 16 16
71.0 64.5 54.8 51.6 51.6
Group B (35)
N 30 22 12 4 1
85.7 62.8 34.3 11.4 2.8
These results showed the effectiveness offered by the operation for patients with
Child C liver cirrhosis. The operation can be useful in cases where it is
impossible to perform shunting procedures or fiver transplantation.
34FP035 INFLAMMATION IMPAIRS NERALLY MEDIATED
CONTRACTION OF GALLBLADDER MUSCLE
ML McKirdy, HC McKirdy, CD Johnson
University Surgical Unit Southampton
Ceneral Hospltal, Southampton UK
It is known that patients with gallstones may have reduced
contractility of the gallbladder. Evidence is accumulating that
physiological gallbladder contraction is neurally mediated. The
effect of inflammation in the gallbladder on its contractility is
unknown. This study was designed to correlate response to neural
stimulation with severity of inflammation in strips of human
gallbladder muscle.
Strips of gallbladder muscle were suspended in an organ bath and
attached to an isometric tenslometer. Electrical field stimulation
(EFS) was applied by 5-10 second trains of electrical pulses (0.3
mse 10Hz) to stimulate nerve cells. Response to a fixed low dose
(15nM) of CCK octopeptide was measured by the increase over
unstimulated tension after I0 minutes. Inflammation was assessed
by a numerical score of nine architectural and cellular features
graded absent, present or extensive.
41 gallbladder strips responded to EFS; 44 did not. In responders
the median inflammation score was 7 (range 3-12) and in non-
responders it was II (5-16; p<0.001). All gallbladders responded
to CCK-OP. There was a significant (p=0.0032) inverse
relationship between inflammation score and increasing tension.
The EFS stimulation characteristics selectively stimulate nerves.
These results show that neurally mediated contraction in the
gallbladder is likely to be lost in the presence of extensive
inflammation. Contractility in response to CCK was reduced by
increasing inflammation. These findings may be related to loss of
nerve tissue or impaired muscle cell function in inflammation.
35FP036 SPHINCTEROTOMY PRESERVINGTHE GALLBLADDER ’IN
SITU’: Effect on gallbladder physiology in an experimental model in
the rabbit.
Pros I, Targarona EM, Martinez J, Balagu6 C, Casals E, Bassa P,
M, Trias M.
Service of General and Digestive Surgery, Biochemistry and Nuclear
Medicine. Hospital Clinic. University of Barcelona, Barcelona, Spain.
Endoscopic sphincterotomy leaving the gallbladder ’in situ’ (EE-GiS) has emerged as an
useful alternative to surgery,but little interesthasbeen paid togallbladderfunction after ES,
and several studies report contradictories results. AIM: To study the modifications in
gallbladder function after sphincterotomy in an experimental model of lithogenesis in the
rabbit. MATERIAL AND METHODS: 38 maleNew Zeland rabbits were used. Group I,
Control. Group II, Surgical sphincterotomy (SE). Group III, Gallbladder lithiasis induced
by a lithogenic diet (colestanol 5%) during 2 weeks (Group IIIa) and 6 weeks (Group IIIb).
Group IV. SE after induction of gallstones. Group V. SE previous to the induction of
gallstones. A biliary scintigraphy with HIDA, weight of the gallstones, hepatic and
gallbladder bile composition and hepatic blood function test (GGT, Alkaline Phosphatase
(APh)an Bi) were measured. RESULTS: HIDA observed the gallbladder fillingin all cases
with a increased excretion fraction in the SE animals. In all the groups, gallstones were
induced,butSE precluded the formation of gallstonesinGroupV. Dry weightofthe stones
was lower in the SE animals than in controls. Hepatic function blood test were in normal
range in all cases.(Table I).
Groups % Stone weight HIDA APh (ui/l) GGT(ui/l)
lithiasis (rag) Eject.frac.
induction
Control 57.6+15 % 267+64 7.2+3.1
Surrg Sphincterot. 51.6+13 % 160_36 7 +2.8
Galltosnes 2 w. 100 % 66.4+59mg 72.5+6 %, ** 232.60 6.7+1.1
Litiasis 6s 100 % 276.5+319 mg 183+_44 13.4+5.8
Litiasis + EE 100 % 105.3+105 mg* 86.8+5 %, 158Y.36 7.6+3.1
EE + litiasis 66 % 58.1+69 mg* 91.8+3.6%** 113+47 6.8+1
*p=0.0007 *#.02 tip=0.01
SE decreased colesterol levels in gallbladder bile, and increase ledthin range in hepatic bile.
CONCLUSIONS:l.Colestanol gallbaldder- stone induction is inhibited by SE. 2. After SE,
gallbladder fillingby isotope is preserved,but the empting of the gallbladder is increased,
demonstrated by biliary scintigraphy with HIDA. 3. SEmay inhibit lithogenesis because it
facilitates a better empting of gallbladder.
36FP037 INTRAMURAL NEURAL PATHWAYS BETWEEN
THEDUODENUM AND SPHINCTER OF ODDI IN
THE AUSTRALIAN BRUSH-TAILED POSSUM
IN VIVO.
J Toouli. JR Harvey, RA Baker, & GTP Saccone
Department of Surgery, Flinders Medical Centre,
Bedford Park, South Australia 5042.
Balloon distension of the duodenum can provoke a change in sphincter of Oddi
activity. The mechanism(s) which mediates such a response has not been defined.
The aims of this study were to determine if: (i) electrical field stimulation of the
duodenum influences sphincter of Oddi activity (ii) this response is neurally
mediated (iii) these pathways are intramural and (iv) nicotinic and/or muscafinie
receptors are involved. Twenty eight anaesthetized Australian Brush-tailed
possums (Tfichosurus vulpecula) were used. Electrical field stimulation [70V,
0.5ms, 5-60Hz, 10-20s] on the anterior serosal surface of the duodenum at 2, 3, 4,
and 6 cm proximal or distal to the sphincter of Oddi, was used to stimulate neural
pathways. The sphincter of Oddi phasic contractions were recorded by
manometry. Tetrodotoxin (91.tg/kg) was administered by close intraarterial
injection to achieve neural blockade. Hexamethonium (30 mg/kg) and atropine
(30 I.tg/kg) were administered i v. sphincter of Oddi activity was quantified by
measuring the area under phasic contractions (ram2 per 30 see). The response was
expressed as a% of the pre-stimulus activity.
All possums displayed spontaneous sphincter of Oddi phasic contractions.
Electrical field stimulation of the proximal and distal duodenum produced
excitatory sphincter of Oddi responses in all animals. These responses were
frequency-dependant and maximal at 30Hz. The responses were produced when
the duodenum proximal to the sphincter of Oddi (up to 4-5 era, not at or beyond
the pylorus n=4) or distal to the sphincter of Oddi (up to 4 era; n=4), was
stimulated. The responses were abolished by either pretreatment with
tetrodotoxin (n=4), or transsection of the duodenum between the site of
stimulation and the sphincter of Oddi (n=3). Hexamethonium did not significantly
alter the sphincter of Oddi response to proximal (n=6) or distal (n=8) duodenal
stimulation. Atropine reduced sphincter of Oddi response to proximal duodenal
stimulation by 58.5 + 8.5 % (n=6) and to distal duodenal stimulation by 34.0 d:
9.1% (n=8) (both P<0.03, Wilcoxon Test).
In conclusion, we have demonstrated the existence of intramural neural pathways
between the sphincter of Oddi and the segment of duodenum 4cm proximal and
4era distal to the sphincter of Oddi. These postganglionic pathways involve
muscarinic receptors.
37FP038 BILE STASIS AFTER TRUNCAL VAGOTOMY
R Patankar, I Bailey, A Sanderson
C D Johnson
University Surgical Unit Southampton
General Hospital Southampton UK
The increased incidence of gallstones after truncal vagotomy
has been attributed to bile stasls. CCK is known to be the
principal hormonal mediator of gallbladder contraction. Our
aim was to study the effect of truncal vagotomy on gallbladder
contraction and CCK levels in response to a meal.
We studied 7 patients after truncal vagotomy and pyloroplasty
and 13 normal subjects. After an overnight fast, gallbladder
volume was measured in the fasting state and at 15,30, 45, 60
and 90 minutes after a solid fatty meal using the Ellipsoid
formula (Dodds). CCK was measured by a specific radlolmmuno
assay at the same times.
TABLE
vagotomy
median (range)
Baseline (I. 12(0.92-2.29)
CCK pmol
Maxlmum 16.49 (9.12-18.04)
CCK pmol
Integrated 621.07 (307.7-846.0)
CCK
Fasting 17.55(12.27-31.33)
volume
Residual 6.55(4.49-15.23)
volume
Ejection 63.4(51.38-68.2)
fraction
Normal
Median (range)
0.56(0.31-1.15) p<0.01
5.62(2.49-10.84) p<0.01
300.5 (160.9-642.9) p<0.02
13.52(7.7-40.31) p<O.05
3.03(1.07-6.84) p<0.01
78.29(61.3-90.67) p<O. O1
Gallbladder contraction was triphasic in both groups with a
phase of relaxation separating two contraction phases.
Plasma CCK was significanty elevated after truncal vagotomy
and may contribute to post vagotomy symptoms. There is decreased
contractility of the gallblader with a lower ejection fraction
and a higher residual volume after truncal vagotomy with
consequent bile stasis. These findings suggest that reduced gall-
bladder emptying after truncal vogotomy diminishes feedback
inhibition of CCK release.FP039 EFFECT OF BILIRUBIN FREE RADICAL ON
THE PRECIPITATION OF T-TUBE BILE
XS Zhou, DR Xiu, XB Fu, T Shen
Department of Surgery, Third Teaching
Hospital, Beijing Medical University
Beijing 100083, China
We had reported at the 4th World Congress of HPB Surgery
that free radical (FR) appears in gallstone in vivo, and
that the presence of FR was essential in pigment
gallstone (PS) formation. The AIM of this study is to
explore the effect of FR on the precipitation of calcium
bilirubinate (CAB) and glycoprotein (GP), the main
ingredients of PS, from human bile in vitro.
60 FR intensity of bilirubin was enhanced by Co radiation
(BrE) or reduced by ascorbic acid and mannitol treatment
(BrR). When this was confirmed by electron paramagnetic
resonance spectra, 0.5 ml of BrE or BrR solution
(Smg/ml, pH=8.4) was separately added into two 5 ml
aliquots from each of 14 T-tube bile samples. After 36-
hour incubation, the weight of dried precipitate, amount
of GP and CaB in it, contents of GP, total bilirubin
(TBr) and total calcium (TCa) in supernatant were
measured and compared between paired aliquots (cf.
table). Weight, CaB and GP of precipitate from BrE bile
were significantly higher than those from BrR (p<0.05).
The difference of components in supernatant (although
p>0.05) matched the differences in precipitate.
Indices n BrE(x+s) Difference x+s
Wt of prec (mg) 9
GP in prec (mg) 13
CaB in prec (mg) 9
GP in sup (mg/ml) 13
TCa in sup () 14
TBr in sup (m) 10
22.8+/-8.3
0.109+/-0.063
6.38+/-2.48
3.02+/-2.42
57.3+/-29.7
0.24+/-0.16
3.01+/-3.86
0.024+/-0.031
1.43+/-1.07
-0.09+/-0.29
-4.93+/-13.5
-O.30+/-O.67
Note: GP is expressed as bovine
Difference=BrE-BrR. Paired t-test,
submaxillary mucin.
*:p<0.05, **:p<O.Ol.
CONCLUSION: FR might initiate the precipitation of CaB
and GP, the first step of PS formation. (Supported
by National Natural Science Foundation of China)
39FP040 BZLZI%RY PNCREI%TIC BZLIO-PNCRE&TIC
REFLUX
S Houry, P Bedossa, L Nguyen Thanh,
M Huguier
Department of Surgery, Tenon Hospital
4rue de la Chine 75020, Paris.
Long term duodenogastric reflux has been implicated
in the genesis of gastric stump carcinoma after
previous partial gastrectomy for a benign disease.
The aim of this experimental study is to assess the
effect of a permanent biliary (BR), pancreatic (PR),
and bilio-pancreatic reflux (BPR) on gastric mucosa
After 2 months exposure, gastric mucosa did not
display any macroscopical changes wathever the kind
of reflux. On histological examination no intestinal
metaplasia, hyperplasia or dysplasia were found. The
only lesion found was the presence of numerous intra
mucosal cysts nearly the anastomosis. The mean number
of intra mucosal cysts was 119 for BR (n=5), 106 for
PR (n=6), 60 for BPR (n=5) and 13 for control group
(gastric suture n=5)
Long term exposure (one year) was investigated on
BPR (n=9). Macroscopic examination showed a protruded
lesion on the anastomosis of 8 rats. On histologic
examination these tumours were in 6 cases an
adenocarcinoma and in 2 cases a benign submucosal
adenocystic proliferation. The six adenocarcinoma
occured in five cases on an adeno-cystic
proliferation, and in one case on an inflammatory
granuloma.
Our results showed a clear corelation between long
term exposure of BPR and gastric carcinoma in rats.
Histologic investigations suggest that carcinoma
arise through adenocystic proliferation, condtition
similar to human gastritis cystic polyposa considered
as a premalignant disease. This experimental model
could be usefull for other investigastions.FP041 SCLEROSING CHOLANGITIS INDUCED BY SCOLICIDAL
AGENTS INJECTED INTO THE BILIARY TREE OF RABBITS
Z Y,Imaz, PekrO, E S6zOer, A Kahya, A Ye,ilkaya
Depalment of Surgery, Gevher Nesibe Hospital,
The University of Erclyes, Kayseri, Turkey
This study was performed at the University of Erciyes in Experi-
mental Research Laboratory between November 1991 and August
1992; to investigate the effect of soliidal agents, especially silver
nitrate 0.5%, on liver and biliary ducts and to find out whether
these agents caused secondary slerosing cholangitis or not.
Three groups rabbits were taken in this study. Each group was inc-
luded 15 rabbits. After laparotomy; The first group of rabbits was
given sodium chloride 0.9% into biliary tract. The second group of
rabbits was given silver nitrate 0.5%, and the third group of rabbits
was given formaline 5%. Blood samples for SGOT, SGPT and ALP
analises and liver wedge biopsies were taken. Five rabbits from
each group were sacrified at the end of the first, fourth and eighth
weeks. Liver, gall bladder and choledo biopsies for histopatholo-
gic study were done. There was no histopathologi and biochemi-
cal change in the first group. The eighth week ALP values were
significantly different from the beginning values in the formali-
ne group (p < 0.05). The first and eighth week SGOT values and
the eighth week ALP values were significantly different from the
beginning values in the silver nitrate group (p < 0.05). In the both
of formaline and silver nitrate groups, some of macroscopic fin-
dings and more of microscopic findings of secondary sclerosing
cholangitis were found.
As a result as formaline was found responsible for sclerosing
cholangitis earlier, silver nitrate 0.5% was also found responsible
for slerosing cholangitis. Therefore, In the hydatid disease, any
sclerosing scolicidal solution should not be given into the cyst cavi-
ty, till the solution must be proved not to be responsible for sclero-
sing cholangitis.
41FP042 EXPERIMENTAL SCLEROSING CHOLANGITIS
IN RAT INDUCED BY FORMALIN INJECTION
IN THE BILIARY TRACT.
S Houry, P Bedossa, JP Benhamou,
M Huguier.
Department of Surgery, Tenon Hospital
4 rue de la Chine 75020 Paris
Sclerosing cholangitis has been reported after
surgical treatment of hydatid disease of the liver,
and has been hypothetically attributed to the caustic
effect of the scolicidal solution diffusing into the
biliary tree trough a cystic-biliary fistula. The aim
of this study was to assess the effects of scolisidal
solutions on biliary epithelium.
In 146 rats we have injected directly into the
biliary tract 0.15 ml of isotonic saline (control
group), 20% hypertonic saline, 0.5%, and 2% formalin.
Histologic investigations performed 3 months after
injection showed no change in biliary structure in the
control group (n=11). In hypertonic saline (n=14), and
0,5% formalin (n=12) groups, we observed very mild
change of biliary epithelium, and no fibrosis. After
2 % formalin injection (n=16), there was periductal
sclerosis in 11 rats and 4 of them developed pseudo-
cirrhosis.
Sequential immunohistochimical study showed no
change in control group (n=24). In 2 % formalin group
(n=36), a mononuclear infiltrate inside and around the
bile duct occured 7 days after injection and persisted
until one year. At the later stages of the disease,
Lymphocytes infiltrations were mainly T-cells. Ia
antigene was expressed in biliary epithelium since the
7 th day.
Cholangiographic study showed normal aspect after
hypertonic saline (n=11),and 0,5 % formalin (n=11).
Strictures and dilatations of the biliary tree were
observed in 10 rats after 2 % formalin injection
(n=11). These strictures were confined to the ampula
and the convergence in 4 rats, and located in the
intra hepatic ducts in the others.
Our results suggest that 20% hypertonic saline and
0.5% formalin provide epithelium changes without
sclerosis. 2% formalin provide sclerosing cholangitis
Immunohisto- chimical study suggests a local cell
mediated immune reponse in the pathogenesis of these
lesions. 2 % formalin provide an experimental model of
sclerosing cholangitis.FP043 THE PREVENTION OF FISTULAS WITH THE FIBRIN
SEALANT IN PANCREATIC SURGERY: PERSPECTIVE
RANDONIZED TRIAL
V. Costantino, A.Alfano D’Andrea, C. Longhini,
C. Pasquali, S. Pedrazzoli.
Semeiotica Chirurgica, University of Padova,
Italy.
Severai Authors suggested the use of human fibrin sealants in pan-
creatic surgery to prevent fistuias. We performed a perspective
randomized study incIuding 97 patients who underwent resective or
derivative surgery, 34 femaIes and 63 maIes. 43 of them (Group A)
had either the pancreatic anastomosis or the pancreatic resection
seaied with fibrin glue during operation and 54 (Group B) had not.
Twenty patients in group A and 26 patients in group B had an infiam
matory pancreatic disease, whiie 23 patients in group A and 28 in
group B had a pancreatic tumor (exocrine or endocrine). Sixteen pa-
tients in group A and 14 in group B underwent pancreaticoduodenec-
tomy (PD); 16 (A) and 24 (B) had a pancratico- or cystoeunostomy
(PJA); iO (A) and I3 (B) had a ieft pancreatectomy (LP) and i (A)
and 3 (B) underwent a tumor excision (TE). The seaIant was made ad-
ding 500 U trombin to speed up soIidification and either the anasto
motic edges or the pancreatic sutures were seaied with spray. AII
the patients were treated and foiiowed-up by the same surgicaI staf
The patients were randomized at the moment the surgicaI treatment
was chosen, ividing the patients into 2 different Iists going to
have either a resective or a derivative operation. We considered
onIy radioiogicaIiy assessed fistuIas. After surgery weobserved an
overall number of 12 fistuIas in 97 operations (12.7). Six fistu-
las were found in group A (13.9) and 6 in group B (11.1%). Five
fistulas (16.1) occurred in patients with pancreatic cancer (3 gr.
A and 2 group B), 6 (13.0) in patients with pancreatitis (3 in gr.
A and 3 in group B), 1 occurred in a patient in group B with an en-
docrine tumor. According to the surgical procedure, we observed 5
fistulas (16.)in case of PD (4 in gr. A and 1 in gr. B), 5 (12.5)
after PJA(2 in gr.A and 3 in gr.B), in 1 patient in group B after
LP and in 1 patient in group B after TE. Our results do not show any
statistically significant difference between the patients treated
with fibrin sealant and the control group. We point out that the
highest incidence of fistulas was observed in the patients with pan-
creatic cancer in group A (18.7) and in patients who underwent PD
in group A (25.0).
4FP044 VARIATIONS EXIST IN THE PROCOAGULANT
ACTIVITIES OF HUMAN PANCREATIC CARCINOMAS
A K Kakkar]*, M F Scully2, S. Tebbut and R C N
Williarhson’.
Department of Surgery., Royal Postgraduate Medical
School, Hammersmith, I.bndon, W12 and rhe
Thrombosis Research Institute, Chelsea,
London, SW3, UK
It has long been recognised that carcinoma of the pancreas is associated with a
high incidence of thrombotic complications. Perhaps cancer cells generate
procoagulant activity (PCA), which would not only predispose to thrombosis but
also play an important role in mmour dissemination. Antithrombotic therapy at
the time of implantation of certain experimental mmours will reduce metastatic
potential. Since expression of tissue factor (TF) on the cell surfac may activate
local coagulation, expression of TF is an important determinant of PCA.
We studied the PCA of 4 cell lines derived from human pancreatic
adcnocarcinoma with normal and factor VII-deficient plasma to assess the role
of TF in the generation of PCA.
Cell Lines PROCOAGULANT ACTIVITY (PCA)
Thromboplastin Units/104 cells
Total TF ddent TF independent
CaPanc2 6660 6560 100
Panel 70 60 10
BXPC3 3500 3450 50
Mia Pane 120 110 10
There is a great variation in the ability of human pancreatic carcinomas, of
different origin, to generate thrombin, and this is particularly marked in TF
dependent pathways. Should this ability correlate with biological behaviour, a
new therapeutic pathway using specific antithrombins might become available.FP045 RESULTS OF PARTIAL RESECTION OF THE
PORTAL VEIN OR SUPERIOR MESENTERIC VEIN
IN PANCREATICODUODENECTOMY FOR CARCI-
NOMA OF THE PANCREATIC HEAD REGION.
JH Allema, M Reinders, T v Gulik, DJ v Leeuwen,
LTh de Wit, PCM Verbeek, MN vd Heyde,
Department of Surgery, HPB-unit, Academic Medical
Center, Amsterdam
The aim of this study was to evaluate the value of partial resection of the portal
vein or superior mesenteric vein in patients undergoing pancreaticoduonectomy
for carcinoma of the pancreactic head region.
Patients and methods: Between 1983 and 1992 196 patients underwent
pancreaticoduodenectomy for carcinoma of the pancreatic head region. Partial
resection and reconstruction of the portal vein or the superior mesenteric vein
was performed (end to end anastomosis or venous graft) in 20 pts in which
infiltration of the portal vein or superior mesenteric vein was found
peroperatively, in combination with subtotal pancreaticoduodenectomy (11 pts)
and total pancreatectomy (9 pts).
Results: In the group of patients with venous resection hospital mortality was
10% (2pts). Major complications were seen in !1 pts (55%)" haemorrhage in 5
pts, intra-abdominal infections in 5 pts and mesenteric vein thrombosis in 1 pt.
Relaparatomy was necessary in 5 pts (25%) and percutaneous drainage in 6 pts
(30).
In the group of patients with standard total pancreatectomy without venous
resection (24 pts) hospital mortality was 16% (4 pts) and morbidity was 77%
(19 pts). In the group of patients with subtotal pancreatectomy without venous
resection (152 pts) hospital mortality was 5% and morbidity 40%.
In the group of patients with venous resection, pathology showed a pancreatic
carcinoma in 11 pts, an ampullary carcinoma in 4 pts and a distal bile duct
carcinoma in 5 pts. Only 3 pts had a radical resection (tumour free margins).
One year survival was 26% and two year survival 11%, as compared to 69%
and 50% resp. in the group of patients without venous resection. The tumour
size and the differentiation grade were not significantly different from those in
the group of patients without venous resection.
.Conclusions" Partial resection of the portal vein or superior mesentedc vein in
(sub)total pancreaticoduodenectomy for infiltrating carcinoma resulted in a low
rate of radical resections and did not lead to improved survival.
45FP046 PLASMA GASTRIN AND CCK RESPONSE AFTER
PYLORUS PRESERVING
PANCREATODUODENECTOMY & DEFUNCTIONED
ROUX LOOP PANCREATICOJEJUNOSTOMY.
L.J. Formela. A.N. Kingsnorth, *D. Chen,
Department of Surgery, University of Liverpool U.K.
and *Department of Pharmacology, University of
Lund $223, Lund, Sweden
Thcrc arc several alternative methods to re-establishing continuity of the
gastrointestinal tract following Billroth II conventional (B2PD) or Longmirc-
reconstructed pylorus preserving pancrcatoduodcncctomy (L-PPPD). B2PD
abolishes the postprandial gastrin response whereas the response after L-PPPD is
similar to controls. In the present study a novel reconstruction after PPPD has
been designed to separate the biliary and pancreatic secretions by restoring
continuity in the Billroth I manner with the pancreatic remnant anastomoscd to a
separate dcfunctioncd Roux loop (D-PPPD).
Gastrin pmol/L andCCK pmol/L responses wcrc measured in the fasting state and
after a standard meal of 250mi 15% protein 30% fat 55% CHO with an energy
value of 525I(J. Basal gastrin and CCI( wcrc similar (p < 0.I) in controls, B2PD
and D-PPPD patients. In controls and D-PPPD but not in B2PD, postprandial
gastrin rose at 10min from 8 + 1.9 pmol/L to 13 + 2.3 pmol/L, and from 7 + 2.1
pmol/L to 15 + 1.9 pmol/L, and remained elevated for 20 minutes. In the D-
PPPD patients CCK levels remained low (0.2 +_ 0.09 pmol/L) after the test meal.
In controls postprandialCCK rose from 0.5 + 0.1 pmol/L basal to 11 + 2.1 pmol/L
and returned to basal at 60 min. In B2PD post-prandialCCK rose at a similar rate
and remained elevated for 80 min.
CCI( is trophic to the pancreas. Abolition of the postprandialCCK response after
D-PPPD removes this important potential stimulus for turnout rcgrowth in patients
rcscctcd for cancer.FP047 PMICRETOGASFROSTOI FOLLOIIIIIG
SAFE
.IP AxJu, C C, C George., J
C.H.U. RS I.paCmect oil IIeJtct SwgeJUt
4, uxe Lct.teg 49033 ANCRS CEDEX 01 FRANCE
The propensity for leakage and disruption at the site of the pan-
creaticojejunostomy is a major reason for morbidity and death after
pancreaticoduodenal resection. The purpose of this study wa to
evauate the roe of pancreaticogastrostomy as an aternative
method of restoring pancreaticointestina continuity after pancrea-
ticoduodenectomy.
From January 1989 to December 1992, 32 patients have undergone
pancreaticogastrostomy after pancreaticoduodenectomy at our insti-
tution. Tenty two patients were men, and ten women. The mean age
as 60.5 years range 42-74 years Pancreaticoduodenectomy was
performed for pancreatic carcinoma (16 patients) ampuary carci-
noma 110 patients), duodena carcinoma (2 patients) and chronic
pancreatits (4 patient
There was one postoperative death, for an overa operative morta-
lity rate of 3%. There was one pancreatic fistula 13%) which reco-
vered ith further surgery. The average postoperative stay in the
hospita was 14 days.
These results agree with data concerning pancreaticogastrostomy
published in iterature 11). Trypsin neutraisation by gastric
acidity may explain the very gow incidence of pancreatic fistuga
reported. In ong term foow-up externa pancreatic insufficiency
does not seem to occur. Radioogic and endoscopic examination of
the pancreatic duct is easy. This method of reconstruction merits
widespread utiisation due to tis simplicity and safety.
(1] DELCORE R. AND AL Pancreatogastrostomy, a safe drainage
procedure after pancreatoduodenectomy.
Surgery 1990, 108 641-647
47FP048 THE PROBLEM OF DELAYED GASTRIC EMPTYING IN
THE EARLY POSTOPERATIVE PERIOD AFTER PYLORU$
PRESERVING PANCREATODUODENECTOMY (PPPD).
Possible role of gastric motor dysfunction.
W.A.J.J.M. Haagh, L.M.A. Akkermans, H. Obertop.
Depts. of Surgery, University Hospital Utrecht,
Utrecht, The Netherlands.
Delayed gastric emptying (DGE) has been reported as a frequent complication of PPPD,
with an incidence of about 30 %. The cause of this phenomenon is probably multifactorial.
We studied gastric myoelelectric activity, gastrointestinal symptoms and gastric emptying
in the preoperative and early postoperative course in pancreatic and periampullary (PP)
cancer patients to elucidate the possible role of gastric motor dysfuntion in the etiology of
DGE in these patients.
G&,tric emptying (GE) of a nutrient-rich liquid meal was studied in 22 preoperative PP
cancer patients with no duodenal obstruction as evidenced by endoscopy or radiography
(13 ’, 9 ; mean age 61 + 14 yrs) using Applied Potential Tomography, a technique
measuring changes in resistivity in a thick cross-section through the abdomen at the level
of the stomach. Myoelectric activity was measured concurrently by surface
electrogastrography (EGG) during hour fasting and 1/ hours postprandially and
analyzed by computerized power spectrum analysis. Thirteen of these patients were also
studied within the first 2 weeks following PPPD. Also symptoms of nausea, vomiting,
regurgitation, early satiety and fullness were scored on a scale from 0 to 3 both
preoperatively and postoperatively. The same measurements were done in 25 sex and age-
matched healthy controls. Delayed gastric emptying was defined as t/ > 180 rain, being
the mean + 2 SD of the t/ in these normal subjects.
Gastric emptying was delayed in 7 preoperative PP cancer patients (32 %). There was a
significant negative correlation between g&tric emptying and pre-and postprandial mean
gastric frequency in these patients. DGE occured in five of 13 postoperative patients after
PPPD (38 %). The postprandial: fasting power ratio in the postoperative patients was
significantly decreased compared to preoperative patients and controls (resp. 1.97; 4.92;
7.60, p < 0.05), indicating a decrease in gastric motor activity in these patients. Three
of the postoperative patients with DGE also presented with DGE in the early postoperative
period (60%). Also there was a clear association between postoperative DGE and the
occurence of surgical (intraabdominal) complications. Gastric dysrhythmias were not
observed in the pre -and postoperative period. No significant correlation could be
demonstrated between DGE and symptoms.
Conclusions: 1) Preoperative DGE occurs rather frequently in PP cancer patients, which
probably involves disease-related effects. 2) Gastric motor dysfunction, which may be pre-
existent, can play a (minor) role in the occurence of DGE in the early postoperative
period.
48FP049 SURGICAL SPLANCHNICECTOMY IN
PALLIATIVE TREATMENT OF PANCREATIC
CANCER
G. MANGIANTE, C. IACONO, G. PRATI,F. NIFOSI’,
A. ISCHIA* ,A.MOMBELLO **,N. CRACCO e G. SERIO
ISTITUTO DI PATOLOGIA CHIRURGICA
*3th RIANIMAZIONE OSPEDALE CIVILE
**ISTITUTO DI ANATOMIA PATOLOGICA
UNIVERSITY OF VERONA (ITALY
In the treatment of pain from pancreati neoplasms (NPP) dsouragng results have been
achieved by surgical splanchncectomy.Nevertheless, these techniques complete a palliative
surgical strategy of unresectable pancreatic ancer. The first step to ahleve a
satisfactory and long lasting relief of RPP s the correct anatomical identlfcatlon of
semilunar gangllons (SG) and splanchnc nerves(SN}. In ths lght we tried to estimate the
exact locatlon,the number,the shape,and the lenght of SN and SG n 15 corpes (mean age 39,9
years- range 21-74,F/MffiS/10 ). We also discuss which surgical approach to splanchnlcectomy
should be preferred in the presence of tumors located on the head ,or body and tall of the
pancreas.
The man results are:
Right and left NS always pierce the diaphragm laterally the crus.On the rght side SN
always enter the abdomen posterior to Inferior vena cava(IVC) .On the left side SN perce the
daphgram strictly thickened to the left edge of the aorta(A) in the 66,6 % of the
cases,close to the left edge in 26.6 %,and close to the right edge of left adrenal gland n
6.8 %. SN slide almost horzontally on the diaphragmatic bundles toward, and reach an area
delimited by celac trunk(CT) and superior mesenterc artery(SMA)o The lenght of the right
SN Is 4.1 cm of mean(range 2 to 5.4 cm):the thickness s between 4 and 6 . The left SN s
shorter (mean 2.4 cm- range 1.5-3 cm ).Right SG vary from 1 to 6 ganglonar bodies wth
various szes from 5 to 3 cm; left SG vary from 1 to 4 sizes between 4 to 2.6 }. On
the left both SN and SG are completely covered by superior edge of the head and body of the
pancreas and on the left side their detection s rendered easy after splenopancreatIc
moblllzatlon. The shape of the ganglions is varies from a thlck streak Intermlngled wlth
swellings and slngle masses, rosary beads-llke. The gangllons are always firm, pearl-
coloured, easily separated from lnfolandular nodes. The postganglonar fibers spread from
GS, lke a shower, n the pancreas, and surround. In the chest, right and left SN get
contributions of fibers from the sxth to the tenth thoracic ganglla.These fbers become a
sngle bundle at a distance of 3.6 cm from the dlaphragm,always strictly thickened to the
prevertebral fascla.From May, 1990 to June, 1992 we submitted 20 pts with unresectable
pancreatic cancer to billary-enterlc by- pass plus blateral splanchnicetomy. All the pts
had complalned severe upper abdominal paln.Postoperatve ortalty was nil at 1-month
postoperative follow-up 95 % of pts achieved complete pan rellef.
Mean survival tSme was 7.9 months, and mean pan-free Interval was 5.7 months.Pan
recurrence was manaued bY Dercutaneous cervical cordotony (1),cordotomy+narcotlc drugs(5),
and narcotic drugs only( 12 .Two pts ded of progression of pancreatic ancer being rendered
completely pan free. Two patient are alive without pan recurrence after 6 and 8 months
respectively from the operation.
Palliative surgical procedure offers considerable benefit for the patients with unresetable
pancretlc cancer. Taking into account the above mentioned results we beleve that neoplasms
of pancreatic head are the most suitable conditions to perform a surgical splanchnlcectomy by
the right side through the hepatoduodenal legamentum,wlth a complete moblzatlon of IVC,
whereas the retroduodenal-pancreatc approach seems to be more dlffcult. On the left the
approach s particularly complex. The approach trough the , .or edge of the pancreas,
suitable for pancreatc body or tal neoplasms, s complicated by the presence of the
tumoral mass, as reported in our surgical seres. In presence of left neoplasms the
transhatale approach by Dubos s more sutable,n spte of ts complexity.
Recurrence of pan was treated by comblnaton therapy, such as percutaneous cervical
cordotomy and/or narcotic drugs.
49FP050 ADJUVANT RADIO-CHEMOTHERAPY FOLLOWING
RESECTION OF PANCREATIC ADENOCARCINOMA:
EARLY RESULTS OF A PROSPECTIVE STUDY
W Kmiot: on behalf of the UK
Pancreatic Cancer Trials Group
Dept of Surgery, Dudley Road Hospital
Birmingham, B18 7QU, UK
Resection for pancreatic cancer is associated with a 5
year actuarial rate (YASR) of 5-15%. Adjuvant therapy
may be useful but there has only been one study
published. The North American Gastrointestinal Tumour
Study Group (GITSG) phase III study reported an
improvement following post-operative radiotherapy and
5-FU i.v. weekly in 20 patients with pancreatic cancer
(43% 2 YASR vs 18% in control arm).
In order to ascertain the value of the GITSG protocol,
this was repeated by members of the UK Pancreatic
Cancer Trials Group. 27 patients with adenocarcinoma
of the pancreas (N=23) or periampullary adenocarcinoma
(N=4; one with resected solitary liver metastasis)
have so far been recruited. There were 16 men and 11
women with a mean age of 59.4 (range 40-76) years. A
standard Kausch-Whipples operation was performed in 11
patients, 13 had a pylorus-preserving head resection,
2 had a total and 1 had a distal pancreatectomy.
Lymph node metastases were present in 17 cases; the
histological grade was 1=8, 2=11 and 3=8. The
radiotherapy was well tolerated with only one related
complication There was no significant drug
toxicity. t a median follow-up of 12 (range 3-36)
months the 2 YASR was 30%; 14 patients were dead, 12
alive and 1 lost to follow-up.
These results indicate that post-operative radio-
chemotherapy is well tolerated. The 2 YASR was
intermediate between the treated and control arms of
the GITSG study. A larger phase III trial may
be necessary to establlsh the efficacy of the GITSG
protocol, unless improved survival data are obtained
with further follow-up.
5oFP051 REQUIREMENT OFGAMMA LINOLENIC ACID IN
HGFAND TGF[ INDUCED INHIBITION
OFHEPATOMA CELL GROWTH
WG Jiang and MCA Puntis
Department ofSurgery, University ofWales
College of Medicine, Cardiff, UK
Gamma linolenie acid (GLA) is a eytotoxie agent for certain cancer cells. We
have investigated the effects of GLA and its lithium salt (LiGLA) on hepatoma
cell growth as regulated by hepatoeyte growth factor (HGF) and transforming
growth factor beta (TGFI3).
The human hepatoma cell line, PLC/PRF/5, was cultured with or without
eytokines, in the presence or absence of fatty acid (GLA and water soluble
lithium salt GLA-LiGLA). The cell growth was quantified by a colodmetrie
method and shown as percentage growth compared with cytokine and FA free
control. Statistics is Student T test and significant level was taken at p<0.05 (*).
culture medium HGF(4ng/ml)
Control 100% 96.7+1.7%
With GLA 86.5+2.8%* 74.3_+3.1%*
With LiGLA 87.9+2.7%* 77.2_+3.2%*
TGFI(5RU/ml)
85.2_+2.1%*
45.4+_1.9%*
70.0_+1.2%*
Both HGF and TGFI3 showed a concentration dependent inhibition of hepatoma
cell growth and this is significantly enhanced by the presence of GLA and
LiGLA. Lipid peroxidati0n account for part of the FA effects (tocopherol causes
partial block of the effect). Other enzyme inhibitors (indomethacin and
Nordihydroguaiaretic acid) have no effects. The morphological changes of the
cells indicate that both necrosis and apoptosis are involved.
It is concluded that HGF and TGFI3 are both hepatoma growth inhibitors and
GLA can enhance this effects, which may have clinical benefits.
51FP052 HUMAN KUPFFER CELLS ARE CYTOTOXIC
AGAINST COLON TUMOR CELLS.
G Heuff, B Schuurman, R Beelen=, S Meyer.
Dept. of Surgery, = Dept. of Cell Biology,
University Hospital and Faculty of Medicine,
Free University, Amsterdam, the Netherlands.
Experimental animal models have demonstrated that Kupffer cells (KC)
play an important role. in controlling the growth of liver metastases. It has
been speculated that human KC are also cytotoxic against tumor cells. By
understanding the cytotoxic mechanisms of human KC, strategies to
stimulate human KC can be outlined to prevent or eradicate hepatic
metastases. However, so far no method has been available to isolate fresh
human KC from liver biopsy material in large quantities to study supposed
tumoricidal capacities of these cells.
This study describes a new procedure for isolation of KC from liver wedge
biopsies (3-5g) without time consuming perfusion techniques. Liver tissue
homogenate was incubated with pronase/DNAse for 45 min with conti-
nous pH registration and neutralization. The cell suspension was freed
from erythrocytes, lymphocytes and cell debris by a nycodenz gradient
and KC were finally enriched by counterflow centrifugal elutriation. Purity
of KC was determined with the macrophage specific monoclonal an-
tibodies CD68. Cell-mediated cytotoxicity of KC, with or without activa-
tion of gamma-interferon (IFN) was measured by an in vitro MTT-
colorimetric assay against SW948 cells (a human colon tumor cell line).
From liver wedge biopsies 2x10 KC per gram were harvested with a
purity of > 95%. Maximum spontaneously cytotoxicity of non-activated
KC was 50% at an effector to target ratio of 10. After activation of KC
with IFN, cytotoxicity against the tumor cells increased to 85% (E/T 10).
In conclusion, this new method of KC isolation is a useful and simple
method to isolate fresh human KC from liver wedge biopsies without
perfusion. Moreover, it enables us to study antitumor capacities of these
cells. KC were spontaneously cytotoxic against a colon carcinoma cell
line. Furthermore, cell mediated cytotoxicity of KC increased after activa-
tion with IFN.
52FP053 REGRESSION OF AN ESTABLISHED MACROSCOPIC
LIVER TUMOUR BY IN VIVO RETROVIRAL-MEDIATED
TRANSFER OF A SUICIDE GENE
Y Panis, M Caruso, D Houssin, JL Salzmann,
D Kl atzmann
Laboratoire de Recherche Chirurgicale, Facult
de Mdecine Cochin-Port-Royal and CNRS URA
]463, H6pita| La Piti, Paris, France
Aim of the work we investigated whether the direct intratumoral
transduction Of a suicide gene might induce the elimination of an
established liver tumour. To specifically target the delivery and
expression of the suicide gene into dividing cells, we used
retroviral-mediated gene transfer and the herpes simplex virus
type ] thymidine kinase conditional toxin (HSV|-TK). Non toxic
nuc|eoside analogs such as ganciclovir are metabolized by HSVI-TK
i nto compounds that are toxic for dividing cel | s.
Animals and methods In 25 BDIX rats, a single liver tumour was
induCed by injecti6n of DHDKI2 colon cancer cells under the liver
capsule. At Day 5, tumour diameter ranged between 2 and 3 mm
rats underwent an intratumoral injection of cells producing either
HSVI-TK (treated group ; n=13) or (a nucleargalactosidase
encoding marker gene) nls-lacZ (control group n=12) expressing
recombinant retroviral particles. At Day lO, all the rats were
given ganciclovir (150/mg/kg twice daily for 5 days). Autopsy was
performed at Day 15.
Results a dramatic reduction in tumour volume was noted in the
rated compared to the control group 8.1 +_ 6.7 and 86.3 + 65.1
mm, respectively, p KO.O00|). In the treated animals, the esidual
tumours were mostly made up of a massive fibrotic reaction with
few or even no remaining tumoural cells.
Conclusion Our study shows the regression of an established
i-iver tuhiour after in vivo transfer of a suicide gene. This
efficient therapeutical approach might be an ultimate treatment
for disseminated liver metastases in humans, and could also be
applied to the treatment of a large variety of solid tumours.
53FP054 HEPATOMA CELLGROWTH STIMULATED
BY INTERLEUKIN-3
WG Jiang and MCA Puntis
Department ofSurgery, University ofWales
College of Medicine, Cardiff, UK
Interleukin-3 (IL3) is a haematopoietic growth factor and has been used
following radical chemotherapy for solid turnouts However there is a growing
concern as to its possible stimulation of the malignant cells. We have
investigated the effects of IL-3 on hepatoma cell growth.
A human hepatoma cell line, PLC/PRF/5, was used. Cells were cultured with
recombinant human IL-3 at a wide rangeof concentration for up to 7 days and
the cell growth is shown as mean (+SEM) percentage growth compared with
control (culture medium only). Statistics is Student t test.
IL3(0.5ng/ml) IL3(lng/ml) IL3(5ng/ml) IL3(lOng/ml)
growth 103.5+1.6% 106.4+1.5% 114.0+2.1% 119.25:4.9%
p value =0.12 --0.01 =0.001 =0.01
IL-3 showed a significant concentration dependent stimulation of the cell
growth and the stimulation was observed from day 2 to day 7. To determine the
possible relationship between IL-3 and other cytokines on cell growth, a variety
of other cytokines were tested. The stimulatory effect of IL-3 was significantly
enhanced by IL-4, IL-6, and IL-10, but was completely reversed by IL-8 and
TGFII. There was no significant effect on IL-3 induced cell growth by IL-1,
IL-2, IL-5, IL-7, and TNFa.
It is concluded that IL-3 is a hepatoma cell (PLC/PRF/5) growth up-regulator
and therefore an important factor in controlling hepatoma growth.
54FP055 HEPATIC IMMUNE FUNCTION IN THE
RESISTANCE TO BACTERIAL TRANSLOCATION
INDUCED BY INTRAPERITONEAL
IMPLANTATION OF BIOMATERIALS
W Guo, R Andersson, XD Wang, S Bengmark
Department of Surgery, Lund University, Lund, sweden
Introduction;.
The liver constitutes the majority of reticuloendothelial system (RES) function,
providing a barrier to the passage of intestinal bacteria and toxins to the
systemic circulation. Intraperitoneal biomatedal promotes bacterial translocati0n
from the gastrointestinal tract. However, the role of hepatic immune function
against bacterial translocation is not defined. The purpose of the study was to
investigate the role of hepatic function in the resistance against bacterial
translocation after intrapedtone biomatedal implantation.
Meth0ds;
Rubber drains, knitted dacron and silicone elastomer with areas of 3 and l0
em2, respectively, were implanted into the right-lower part of the abdominal
cavity of Sprague-Dawley rats under aseptic condition. Hepatic retieulo-
endothelial function, epresse as the phagocytic index (k) and hepatic uptake
of 125I-labelled E. oli was measured 1 day after implantation.
Results:
A significant elevation of the phagocytic index (k) was noted in groups with
intrapedtoneal implantation as compared with sham operation. The hepatic
uptake of 25I-labelled E. coli significantly increased after intraperitoneal
implantation, of different biomatedals. Translocation of bacteria from the
gastrointestinal tract was also observed. The increase in phagocytic
index/hepatic uptake of 2SI-labelled E. coli and the incidence of bacterial
translocation depended on the size of the biomatedal implanted. An inverse
correlation existed between the hepatic uptake of 2SI-labelled bacteria and the
incidence of bacterial translocation to the liver.
Conclusion:
Hepatic RF function increased after intrapefitone implantation of
biomatefials, reflecting a enhanced phagocytic function of Kupffer cells. It
appears that the liver is an important part of host defense in preventing bacterial
translocation induced by intraperitoneal implantation of biomaterials.
55FP056 REDUCED SPLANCHNIC BLOOD FLOW FOLLOWING
SURGERY IN OBSTRUCTIVE JAUNDICE
IS PREVENTED BY ENTERAL CHOLESTYRAMINE.
A Houdijk, P van Leeuwen, M Boermeester and R Wesdorp.
Department of Surgery, Free University Hospital,
Amsterdam, The Netherlands.
Surgery in patients with obstructive jaundice causes deleterious hemodynamic distur-
bances, possibly related to gut derived endotoxemia.
This study evaluates the effects of preoperative binding of gut endotoxin by cholestyra-
mine on hemodynamics with special reference to splanchnic blood flow.
Male Wistar rats (n=20 per group, weight 250-300 g.) received the endotoxin binder
cholestyramine (CHOL,150 mg/day) or normal saline (SAL) twice daily in the same volume.
This treatment started on Day 1 and was continued until the end of the experiment. On
Day 7 groups were randomized to receive a SHAM operation (SH) or bile duct ligation
(BDL). This resulted in 4 groups (n 10 each) i.e. SH-SAL, SH-CHOL, BDL-SAL and BDL-
CHOL. Subsequently rats were subjected to a surgical trauma by performing a xyphoi-
dectomy on Day 20 and splanchnic organ blood flows were measured the following day
using the radiolabeled microsphere technique.
A portion of the splanchnic organ blood flows is shown and expressed in mlmin"1 (mean +/-
SEM). Portal blood flow was computed by the sum of the flow to the individual splanchnic
organs.
Groups 8HAM In 20) BDL-SAL In 10) BDL-CHOL In 101
Portal venous flow 16.32 * 1.081 13.13 + 1.12e 15.95 + 0.61
Stomach 0.92 + 0.202 1.63 + 0.19 1.80 + 0.1811
Spleen 1.63 + 0.20 1.61 + 0.167 2.10 + 0.12TM
Pancreas 0.81 + 0.143 0.50 + O.09e 0.90 + 0.09
Small Intestine 11.02 + 0.904 7.73 + 0.42e 8.72 + 0.401
Colon 2.20 + 0.146 1.83 + O.131 2.36 + O.15
SHAM vs. BDL-SAL; p<O.05, 2 p<O.05, 3 p<0.05, 4 p<0.01, 5 p<O.05. BDL-SAL vs.
BOL-CHOL; 6 p<O.05, 7 p<O.05, 8 p<O.O01, 9 p<O.05, 10 p<O.05. BOL-CHOL vs. SHAM;
11 p<O.05, 12 p<O.05, 13 p<O.05. Students T-test using Bonferroni correction.
Surgery in saline treated BDL rats resulted in a significant decrease in portal venous blood
flow. This was due to a decrease in flow to the pancreas, small intestine and colon.
Stomach flow was increased. Cholestyramine pretreatment prevented the decrease in
portal venous flow by increasing blood flow through spleen, pancreas, small intestine and
colon.
It is concluded that preoperative treatment with the endotoxin binder cholestyramine
prevents the fall in splanchnic blood flow following surgery in the bile duct ,gated rat.
Endotoxin is important in the development of postoperative complications in the bile duct
,gated rat and the reduced splanchnic blood flow might enhance translocation of gut
derived endotoxin.
56FP057 THE EFFECT OF PORTAL BRANCH LIGATION
IN COMBINATION WITH OR WITHOUT
DEARTERIALIZATION ON AN EXPERIMENTAL
LIVER TUMOUR
B G Persson, L Q Wang, S Bengmark
Department of Surge_r),, Lund University,
Lund, Sweden
Portal blood supply may play some role in ischemic treatment of
experimental liver tumours. However, normal liver parenchyma can not
tolerate 60 min of repeated total devascularizations (occlusion of artery and
portal vein). In this experiment portal deviation (portocaval shunt) was
replaced with ligation of the portal branch supporting the tumour-beafing
lobe. Twenty seven rats were subjected to sham-treatment (n=6); portal
branch ligation (PBL) (n =7); 120 min of repeat dearterializations (n=7) and
portal branch ligation (PBL) combined with 50 min of repeat
dearterializations (n=7). The results showed that portal branch ligation alone
did not alter the tumour growth compared with sham-treatment (p> 0.05).
However, 120 min of repeat dearterializations effectively decreased tumour
growth (p<0.05 vs all the other groups). There was no growth delay
following portal branch ligation in combination with 50 min of repeat
dearterializations (p> 0.05). Significant atrophy of the corresponding lobe
followed PBL regardless if it was combined with repeat dearterializations or
not (p< 0.001). Aminotransferases remained normal after PBL with repeat
dearterializations for 50 min (p> 0.05).
In conclusion, portal branch ligation did not retard tumour growth by its
own, nor did it increase the antitumour effect following repeat
dearterializations for 50 min. This study further confirmed that repeat
dearterializations for 120 rain alone is to delay tumour growth. It might have
implications in clinical use of repeat dearterializations for the treatment of
liver tumours.
57FP058 PHOSPHOLIPID DEPLETION OF LIVER
TUMOURS AFTER A SINGLE OR REPEAT
DEARTERIALIZATIONS
LQ Wang, BG Persson, N Xu*, S Bengmark
* Department of Surgery and Internal Medicine ,Lund
University, Lund, Sweden
Depletion of Phospholipids in ischemic cells is a causal event in ischemic
injury. Deacterialization of hepatic tumours might induce phospholipid
degradation in tumour cells as well. Phophatidylserine (PS) and
phosphatidylinosital (PI) significantly decreased in tumours undergoing a
single dearterialization for 2 hours compared with sham-treatment (p< 0.01).
Phosphatidylcholine (PC) also decreased but without a significant difference
compared with control (p> 0.05). The ratio of tumour/liver phospholipids
was significantly reduced compared with control (p< 0.01) after a single
dearterialization. Thus, dearterialization induced a fast degradation of
tumour phospholipids without affecting the normal liver.
Repeat dearterializations for 2 hours during 5 days further reduced total
tumour phospholipid. PC and PE were more significantly affected by repeat
deartedalizations (p < 0.01 and p< 0.05 vs control respectively). The ratio
PC/LPC (lysophosphatidycholine) dropped remarkably (p< 0.01 versus
control) indicating relative accumulation of LPC.
The decrease of phospholipid was consistent with the growth delay of tumour
undergoing repeat dearterializations. Phospholipid degradation was paralleled
by a delay in tumour growth that was significantly retarded by repeat
dearterializations (p< 0.01 vs control). Further, ASAT and ALAT remained
normal even after repeat dearterializations for 5 days, which suggested that
repeat dearterializations was selectively delivered to tumour tissue sparing
normal liver cells. In conclusion, repeat dearterializations selectively induce
liver tumour ischemia and efficiently retarded tumour growth without any
visible damage to normal liver parenchyma.
58FP059 DECREASING PROBLEMS WITH INCREASING
EXPERIENCE. ANALYSIS OF 150 CASES OF
LAPAROSCOPIC CHOLECYSTECTOMY
V Pegan, M Sever
Department of Gastroenterologic Surgery,
University Medical Centre,Ljubljana,Slovenia
In the year 1992 we performed 151 laparoscopic cholecystectomies. After the
optimistic start certain problems arose, all resulting from a lack of experience.
Fortunately, all complications but one a hepatic duct injury were managed
without major harm to the patient. Among our patients there were 120 women
and 30 men, ranging in age from 13 to 82 years. The laparoscopic procedures
were performed by four surgeons, alternating in the roles of the operator, the
cameraman and the assistant. Conditions such as acute gallbladder infection and
large stones, formerly constituting a strict contraindication, lost their
significance with increasing number of cases. Among our first 50 patients there
were six cases of conversion; later on no conversions were necessary.
The preoperative assessment, including the patient’s history, laboratory
parameters and high-quality US scans, was considered adequate, offering
reasonable guarantee that no significant bile duct pathology would be
overlooked. Intraoperative laparoscopic cholangiography was performed
without problems in only four cases. The mean operative time was 65 minutes
and the mean hospital stay 3.5 days; the patients returned to work in seven to
ten days.
Conclusions: For the patient’s benefit, surgeons are sacrificing their three-
dimensional sight and tactile capabilities. A one-handed surgeon with only one
eye left would still be able to perform a laparoscopic operation. In the hands
of a skilled and experienced "laparosurgeon" the method is perfectly safe.
59FP060 BILE DUCT INJURY DURING LAPAROSCOPIC
CHOLECYSTECTOMY
H T Khawaja,
I S Benjamin
J A Rennie, E R Howa.rd,
Department of Surgery, King’s College
Hospital, London SE5 9RS, U.K.
Bile duct injury (BDI) during laparoscopic cholecystecto-
my (LC) appears to have a higher incidence than during
open cholecystectomy (OC). We report our experience with
12 patients treated in our institution for BDI sustained
during elective LC.
Three cases had been converted to OC due to technical
difficulties and suspicion of BDI which was confied in
two patients who underwent immediate hepaticojejunostomy
(HJ). BDI was not substantiated in the other patit, who
later developed a common hepatic duct stricture wch
required a HJ. The remaining 9 patients had no rerted
technical problems during LC but represented with BDI.
Three patients had generalised peritonitis due to bile
leak" of these was referred for definitive treaent
and had a HJ, but 2 initially underwent unsuccesful
repair over a T-tube and ultimately had HJ. Six pients
developed a common hepatic duct stricture (with a locali-
sed bile leak in 2). Five of these underwent successful
HJ" the sixth was referred with a complex hilar stricture
following an HJ and was treated by percutaneous dilata-
tion. The median time from LC to the definitive surgical
procedure was 18 weeks (range: 0 52). None of t
patients had operative cholangiography and most BDI were
not recognized immediately. The mechanisms of these
injuries were not always clear at reoperation.
The inherent risk of BDI may be greater in LC than in OC,
but this may be further increased by distortion of the
anatomy, excessive use of diathermy or inexperience. The
problem of training surgeons in laparoscopic procedures
persists and should be urgently addressed.
6OFP061 PREOPERATIVE PREDICTIVE FACTORS OF BILE
DUCT STONES IN PATIENTS UNDERGOING
CHOLECYSTECTOMY.
A Gainant, P Bothorel, M Minani, P
Cubertafond
Chirurgie A, C.H.R.U. Dupuytren,
Limoges, France.
Routine intraoperative cholangiography for detection of
common bile duct (CBD) stones in patients undergoing
laparoscopic cholecystectomy is discussed, and many
authors prefer selective cholangiography, performed
only in patients with high risk of CBD stone.
The aim of this study was preoperative
of patients with high risk of CBD stone.
identification
From october 1990 to december 1992, 192 patients with
symptomatic gallstones, without evidence of duct stone,
underwent open or laparoscopic cholecystectomy. In all
patients preoperative data included, clinical
examination, research of previous history of jaundice
or pancreatitis, liver biochemestry measurement,
biliary tract ultrasonographic examination. All
patients underwent operative cholangiography (O C).
147 patients had norma
found to have duct st
exploration by choledo
patients. There was
analysis of preopera
having or not CBD st
were significantly mot
stones. They were pa
of serum levels of to
alanine amino transfer
alkalin phosphatase
on sonography. Mul
four factors had i
predicting CBD s
phosphatases > ii0
bile duct diamete
history of
least one
was present
was i00 %
associated
1 cholangiogram. 45 patients were
one on O C. They underwent CBD
cotomy Stones were found in 43
two false positive. Univar iate
tive findings between patients
ones showed that nine variables
e frequent in patients with CBD
st history of jaundice, elevation
tal bilirubin, direct bilirubin,
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61FP062 CHOLESTEROL STONE RBCURRENCE IN THE CYSTIC
REMNANT AFTBR LAPAROSCOPICCHOLECYSTEMY
F Cetta, F Lombardo,M Giubbolini, A Cappelli,A Pecchi,
*A Cariati,
Inst. of Surgical Clinics and *Anestesiology, University of
Siena and Inst. of Surgical Clinics, *University of Genoa, Italy
In a previous study(), we have shown that: (i) cholesterol stones can recur after
postcholecystectomy stones; (ii) in patients with associated jaundice and
pancreatitis, the removal of cholecystectomy and initially form in a long cystic
remnant (LCR) (11 of 63 patients with the LCR determined the complete and
persistent relief of symptomskOn the other hand: (i) the LCR itself rarely causes
symptoms. Therefore, the excision of a LCR without associated stones will not
eliminate postcholecystectomy symptoms in the great majority of patients; and
(ii) the exact percentage of patients with LCR who are going to develop non
brown gallstones many years after cholecystectomy is unpredictable, even if it is
not negligible. Concerning stone recurrence, LCR can be defined as "a cavity
lateral to the common duct, lined by gallbladder mucosa, acting as a mini-
gallbladder, regardless of its length, ranging in our series from 0.8 to 4.5 cm".
After the wide diffusion of laparoscopic cholecystectomy, which deliberately
leaves a long cystic stump, it is presumed that also the number of
postcholecystectomy stones related to LCR is going to increase, in the long term
period. Since these stones are mostly cholesterol, possible prophylaxis using bile
acid therapy could be indicated in selected cases. Therefore, a double blind trial
with bile acid therapy was undertaken. Twelve patients with a cystic stmnp longer
than 15 mm after laparoscopic cholecystectomy were enrolled. Patients with a
presumed residual LCR were selected among those showing a particularly long
and tortuous cystic duct at cholangiography. In particular, in 2 patients the cystic
duct had a very low confluence, close to the ampulla of Vater. One of the last 2
patients plus 5 of the remaining 10 with LCR were treated by
tauroursodeoxycholic acid (7 mg/Kg/die) to prevent cholesterol stone
reformation. The remaining 6 patients didn’t receive any treatment and were used
as control. Ultrasound examination was scheduled every year and
cholangiography every 3 years. At the moment, after a 6-month-follow-up, no
patients in either group developed symptoms or gallstones.
1) Cetta F et al Gastroenterology: 1992; 102: A306.
62FP063 MANAGEMENT OF COMMON BILE DUCT STONES IN THE
ERA OF LAPAROSCOPIC CHOLECYSTECTOMY
G W W Gross, P Schauer, K R Sirinek
Departments of Medicine and Surgery, Audie L.
Murphy Memorial VA Hospital & The University
of TX Health Science Center, San Antonio, TX
Since the recent advent of laparoscopic cholecystectomy (LC),
many have advocated a laparoscopic rather than an endoscopic
(ERCP) approach to common bile duct stones (CBDS). This study
reviewed the use of pre/postoop ERCP to manage CBDS during our
initial experience with LC. Over an 18-month period, 450
patients underwent LC. Pre-LC ERCP was done if CBDS were
suspected due to biochemical or sonographic findings, and intrao
operative cholangiogram (IOC) was also obtained at LC in selected
patients. Failure to achieve a cholangiogram or clear CBDS at
ERCP usually resulted in open cholecystectomy (OC). 105 patients
initially intended for LC (of whom 87 timately underwent LC)
received pre-op ERCP; cholangiography was successful in 92,
revealing CBDS in 35, with extraction achieved in 29 and
endoscopic sphincterotomy (ES) performed in 34. IOC revealed
CBDS in 2 patients with "clear" CBD at prior ERCP. During this
period, ii patients underwent postoLC ERCP due to suspicion of
bile leak or retained CBDS (Table)"
TABLE" Post-LC ERCP Abnormalities in ii patients
Findings # Cases
Bile duct leak only I
Bile duct stricture only I
Stricture + leak 3
Retained CBD stones 2
Endoscopic Management
Stent placement
Dilatation/Stent
ES all;stent 2/3
ES/extraction
(The unstentable stricture required hepaticojejunostomy)
Conclusion: Fmploying our approach to CBDS, 4 patients (0.9%)
suffered significant bile duct injurie ,.strictures), vs. an
established 0.2-0.3% rate with simple OC. Since both open CBDE
and LC are known to increase the rate of bile duct injury, we
anticipated that laparoscopic CBDE/CBDS extraction would only
further increase this risk. Therefore, we contend that, at the
present level of technologic capability, widespread application
of laparoscopic CBDS management is inadvisable and that ERCP
should be the J’avored approach to this problem.
63FP064 C0 At 0  0.  IN
PATID TS AFTER LAPAIt0SCOPIC
CHOLECYST CTOMY
M.lrawczyk, W. Patkowski, I. Zieniewicz,
B. Najnige, P. Nyckowski, M. Frqczek
Dept. o! General Surgery & Liver Diseases,
Medical Aademy of Warsaw, Poland
The aim o! the study was to compare the lung function in
two groups of patients after laparoscopic [ LCh ] and open
cholecystectomy [ OCh .
From June 1991 to November 1992, 225 LCh and 250 OCh were
performed. Two groups o! 80 patients each, age and sex mat-
ched, were analyzed restrospectively, without randomization.
The respiratory system sufticiency was evaluated with spiro-
merry preoperatively and on lst,Tth and 14th day postoperati-
vely. The following parameters were analyzed volumetric
VC [ vital capacity ], functional FVC [ vital capacity during
forced full expiration ], FEV [ iored expiratory volume in
I sec. PEF peak expiratory flow rate ], PIF peak inspira-
tory flow rate ], FEV [ FEV1/VC ], MEF { mean expiratory
flow 25 ], MEF 50 [ mean expiratory flow 50 ].
Results All oi functional tests on the 1st postoperative day
were diminished- 12 16 in LCh group and 38 46 in
OCh group. Spirometric values on 7th postoperative day were
normal in LCh group, when in OCh patients were diminished
about 20 . In later group, normalization of the functional test
took place after 14 days. In LCh group neither atelectasis nor
pneumonia were observed postoperatively, however they
occured in 10 of OCh patients.
We conclude, that laparoscopi. cholecystectomy is the opera-
tion much less affecting the lung function, when compare to
open cholecystectomy.FP065 THE ACUTE PHASE RESPONSE AFTER LAPAROSCOPIC CHO-
LECYSTECTOMY AND AFTER OPEN CHOLECYSTECTOMY
L.Dominioni,S.Cuffari, G.Giudice, G.Carcano,
L.Nicora, R.Dionigi.
Department of Surgery, University of Pavia-Vare-
se,Ospedali Multizonale e "Del Ponte"Varese, ,Italy
The aim of this work was to assess the acute-phase alterations of blood
lymphocyte subsets, plasma proteins and selected hormones in patients
undergoing laparoscopic cholecystectomy (LC) and open cholecystectomy (OC),
to compare the effects of surgical trauma resulting from the two different
procedures.
METHODS. Fifty-seven well nourished patients candidates to cholecystectomy
for uncomplicated cholelithiasis, without indication to common bile duct
exploration, were prospectively randomized into two groups undergoing either LC
(n=30) or OC (n=27), using the same type of general anesthesia. In each patient
blood samples were drawn preoperatively and at various time intervals after
surgery, to determine the concentration of lymphocyte subsets CD3, CD4, CD8,
OKDR and the plasma levels ofC-reactive protein (CRP), cortisol and prolactin.
RESULTS. The duration ofoperation and ofgeneral anesthesiawas similar in the
two patient groups. The postoperative hospital stay was shorter after LC than after
OC (3.1(0.5) vs. 7.1(1.6) days; P<0.001). After OC a significantly greater
(P<0.05) depression ofblood CD3 and OKDR counts was found, as compared to
LC. Moreover, OC patients showed a significantly greater postoperative acute
phase increase of plasma CRP (P<0.001), of cortisol (P<0.05) and of prolactin
blood levels (P<0.001).
CONCLUSIONS. The significantly lower acute phase responses ofimmunologic
and metabolic parameters observed after LC support the concept that the
laparoscopic procedure is less traumatic.
65FP066 Prospective hemodynamic study during per-coelioscopic
cholecystectomy in 15 patients ASA III and ASA IV
D.Pezet 1, C.Ferric,r 2, K.Slim 1, F.luiz 2, V.Tubel’ 2,
L.Fourgeaud =, P.Schoeffler =, J.Chipponi ’.
1)Service de Chirurgie and 2)Dept. d’Anest, et Rea. BP 69
63003 Clermont Fd France
The postoperative benefits of percoelioscopic cholecystectomy (PCC) push the clinician
to utilize this procedure for patients with bad general state of health .The ai.rn o.f this
study was to evaluate the hemodynamic consequences of PCC in patients(pts) staged III
or IV for the American Society of Anesthesiology (ASA).
Fifteen pts mean age 70,5 +/- 10,3 years (41-87) were Included in this study. Mean
weight of 14ptswas 62,45 +/- 5,66 kg, I pt was obese (180 kg). All patients have billary
symptoms. Three pts were staged ASA IV and 11 staged III. This staging was due to
cardiovascular or pulmonary failure for 14 pts and for morbid obesity for 1 pt. During the
procedure radial artery catheterisation provided the arterial pressure values (systolic,
diastolic, mean) and blood samples for blood .gases and pH measurement. Continuous
capnography was made. Cardiac output, pulmonary artery_ and wedge pressure were
provided by a Swan Ganz catheter witch also permitted the determination of systemic and
pulmonary vascular resistances. In all pts anesthesia was Induced using etomidate
(0,3mg/k.g) and fentanyl (7 microg./Kg) Atracurium (0,3 .mg/kg) provided
myoresolution. Maintenance of anesthesia was realized with fentanyl,atracurium and 1,5
isoflurane in a mixture of nitrous oxyde and oxygen (FIO2:0,5).This protocol was
accepted by the ethical board .The pneumoperitoneum pressure was always inferior to 12
mm of Hg. In 8 cases there was a cholecystitis, in 6 cases the gallblader was not
inflammatory and in 1 case there was an empyerna of the gallbladder. No conversion .in
laparotomy was necessary .The mean duration of PCC .was 76,3 +/- 24,4 mn (52- 150).
There was no morbidity or mortality with a mean hospital stay of 6,2+/- 3,5 days (4-12).
Among all Parameters registrated or calculated we analysed mean value of the 15 pts .of mean arterial pressure (MAP), cardiac index(CI) (Cardiac output / s.q.m.) and systemic
arterial resi.stances(S_AR) at time (T)I after inluction of anesthesla, T2after insuflat!on of
pneumoperltoneum, T3 immediatly after 15 proclitic position, T4 after 30 mn of 15
proclitic position and T5 after evacuation of pneumoperltoneum. Stastistical analysis was
made byBarlett test.
Results are summarised in Table
,,T1. T2 T3 T4 T5
MAPmmHg 88.6+_/-24,4 ; .97.6+./..-_!6,.2:92.2+/.31;7 _95.9+_/,22.5 ".95.9+/,14
CII/m 1.78+/.0.45 .....1.87+/.38 2.28+_/.83 _._2.23+/-0.68 .2.98+_/1.21
SARdvn.$/om:_3886+/-1633 3619+/,681. "_3442+/.1281 2994+/.307-" 2705+/-970
During the procedure the Mean arterial pressure remained stable. A decrease in systemic
arterial resistances was observed but not stastlstica_lly significant. The cardiac index was
increased, reaching a significant difference at T5 (p<0.003) In a few pts, poor
hemo_dynamic conditions requiered special hemo._dya,talc treatment during the. procedure Majoration of vasodilatation u.$1ng nicardiplne (3pts), nitroglycerine (2pts)
and inotropic support using dopamine (2pt$).
Percoelioscopic cholecystectomy is possible In ASA III and IV patients If the
hemodynamic parameters are monltered (and corrected) during the procedure
Vasodilatators (le isoflurane, nicardipine and/or nitroglycerine) havelarger indications to
maintain the cardiac index in these patients despite the adverse hemodynamtc effect of
pneumoperitoneum.FP067 TREATMENT OF HEPATOCELLULAR CARCINOMA
BY ARTERIAL CHEMOEMBOLIZATION
Marchiori L, Mansueto GC, Bortolasi L,
Dal Dosso I, Colombari R, Bellini A,
Nifosi F, Nicoli N.
PATOLOGIA CHIURGICA
POLICLINICO BORGO ROMA
37100 VERONA ITALIE
From 1989 to october 1992, 102 pts with
hepatocellular (HCC) carcinoma were treated by
chemoembolization (CHEM). Ninety-four pts had
concomitant chronic liver disease. HCC was
diagnosed by US, contrast enhanced CT, fine needle
biopsy and alpha-feto-protein level. Admission
criteria were as follow: tumor confined to the
liver with or without hilar nodal involvement,
Child class A or B, white blood count superior to
2.000 and platelets more than 75.000/mmc. All the
patients underwent angiographic chemoembolization
with Lipiodol and Mitomycin-C (42 pts) or DADH (60
pts). In 86 pts we performed transcatheter hepatic
arterial embolization (TAE) which was not possible
in 9 pts due to portal thrombosis and in 7 to
technical cause. In TAE group 73 pts were Child A
and 13 Child B. In 22 cases HCC was single nodular
whereas in 64 was multinodular. In 51 pts tumor was
superior to 5 cm in diameter (in multinodular HCC
only the larger lesion was taken into account). In
35 pts diameter exceeded 5 cm. In 50 pts CHEM plus
TAE was repeated. Seven pts died within one month
after treatment: two for myocardial infarction, two
for liver failure, two for digestive haemorrage and
one for necrotyzing pancreatitis. Excluding deaths
within one month, long-term survival rates were
investigated in relation to various prognostic
factors ( anti-cancer agent, number of nodes, tumor
size, Child and Okuda stage, repeated procedures)
using Kaplan-Meier method. In CHEM plus TAE group
survival rate at 12 months is 47% and 35% at 24
months after one procedure, while is 90% at 12
months and 54% at 24 months after repeated
procedure. CHEM plus TAE can be considered an
effective measure, but survival is conditioned by
the stage of cirrhosis and the tumor invasiveness
and size.
67FP06$ VALUE OF COI.OR DOPPLER SONOGRAPHY
IN DIAGNOSIS OF PRIMARY LIVER TUMORS
A Weim,nn, J Klemprlauer, H L.ang, P Lamesch,
B Ringe, R Pichlmayr
Klinik for Abdominal- und Transplantationschirurgie,
Medizinische Hochschule Hannover,Hannover,FRG
Introduction
Several controversial reports are dealing with the value of Color Doppler
sonography in the diagnosis of primary liver tumors according to the
vascularization pattern.
Patients and Methods
29 patients with various primary liver tumors were investigated preoperatively
using a pulsed Color Doppler sonography unit SSA 270A (Toshiba, Tokyo,
Japan). Final tumor diagnosis derived in all cases from histological
examination of the resection specimen or in case of irresectability (n=5) from
intraoperative biopsy.
Results
Tumor hypervascularization including pulsatile signals at the periphery, in the
centre of the tumor or both was observed in:
2 AFP negative of 4 cases with Hepatocellular caminoma (HCC), 4 of 4 with
Cholangiocellular caminoma, 3 of 8 with giant hemangioma, 7 of 7 with Focal
Nodular Hyperplasia, 3 of 4 with adenoma and furthermore in one
neumendocrine tumor. The tumor was hypovascular in 2 patients with HCC
one with status after chemoembolization and one with multiple intrahepatic
tumor recurrence on underlying posthepatitic cirrhosis after liver
transplantation 6 years before. Furthermore, the tumor was hypo- or even
avascular in 5 patients with hemangioma and in one with adenomatous
hyperplasia.
Conclusion
With regard to the vascularization pattern, yield of Color Doppler
sonography is low for differential diagnosis and prediction of tumor dignity.
However, valuable information about tumor extension can be obtained in
central tumor lesions close to hilar structures.
68FP069 ADJUVANT REGIONAL CHEMOTHERAPY WITH
CISPLATIN AND LIPIODOL AFTER RESECTION
OF HEPATOCELLULAR CARCINOMA.
G Borgonovo, N Bourokba, D Musset, S Maitre,
H Farah, C Vons, C Smadja, D Franco.
Service de Chirurgie et Service de Radiologie,
HOpital Antoine B6clre, Clamart, France.
Early recurrence is frequent after surgical resection of hepatocellular
carcinoma. The purpose of this work was to assess the value of
postoperative adjuvant regional chemotherapy. Cisplatin (2 mg/kg bw)
diluted in 10 ml of iodized oil (Lipiodol, Lab. Guerbet) was administered
after selective catheterization of the hepatic artery above gastro-
duodenal artery one month after resection and whenever possible 5 and
9 months postoperatively. Between April 1991 and December 1992, 24
patients had liver resection for treatment of a hepatocellular carcinoma.
Thirteen patients were excluded from the study for one of the following
reasons: residual cancer nodules after operation (4 patients), markedly
impaired liver function or ascites (5 patients), spontaneous or surgical
total portal diversion (2 patients), failure in selective catheterization of
hepatic artery (2 patients). Eleven patients received the treatment: 6
patients had three courses of chemotherapy, two patients had 2 courses
and three patients had one course. Side effects of the treatment were
minimal and the mean hospital stay was 3 days. Two patients had
prolonged epigastric pain due to gastritis. Recurrence was looked for in
each patient by ultrasonography, CT scan and measurement of serum
(fetoprotein every 4 months. One patient died on the fourth
postoperative month from spontaneous bacterial peritonitis. All other
patients are alive. None of them demonstrated recurrence with a mean
follow-up of 10.7 months (range 4 to 18 months). Although our results
are preliminary, they suggest that adjuvant regional chemotherapy using
cisplatin mixed in iodized oil might be efficient in the prevention of early
recurrence after resection of hepatocellular carcinoma.
69FP070 SURVIVAL AFTER LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA ON CIRRHOSIS
G Gozzetti, A Mazziotti, GL Grazi,
Jovine, A Frena, M Morganti
2 Dpt. of Surgery, Univ. of Bologna,
S. Orsola Hospital, Bologna, ITALY
Liver resection remains controversial for hepato-
cellular carcinoma (HCC) on cirrhosis, for the lack of
liver regeneration and the risk of hepatic failure and
tumoral recurrence. MATERIALS AND METHODS: Over the past
9 years, 123 cirrhotics were operated on for single
HCCs. An accurate work-up, including angiography with
Lipiodol injection and CT scan, was adopted. Eighty-
three pts. (67.4%) were in the Child-Pough’s group A, 38
(30.8%) were Child B and the remaining 2 (1.6%) were
Child C. Eight pts. (6.5%) had a right hepatectomy, 36
(29.2%) a wedge resection, while in the remaining 79
cases (64.2%) an anatomical segmental resection was
performed. Intraoperative US was always employed.
RESULTS Ten pts. died within 30 days, with an overall
operative mortality of 8.1%; in the period 1987-1992 the
mortality rate dropped to 5.4% (5/92 patients). Seventy
patients (61.9%) are currently alive. Recurrence
occurred in 38 pts. (33.6%). The 3 and 5 year actuarial
survival rates for pts with follow-up > 30 days has been
60.1% and 36.3% respectively. Univariate analysis of
factors influencing survival has shown better results
for pts. 1) without symptoms; 2) with AFP level < 20
ng/dl; 3) who did not receive blood transfusion during
surgery; 4) who had operation shorter then 3 hours; 5)
without satellite nodules around the main tumor; 6)
without microvascular thrombosis and 7) when the tumor
was completely capsulated. On the other hand Cox’s
proportional hazards regression model has shown that
only 1) the presence of a complete peritumoral capsule,
2) the smaller tumor diameter and 3) the absence of
microvascular thrombosis were independent factors
predicting statistically better survival (p<.01). The 3
and 5 year actuarial survival rates for the group of 21
patients with a11 these 3 variables have both been
79.1%. CONCLUSIONS Surgery can be proposed for
cirrhotics with small, encapsulated HCCs and good
hepatic function. Intraoperative US is an essential tool
to avoid unsuccessful operations and to guide limited
anatomical resections. Long term survival could be
expected for selected patients.
7oFP071 FOCAL NODULAR HYPERPLASIAAND HEPATIC ADENOMA
NEW EPIDEMIOLOGICALAND DIAGNOSTICFEATURF
D Cherqui, A Rahmouni, F Charlotte, H Boulahdour, JM Mtreau
M Meignan, D Mathieu, ES Zafrani, PL Fagniez, D Dhumeaux
H6pital Henri Mondor 94010 Cr6teil, France
Focal nodular hyperplasia (FNH) and hepatic adenoma (HA) are both benign liver-
cell tumors occurring predominantly in young women. However, their pathogenesis and
natural history are quite different. HA is usually a direct consequence of oral
contraceptive (OC) intake and may lead to potentially lethal complications
therefore it should preferably be resected. FNH is not induced by OCs and has
virtually no complication therefore it may be observed. The aim of this study of 35
consecutive female patients is to report the present repartition of these lesions and the
results of systematic appraisal of newer imaging modalities in order to avoid
unnecessary liver resection.
From 1985 to 1992, 35 women were referred for supected benign liver tumor. Final
histological diagnosis was obatined in all cases by tumor resection (n=32) or surgical
biopsy (n=3). Imaging techniques included enhanced CT, enhanced MRI and more
recently scintigraphy using TBIDA biliary tracer. CT and MRI were considered positive
for FNH in the presence of a hypervascular lesion with a visible central stellate
element and positive for HA in the presence of a capsule and tumor heterogenicity due
to necrosis and/or hemorrhage. TBIDA scintigraphy was considered positive for FNH
in case of decreased clearance of the tracer by the tumor resulting in a late hot spot.
Results are summarized in the table.
HA FNH
number of patients 4 31
1985-1988 3 5
1989-1992 1 26
symptoms 4/4 8/31
OC intake 3/4 28/31
number of tmnors 4 47
size (cm) 5-15 (m=8,6) 1-10 (m=4,5)
CT + 2/4 25/45 (62%)
MRI + 2/2 39/44 (82%)
TBIDA + 24/27 (88%)
Our results suggest (1) a reduction in the incidence of HA, possibly due to the use of
low-estrogen-content OCs in recent years, (b) an apparent increase in the diagnosis
incidence of FNH, probably due to the diffusion of ultrasonography, (c) that a
hypervascular tumor with a visible central element in an asymptomatic young woman
is almost certainly a FNH and (d) that enhanced MRI and biliary scintigraphy are the
best imaging techniques for the diagnosis of FNH.
71FP072 RESULTS OF LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA IN PATIENTS
WITH A NORMAL LIVER.
G Borgonovo, L Capussotti, C Vons, H Bouzari,
C Smadja, D. Franco.
Services de Chirurgie, H6pital Antoine B6cl,re,
Clamart France, et HSpital Mauriziano, Turin Italie.
Twenty percent of liver resections for hepatocellular carcinoma (HCC)
are done in patients with a non cirrhotic liver. The purpose of this work
was to assess the results of liver resection for HCC in 40 patients with a
normal liver. Mean age (27 males and 13 females) was 56 years
(range" 13 to 75 years). In 85 % of the patients there were symptoms"
pain, fever, or weight loss. None of the patients had liver failure or portal
hypertension. One patient had jaundice resulting from invasion of bile
duct. There were 14 right, 10 extended right, 6 left and 2 extended left
hepatectomies, and 8 segmental liver resections. One patient had
resection of the bile duct. A vena caval neoplastic thrombus was
removed in 1 patient. Liver resection was curative in 35 patients and
palliative in 5. Mean tumor size was 123 + 75 mm (range" 30 to 280
mm). The tumor was encapsulated in 58 % of patients. In 64 % of those,
there was capsular invasion. Satellite nodules were present in 80 %
and invasion of distal portal branches in 76 % of patients. There was no
operative mortality. Five patients (12 %) had a major postoperative
complication’intestinal obstruction in 1 and deep jaundice in 4, which
subsided in 3. In the last patient jaundice persisted leading to major liver
failure. On the 17th postoperative month this patient is awaiting liver
transplantation. One-, two-, and three-year survival rates were
respectively 80, 72, and 35 %. Tumor recurrence occurred in 28 patients
(72 %) and was confined to the liver in only 13. These results suggest
that the prognosis of HCC in patients with a non cirrhotic liver
undergoing resection is approximately the same as that of patients with
cirrhosis. The poor long-term survival might result from the marked
spreading of the cancer within the liver due to late diagnosis in a
population with no survey.
72FP073 OPERATIVE RISK OF MAJOR HEPATIC
RESECTION
R Polastri, H Bouzari, M M Marucci, G Mattalia
L Capussotti
Department of Surge..ry, Ospedale Mauriziano
"Umberto I", Tonno, Italy
Indications for liver resections have expanded with the extension of surgical limits for primary
and secondary malignant liver tumours and increased diagnosis of benign liver tumours. We
report our experience of major hepatic resections to evaluate the intra- and post-operative risk
of this procedure.
Between October 1980 and November 1992, 322 hepatic resections were performed; of these,
129 were major hepatic resections. 69 patients were males and 60 females. The mean age was
57 years (range: 2-78). 19 patients had liver cirrhosis (Pugh A). 96 patients had malignant
diseame: hepatocellular carcinoma (n.39), cholangiocareinoma (n.4), mixed primary liver cancer
(n.4), hilar carcinoma (n.8), colorectal liver metastases (n.33), other liver secondaries (n. 8); and
33 had a benign liver tumour.
Hepatectomies were defined according to the anatomic classification of Couinaud. There were
79 fight hepatectomies, 22 extended fight hepatectomies, 21 left hepatectomies, 4 extended left
hepatectomies and 3 trisegmentectomies. In 45 cases we have performed other organ resections
in addition to hepatic resection. From 1984 intraoperative ultrasonography was performed in
all patients. In 22 we have avoided abdominal drainage.
There were 7(5.4%) intraoperative complications. In 2 instances of fight hepatectomies
extended to the segments IV and I we have injured the left hepatic duct. In all 2 cases they are
sutured using a T tube protection. In 3 patients with large mmours adherent to the cava vein
we caused a small injury of the latter: total hepatic vascular exclusion was necessary for 5
minutes in 2 patients. A partial improper closure of remnant left hepatic vein was made in the
sixth patient, who had a fight hepatectomy extended to the segment IV. An end-to-end suture
was performed in total hepatic vascular exclusion. In the last patient, who had a fight
hepatectomy and a portal resection for hilar cancer, we had a torsion of an end-to-end portal
anastomosis and we performed a reanastomosis. The median blood transfusion requirement was
2 units (range: 0-7); 37 patients did not require blood. The median operative time was 288
minutes (range: 150-600). Intraoperative complications were strictly related to the tumour size:
6 out of 7 patients had a tumour diameter of 10 to 30 cm. (average: 18.1 cm)
Two patients (1.5%) died 1 and 6 days after operation for myocardial infarction. 68
postoperative complications occurred in 48 patients (37.2%): pleural effusion (n.34), pneumonia
(n.10), subphrenie collection (n.11), bile leak (n.4), wound infection (n.3), small bowel
obstruction (n.2), pleural empyema (n.1), DIC (n.1) haemorrhagie gastritis (n.1), acute renal
failure (n. 1). Four patients (3.1%) underwent 6 reoperations: for drainage of subphrenic sepsis
(n.3), small bowel obstruction (n.2), pancreatic fistula (n. 1). In addition, 8 patients underwent
percutaneous drainage of subphrenie abscesses.
The mean postoperative stay was 18 days (range: 6-102). Many pre- and intraoperative factors
were analysed: only intraoperative blood transfusions correlated with a higher rate of
postoperative complications and a longer postoperative hospital stay (p < 0.01).
73FP074 PROGNOSTIC FACTORS IN SURVIVAL AFTER
PORTOSYSTEMIC SHUNTS.
G.P.Spina, R.Santambrogio, E.Opocher, A.Pisani
Ceretti, M.Intra, P.Garancini *, G.Gallus *.
Ist.Scienze Biomediche S.Paolo-Univ. Milano
* Ist.Scientif.S. Raffaele Univ. Milano
Multivariate survival analyses using Cox’s Regression Model corre-
lated long-term survival with clinical data from 239 cirrhotics
with porto-systemic shunts for the prevention of variceal bleeding
of the 12 years (from 1980 through 1992). There were 88 patients
with alcoholic cirrhosis and 151 with non-alcoholic cirrhosis. The
severity of liver disease was assessed according to the Pugh’s clas-
sification (A=87; B=I50; C=2) and to the hepatic score index (0.56
0.08; range 0.38-0.81) calculated on 12 clinical laboratory parame-
ters. (i) 127 patients underwent a total shunt and 112 a selective
shunt. Mean follow-up was 57.438 months (range 12-142 m.). Five
years survival was 59%. During follow-up, 81 patients died from
their liver disease and 43 from various causes urelated to their li-
ver disease. Five years survival curves showed a significant diffe-
rence between hepatic score classes (<0.55=67%; 0.56-0.63=61%;>0.64=
36%; p<0.001), alcoholic and non-alcoholic cirrhosis (45% vs 66%;
p<0.05) and alkaline phosphatase values (normal=63%; abnormal=49%;
p<0.05). Ten preoperative variables (Pugh’s score or hepatic score
index, kind of shunt, portal thrombosis, portal perfusion, age, eth-
iology, alcohol abuse, platelets count, alkaline phosphatase and
SGOT) were tested as a prognostic factors in a multivariate analysis
using the Cox proportional hazard. In this highly selected popula
tion of cirrhotics, it showed that hepatic score index was the only
variable significantly related to survival (B=5.04;SE=2.04p=0.0136)
These findings suggest that in this population of cirrhotics the se-
verity of liver disease assessed by a hepatic score index (an enlar-
gement of Pugh’s classification) is the best predictive variable for
long-term outcome after shunt surgery.
(I) G.P. Spina et al. Ann. Surg. 1990; 211: 178-186.
74FP075 FACTORS AFFECTING INCIDENCE OF ENCEPHALOPATHY
POST-PORTACAVAL SHUNT
P Schauer, G W W Gross, B A Levine,
and K R Sirinek
Department of Surgery
The University of Texas Health Science Center
San Antonio, Texas
Proponents of selective and small diameter (Smm),
interpositlon-graft portosystemic shunts maintain that the
incidence of encephalopathy post-total portosystemlc shunt is
secondary to loss of hepatic portal flow across a low
pressure gradient anastomosis. This study assessed and
correlated the incidence of post-op encephalopathy in 72
patients with alcoholic cirrhosis, portal hypertension, and
variceal hemorrhage [Childs’ class A (6%), B (40%), C (54%)
undergoing a side-to-side portacaval anastomosis (PSmm) who
had had portal hemodynamlc studies pre-op, intra-op, and
post-op. Sixteen patients (22%) developed clinlcally-evident
post-op encephalopathy: 9/16 were not encephalopathlc pre-op,
6/16 occurred early (<30 days), 10/16 were late (sepsis 4,
dietary indiscretion 3, multiple and incapacitating 3), 4/16
died post-op, there was no difference in measured portal
hemodynamic parameters in these 16 patients compared to 56
patients without encephalopathy (Table). Encephalopathic
patients had worse hepatic function (Childs’ class C 70% vs
46%) and higher incidence of emergency shunts (38% vs 9%).
Encephalopathy occurs post large diameter portacaval
anastomosis as a result of failure to acutely control
gastroesophageal bleeding by nonoperative means in patients
with poor hepatic reserve and is not secondary to the size of
the anastomosis or the post-shunt pressure gradient across
the anastomosis. A large diameter (25ram) side-to-side
portacaval shunt with an 8% mortality, a 22% encephalopathy
rate (new 12%, incapacitating 4%), and no recurrent variceal
bleeding remains the "gold standard" for the treatment of
variceal hemor::nage in patients with alcoholic cirrhosis.
Pressures(mmH20),XSEM
Preop (WHVP)
Intra-op Portal Pressure
Intra-op Shunt Gradient
Post-op Portal Pressure
Post-op Shunt Gradient
Encephalop(-! Encephalop(+)
377+/-12 428+/-26
191+/-7 201+/-15
15+/-2 18+/-5
174+/-7 208+/-13
36+/-4 45+/-11
75FP076 STRUCTURAL CHANGES OF THE SMALL BOWEL
MUCOSA AFTER PORTACAVAL SHUNT IN RATS
P Sharma, I Hagerstrand, F Bengtsson,
B Jeppsson
Departments of Surgery, Pathology, Clinical
Pharmacology, LundUmversity, Lnd, Sweden
Intestinal absorption of different nutrients and toxic substances is altered after
porto-systemic shunting. This alteration may play a role in the pathogcncsis of
hepatic cnccphalopathy. It is still controversial if porto-systemic shunting also is
accompanied by structural changes of the small intestinal mucosa. Wc therefore
studied small bowel mucosa after portacaval shunt in the rat.
Material and methods: Standard end-to-side portacaval shunt (n=29) and
shamopcration (n=29) was performed under ether anesthesia. Four weeks after
surgery rats were sacrificed and segments of proximal and distal small bowel was
taken in a standardized fashion for light and electron microscopy.
The specimens were examined blindly. Villus height, villus to crypt ratio and
villus size index were assessed on light microscopy. Microvillar height and
microvillar count was analyzed by clcctronmicroscopy.
Results: No differences could be detected in villus to crypt ratio, villus size index
and villus height between shunted rats and rats with sham operation. The vilus
size index was high in the proximal small bowel in both groups and gradually
decreased along the length of the intestine. On electron microscopy no differences
could be detected in microvillar count per unit length of the brush border between
shunted and sham rats. On the other hand microvilli of enterocytes from control
rats were significantly taller compaxed to those in the shunted groups.
Conclusion: In contrast to other studies we have not found any changes of the
small intestinal mucosa after .shunting detectable at light microscopy, but a
significant reduction of the height of microvilli on electron microscopy. The role
of portal venous pressure in the regulation of mucosal absorptive surface by
altering the height of microvilli needs to be studied further.
76FP077 SURGICAL TREATMENT OF BUDD-CHIARI SYNDROME
COMPLICATED BY INFERIOR VENA CAVA OCCLUSION
B M Wang, B Y Ye, Y Tang, Q s Cao
Department of Surgery, Chang Hal Hospital
Shanghai 200433, PR of China
Decompression of the liver by either portacaval or mesocaval
shunts for the Budd-Chiari syndrome complicated by inferior vena
cava occlusion is impossible either due to hypertrophy of the
caudate lobe or prone to failure due to high IVC pressure, as
found during operation in our patients. The outcome of spleno-
pneumopexy is also poor as indicated by 2 patients in this
series (one referred for mesoatrial shunt due to failure of this
procedure performed elsewhere). Six patients with adequate
collateral circulation between the hepatic veins and IVC have
had cavoatrial shunts. Seven patients with adequate collateral
circulation of the occluded IVC have had mesoatrial shunts. One
patient with severe venous hypertension of the lower extremities
(varicosity, edema, pigmentation, and venous ulcer) had combined
mesocaval and cavoatrial shunts. All of these shunts were con-
structed using a 14 or 16 mm ring reinforced polytetrafluoro-
ethylene graft.
Fourteen patients treated by shunts recovered well with resolut-
ion of ascites, diminution in liver size, and improvement in IVC
pressure gradients. One patient complicated by post necrotic
cirrhosis died of hepatorenal syndrome after a cavoatrial shunt.
All shunts in the living patients have remained patent as deter-
mined by either Duplex scanning or contrast enhanced CT
scanning, during follow-up periods ranging from 3-48 months.
Shunt operation may be the surgical treatment of choice in
patients with Budd-Chiari syndrome associated with IVC
occlusion.
77FP078 SHUNTING PROCEDURES IN BUDD-CHIARI SYNDROME"
LONG-TERM RESULTS
MJ Boudet, G Zeitoun, JM Hay, Y Flamant.
Service de Chirurgie, H6pital Louis Mourier
178, rue des Renouillers 92701 Colombes Cedex, France
The standard surgical treatment of Budd-Chiari syndrome (BCS) is still a shunt procedure
between the portal and the caval system. Depending on whether or not the inferior vena
cava is obstructed, the presence of a negative or weakly positive porto-inferior vena cava
(IVC) gradient precludes a shunt bypass toward the IVC system. In that feature, a shunt by-
pass toward the superior vena cava system is needed.
Between 1/1973 and 12/1992, we performed 71 shunts on 62 patients. In 37 cases (34
patients), portal flow was shunted toward the IVC. In 34 cases (26 patients), the portal flow
was shunted toward the SVC.
From 111981 to 12/1986, 17 patients with a BCS and an inferior vena caval obstruction
were treated by an intrapericardial shunt (IPS) (i.e. mesoatrial shunt). From 1/83 to 12/92,
17 patients were treated by an extrapericardial shunt (EPS) avoiding opening the pericar-
dium. Since 1/87, 14 of these patients were treated by two new procedures, namely a
mesoinnominate (M I) or a meso-extrapericardial superior vena cava shunt.
All patients had pre and intraoperative liver biopsies (LB). LB were classified as follows
centrilobular necrosis (CLN) alone, CLN and severe fibrosis (F), F alone. There were 16
CLN, 28 CLN and F, 27 F.12 patients had a preoperative acute renal failure (POARF)
defined by a blood creatinine level > 120 imol/l. Of these 12 patients, 9 had F.
Results.
Overall results :The overall mortality was 29 %. 9 of the 12 patients with POARF died (75%).
8 of these 9 patients had F on LB (90 %) 1 patient over 9 with POARF and F survived
(10%). The two patients with POARF and no F survived. Statistical analysis showed the
following results POARF vs no POARF (p<0.001) F and POARF vs F and no POARF
(p<0.001).
BCS with free IVC Total early mortality was 27% (9/33) 1 intraoperative death, 4 septic
shocks, 3 upper digestive bleedings, 1 pulmonary embolism. 4 of the 6 patients with
POARF died. All had fibrosis on LB. 2 deaths occurred during the last 10 years and none
during the last 5 years. Follow-up ranges from 1 to 15 years. One patient died 5 years later
of unknown mason. Actuarial survival rate is 73% at I year, 73% at 5 years, 66% at 10 yearn.
BCS with IVC obstruction IP_P 70% of the patients had postoperative ascites. Postopera-
tive mortality was 57%. Of note, between the second and the fourth postoperative month,
4 patients (23%) had a pericarditis (2 acute and 2 constrictive) leading to a pericardial tam-
ponade. 3 of them died even though a pericardectomy was performed.
EPS Of the 14 patients treated since 1987, 1 patient died of a postoperative septic shock.
Overall mortality was 7%. No pericarditis occurred.
Conclusion
Shunt procedures 1/give excellent long-term results 2/should be precluded when
POAR and F are associated.
EPS should be preferred when IVCO obstruction is present.
78FP079 LONG-TERM RESULTS AFTER PORTAL
SYSTEMIC SHUNTS IN BUDD-CHIARI
SYNDROME.
C Vons, G Borgonovo, C Smadja, D Franco.
Service de Chirurgie, H6pital Antoine Bclre,
Clamart, France.
Budd-Chiari syndrome (BCS) occurs in patients with patent or latent
myeloproliferative or coagulation disorders resulting in thrombosis of
major hepatic veins. Portal-systemic shunts are indicated in order to use
the portal vein as an outflow tract from the liver to systemic circulation.
Late results are not yet known. The purpose of this work was to assess
the results of portal systemic shunts in 15 patients with BCS operated on
between 1978 and 1991. Twelve patients had a shunt with the inferior
vena cava and 3 with the right atrium. The etiology of BCS was
polycythemia rubra vera in 5 patients, oral contraceptive use in 4,
pregnancy in 3, disseminated lupus erythematous in 1, and unknown in
2. There was no operative mortality. Twelve patients (80 %) were alive
in december 1992 with a mean follow-up of 62 + 30 months (range" 14
to 164 months). Living patients had a normal life with no ascites. The
only biological abnormalities were a slight cholestasis. One patient had
transient liver failure concurrent with hepatitis C infection. Three patients
died 3, 18, and 84 monhs after shunting, respectively from end-stage
lupus erythematous (1patient) and from blastic transformation of
myeloproliferative disorder (2 patients). In one of the latter, blastic
transformation resulted in hypercoagulability and in acute thrombosis of
a previously patent mesocaval graft, 7 years postoperatively. This was
the only patient with a thrombosed shunt during follow-up. These results
suggest that the evolution of BCS patients after portal systemic shunt is
favorable. Late complications and deaths result from the underlying
systemic or hematologic diseases. Such results should be taken into
account in the indications of shunts vs. transplantation in patients with
BCS.
79FP080 THE SUGIURA-FUTAGAWA OPERATION FOR
PORTAL HYPERTENSION. A 14 YEAR
EXPERIENCE
H Orozco, MA Mercado, E Prado,
T Takahashi, G Rojas, R Zepeda,
S Rivera & K Le6n.
Portal Hypertension Clinic,
Instituto Nacional de la Nutrici6n
The results in a 14 year period with the
devascularizating operation described by Sugiura-
Futagawa are reported here. The operation was done in
patients in which a shunt was not possible to perform.
One hundred sixty-one patients were operated in an
elective fashion, all of them with different kind of
hepatopathies (112 Child A, 44 Child B and 5 Child C).
In 22 patients the procedure was done in one stage
(13.6% operative mortality: 3 patients) and in 76 as a
two stage procedure. 19 deaths were recorded in the 112
patients of the Child A group, with a total of 179
operations. The operative mortality for this group was
16.9% and related to the numbers of operative procedures
10.6% (19 of 179 operations). 38 patients were not
considered for a second stage. Re-bleeding at long term
was 6.8%. Incapacitating encephalopathy was found in 3
patients among the iii survivors (2.7%). Survival
(Kaplan-Meier) was 75% (i year), 70% (5 years), and
69.2% (i0 years). I0 esophageal fistulas were observed
secondary to transection. The Sugiura-Futagawa operation
is an excellent complement in the therapeutic
armamentarium to treat portal hypertension, with a low
re-bleeding and encephalopathy rate.
80FP081 EXPERIENCES WITH IMPLANTATION OF
DIFFERENT TYPE OF PERITONEOVENOUS
SHUNTS
L Harsnyi, P Kupcsulik, W Chanis,
P Kokas
ist Surgical Department,
Medical School, Budapest,
Semmelweis
Hungary
M+M: In the past ii years 92 patients underwent a
surgical procedure because o intractable ascites.
Ethiology o the ascites was alcoholic cirrhosis in
8 cases, chronic aggressive hepatitis in 6 cases,
and Budd-Chiary sy. in more cases. LeVeen-type
and & Denver-type shunts were implanted.
Results: In the early postoperative periode was observed
a good eect (rapid diminution o body weight, a
significant elevation o endogenous creatinine clear-
ance) in 71 o the cases. The elevated serum-ald-
osteron (16&0+280 pg/ml) and renin (.+0. ng/ml)
activity decreased and normalizing tendency o hor-
monal response to concentration-dilution was meas-
ured. The also increased atrial-natriuretic-actor
level remainded elevated however. Early complications
such as bleeding (), thrombosis o the ugular
vein (), DIC (1), hepatic coma (2) and others
occured in l& cases (15). Late complications were
thrombosis, intraabdominal occlusion o the
shunt, & sepsis and others (22).
Conclusion: In conclusion peritoneovenous shunt implan-
tation proved to be useull or reduction o
complains caused by intractable ascites with an
acceptable rate o complications.
81FP082 ANATOMICALLY PRECISE LIVER
SEGMENTECTOMY RESULTS OF TWO
EXPERIMENTAL TRIALS IN SHEEP
H Lanl, A Junge* H Sitter.* H, J ,Klot,ter*,
Dept. o’f Surgery, Hanno.qver eaicai enoo,
rannover, termany
*Dept. of Surgery, Philipps-Universitt
arourg, termany
Liver segmental resection is supposed to provide oncological
effectiveness and preservation of functioni.ng parenchyma
simultaneously which s important especially n patients with
compromised hepatic function. However, there is still little evidence
that segmentectomies can be performed anatomically precise.
Therefore, in two experimental trials a new technique of liver
segmental resection (SR) was evaluated with regard to anatomical
precision and alterations of biochemical profile.
Material and Methods:
According to previous studies the sheep liver is most suitable for
segmental resections. In trial I (3 groups of 10 sheep) either segment
II,III or IV was removed. Resection (SR) was performed after
intraoperative ultrasound guided localisation of the corresponding
segmental portal branch, its ligation after transparenchymal dissection
and staining of the segment by injection of methylenblue. In trial II (2
groups of 10 sheep) a traditional resection (TR) of segment III or a
sham-operation (laparotomy including 200 ccm bloodloss) were
performed. Dissection of liver tissue was carried out with an
ultrasonic aspirator (Sonoca, Quickbom). Precision of segmentectomy
was evaluated by corrosion preparation of the liver. Clinical profile
was assessed by intraoperative bloodloss and changes of liver function
tests (postop. day 1-5).
Results:
Overall, 36 corrosion preparation were technically sufficient for
assessment. In SR anatomically precise resections could be achieved
for segment II and III in 66% each and for segment IV in 50%. In TR
only one resection was anatomically precise (p<0.01, X2-test).
Bloodloss for resection of segment III was nearly the same in SR
(mean and SD: 148 ccm + 61) and TR (140 ccm _.+ 77). Liver
function tests did not differ significantly between SR and TR.
Conclusion:
The new technique pro.red to be a safe and reliable surgical procedure
in anatomically precise liver segmentectomy which might have
advantages in patients at increased perioperative risk.
82FP083 HOW CAN WE SHARE PORTAL BLOOD INFLOW IN
AUXILIARY PARTIAL HETEROTOPIC LIVER
TRANSPLANTATION WITHOUT PORTAL HYPERTENSION?
I Nagashima, L Bergman, R Schweizer
Transplant Service and Surgical Research Laboratory, Hartford
Hospit/d, Hartford, CT, and-University of Connecticut School of
Medicine, Farmington CT. USA
Auxiliary partial heterotopic liver transplantation (APHLT) could be an attractive
treatment for fulminant hepatic failure in which recovery of host liver might be
expected. We studied the functional relation between auxiliary heterotopic partial
liver graft and host liver in the presence of artificially created portal hypertension
in pigs.
16 pigs underwent hepatic artery ligation and APHLT, and were randomly
allated to three groups as follows; group A(n=5)" no treatment of host lrtal
vein, group B(n=6): banding of host portal vein to make the host portal pressure
higher than that of graft by 2 mmHg, group C(n=5)" banding of host portal vein
to make the host portal pressure same as that of graft. Postoperative
immunosupression was done with cyclosporin, azathioprine and steroids.
Basically, the host and graft portal pressure was 8.5+/-0.2 (mean+/-SEM) mmHg
and 10.7+/-0.3mmHg respectively. All the pigs survived well until sacrifice on
day 40 post-operatively. At autopsy, all in group A had necrotic and atrophied
grafts (170+/-27g) with graft portal vein thrombosis, and well hypertrophied host
livers (868+/-103g). All in group B had well hypertrophied grafts (480+/-57g),
and necrotic and atrophied host liver (289+/-52g). Three of 5 in group C had well
hypertrophied grafts (496g+/-37g) as well as host livers (313+/-2 lg), although the
remaining two had the same results as group A. HIDA-scan and histological
inspection showed good correlation between function and macroscopical finding at
autopsy.
APHLT could be a good and acceptable treatment for temporary support in
fulminanthepatic failure. However, itshould be mandatory to band the host portal
vein to make the host portal pressure same as that of graft in cases without portal
hylrtension.
83FP084 PHOSPHOLIPIDS PREVENT ENTERIC BACTERIAL
TRANSLOCATION FOLLOWING SUBTOTAL LIVER
RESECTION IN THE RAT
R Andcrsson, XD Wan, V Soltcsz, W Wan, A At’Rajah,
S Bcngmark
Dcpts of Surgery and Clinical Microbiology, Lund
University, Lund, Sweden
Bacterial infectious complications, including intraabdominal sepsis and bactcrcmia,
following major liver resection can at least partly bc attributed to translocation of enteric
bacteria. Attempts to prevent or treat such infections by use of antibiotics may instead
result in colonization and/or overgrowth of surviving microbes. In the present study, the
effect of enteric administration of phospholipids (phosphatidylcholinc and
phosphatidylinositol) on the prevention of enteric bacterial translocation, induced by
subtotal liver resection in the rat was evaluated.
90 % hepatectomy was performed in male Sprague-Dawley rats. The animals were
allocated to receive saline, phosphatidylcholine or phosphatidylinositol prior to operation.
Enteric bacterial translocation, intestinal mucosal mass and enterocyte protein content
were determined.
The incidence of bacterial translocation significantly increased 2 and 4 h following 90 %
hepatectomy, as compared with sham operated animals. Enteric administration of
phospholipids, however, significantly reduced the incidence of bacterial translocation afte
90 % hepatectomy. Phospholipid treatment also prevented the otherwise occurring
postoperative decrease in intestinal mucosal mass and enterocyte protein content.
Enteral administration of phospholipids thus seems to protect against translocation of
enteric bacteria and prevent from the decrease in intestinal mucosal mass and enterocyte
protein content following subtotal hepatectomy in the rat.
$4FP085 THE ROLE OF LACTULOSE IN PREVENTION OF
BACTERIAL TRANSLOCATION IN OBSTRUCTIVE
JAUNDICE
C Ozaslan, A Turkcapar, S Bengisun, M Kesenci,
A Toruner
General _Surgery Department, IBN-I Sina Hospital,
The Uni,ersity of Ankara, Ankara, Turkey
Despiteimprovement in operative techniques, better pre-operative evaluationand
post operative care and uses of new antibiotics, mortality and morbidity due to
infections and endotoxemia in obstructive jaundice still remain high.
In obstructive jaundice changes in bacterial flora occur because of absence of
bile acids in gastro-intestinal (GI) tract and there is an increase in colonization
of especially gram negative bacteria. Bacterial translocation (BT) may occur
even though there is no damage to the intestinal wall.
In this study, effect of lactulose which decreases endotoxin levels and its
absorption on BT was sought. Four groups of rats were studied; control (n: 10),
sham ligation (n:20), bile duct ligation (n:19), bile duct ligation and oral
lactulose (n’20). In the control group during the first laparotomy specimens
from mesenteric lymph node, liver and caecum were taken for culture. In the
other groups the specimens were taken 14 days after the operation.
In the control group, no bacterial translocation was observed. In the sham
ligation, bile duct ligation and bile duct ligation with lactulose administered,
group BT rats were %5, %36 and % 10 subsequently.
In the group whose bile ducts were ligated, there was an increase in E. coli and
proteus colonization in the caecum. On the other hand in the lactulose
administered group colonization of E. coli and proteus was found to be
decreased.
Lactulose which decreases the endotoxemia exerts its effect by regulating the
flora in the GT tract. The effect of lactulose on flora is through lowering pH
in the caecum.
85FP086 INTESTINAL ENDOTOXINS AS CO-FACTORS OF
LIVER INJURY IN OBSTRUCTIVE JAUNDICE
E Yllmaz, B Mente, E Tatllclolu, Uluolu
G Akyol, N Sultan
Depts. of Surgery, PatholoKy and MicrobioloKy,
Gazi University, Faculty of Medicine,
Ankara, Turkey
The concept of endotoxin-mediated rather than direct liver injury
in biliary obstruction was investigated using the experimental rat
model of bile duct ligation (BDL) and small bowel bacterial
overgrowth (SBBO). Small identical doses of intravenous endotoxin
(LPS) were administered to sham operated rats as well as rats with
BDL. LPS caused a significantly more severe liver injury in the BDL
group, determined by the histologic score of the liver damage and
serum gamma-glutamyl transferase, C-reactive protein and plasma LPS
levels, suggesting the possible contribution of LPS in this type of
liver damage within the framework of an altered Kupffer cell-
macrophage system. After sensitization of the liver to minute
amounts of LPS was documented, the possible role of intestinal
endotoxins in precipitating the liver injury triggered by BDL was
tested. In this respect, we surgically created jejunal self-filling
blind loops (SFBL), which were known to result in SBBO and
therefore increased intestinal endotoxin pool. When BDL was
combined with SFBL, once again a profound liver injury was observed
in contrast with the control group of rats with BDL+self-emptying
blind loops (SEBL).
Small amounts of exogenous LPS and/or the ordinarily innocous
amounts of LPS constantly absorbed from the intestinal tract may be
critical in the hepatic damage caused by obstruction of the biliary
tree. Therapy directed against intestinal endotoxin pool or LPS-
mediated macrophage effectors may offer a new approach to modify or
hamper liver injury in these cases.
86FP087 IMBALANCE BETWEEN TNFct & TNF INHIBITOR
IN PATIENTSWITH OBSTRUCTIVEJAUNDICE
MCA Puntis and WG Jiang
Department ofSurgery, University ofWales
College ofMedidne, Cardiff, UK
Turnout necrosis factor (TNF) is an important mediator in inflammation, but
excessive production may cause host damage. TNF inhibitor (TNF-inh) is a
soluble protein which block TNF actitivity. We have investigated the
monocyte production of TNF and blood levels of TNF-inh in patients with
obstructive jaundice.
29 jaundiced patients and 23 controls were studied. Monocyte TNF
production (LPS stimulated) was measured by the L929 bioassay and shown
as U/ml. TNF-inh was assayed using a TNF cytotoxic inhibition assayI and
shown as percentage inhibition of TNF activity.
Monocytes from jaundiced patients showed greatly increased TNF levels and
also increased TNF-inhibitor levels compared with controls. TNF/TNF-inh
ratios, which reflect the balance of TNF and its inhibitor, are shown as
follows:
Control Jaundiced
All 1.2_+0.8 4.0+1.5"
Benign 1.3_+0.9 1.8_+0.6
Malignant 0.4+0.3 5.1_+2.1"
* p<0.05 vs control, by Student t test
Five patients who died shortly after testing have the highest TNF levels but
relatively low TNF-inhibitor, ratio=14.95:0.8, p<0.05 compared with the rest
ofjaundiced patients, ratio=2.2_+0.7 and this suggests that patients who lack
inhibitor protection have a poor immediate clinical outcome.
We conclude that jaundiced patients have greatly increased monocyte TNF
production and also have increased levels of TNF inhibitor. The regulation of
the balance between TNF and its inhibitor may be an important aspect to
influence patients prognosis.
1. Baughman et al, J Lab Clin Med, 1991, 118:326
87FP088 THE HAEMODAMIC EFFECTS OF 80RNITHIN
VASOPRESSIN IN PORTAL HYPERTENSION
AND CIRRHOSIS
H. Kynaston, J. Yates, N. Davies, B. Taylor,
K. Parsons, S.A. Jenkins
Department of Surgery, Royal Liverpool
University Hospital, Liverpool, U.K.
Previous clinical studies have demonstrated that 8 ornithin vasoprcssin (8-
OV) improves renal function in patients with hepatorenal syndrome. The
aim of this study was to investigate the effects of 8-OV infusion on
systemic haemodynamics and organ blood flow in cirrhotic and portal
hypertensive (PPVL) rats.
Two groups of PPVL and cirrhotic Wistar rats were studied (n = 20 and
12 respectively). Half the rats in each group received a 20 rrn infusion
of 8-OR (0.043 U/hour) whilst the remainder received saline (control
groups). Pulse, mean arterial pressure (MAP) and portal pressure (PP)
were monitored continuously. Cardiac output (CO) and organ blood flow
were measured prior to and after infusion by a dual mierosphere
technique. Intrarenal shunting was determined by a renal/pulmonary
passing fraction method.
In PPVL rats 8-OV caused a significant fall (p < 0.01) in CO (mean
difference + 95% CI = 33; 20,47ml/min), pulse rate (40; 16,65/min) and
PP (4; 2.2,5.6 mmHg) and a rise in MAP (27; 20,33 mmHg). Absolute
renal blood flow (ml/min/g) was maintained by a significant increase in
%CO to the kidneys (mean increase = 8.7% = 5-127o CI). The cirrhotic
group demonstrated similar significant changes in haemodynamics but
neither control group exhibited any alterations. The cirrhotic group
exhibited intrarenal blood flow shunting which was significantly reduced
with 8-OV.
In conclusion 8-OV improves the hyperdynamic state found in PPVL and
cirrhotic rats. Renal blood flow is preserved even though the cardiac
output falls and intrarenal blood shunting in cirrhosis is reduced. These
effects explain in part its beneficial effect on renal function in the
hepatorenal syndrome.
88FP089 DETECTION OF LIVER METASTASES FROM
COLORECTAL CARCINOMA: VALUE OF
IMAGING TECHNIQUES.
B van Ooijen, M Oudkerk, PIM Schmitz, T Wiggers.
Departments of Surgical Oncology, Radiology and
Statistics, Dr Daniel den Hoed Cancer Center,
ROTTERDAM, The Netherlands.
One of the most important prognostic factors determining survival among
patients undergoing hepatic resection for colorectal metastases are the
number of metastatic deposits in the liver. Since a number of more than
3 metastases may exclude a patient from resection, precise evaluation is
essential to prevent needless exploration.
A prospective evaluation of the liver by preoperative ultrasound (US),
conventional computed tomography (CT), and continous CT angiography
(CCTA) was performed in 60 patients with and without metastases. All
patients had a history of colorectal carcinoma and all underwent laparoto-
my. The standard of reference were the findings at laparotomy: palpation
of the liver and intraoperative ultrasonography (IOUS). The imaging
techniques were assessed independently of each other.
One hundred and five liver metastases were identified in 37 patients; 42
metastases were less than 1 cm in diameter. Twenty-three patients had
no metastases. CCTA had a high sensitivity of 94% (99 lesions identi-
fied), in contrast to US (48%, 50 lesions identified) and conventional CT
(52%, 55 lesions identified). The superiority of CCTA is also manifest in
lesions under 1 cm in diameter. However, the high sensitivity is accom-
panied by a high-false positive rate particularly due to variations in the
perfusion of normal liver parenchyma. Overall, CCTA had the highest
accuracy (74%)compared to US and CT (both 57%).
The data indicate that preoperative US and conventional CT have low
sensitivity in the detection of liver metastases and that CCTA can supple-
ment information, although the low specificity of the technique makes its
application difficult. Possibly, experience with image interpretation may
allow the interpreter to accurately predict the likelihood that a specific
lesion represent metastatic disease. In addition, combination with other
imaging techniques may increase the accuracy.
Concltsion: Although CCTA seems to be superior to other preoperative
imaging techniques the too low specificity will hamper its routine
application in patients with hepatic metastases from colorectal carcinoma.
89FP090 INTRAPORTAL INFOSION OF 6-FLOOROOR&CIL
AND LEUCOVORIN STARTED IMMEDIATELY
AFTER HEPATIC RESECTION FOR COLORECTAL
METASTASES. A FEASIBILITY STODY.
R Doci, P Bignami, F Montalto,
M Cataldi, L.Gennarl
National Cancer Institute, Milan
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and survlval will be available.FP091 RADIOIMMUNOGUIDED SURGERY: PROBE-ASSISTED LIVER
RESECTIONS FOR METASTASES FROM COLORECTAL CARCI-
NOMA
A.Benevento, R.Galozzi, S.Cuffari, L.Festi,
G.Carcano, R.Dionigi.
Department of Surgery, University of Pavia-Vare-
se, Ospedale Multizonale di Varese, Italy
The use of mdiolabelled monoclonal antibodies to tumor-associated antigens in
tumour diagnosis and detection is worldwide accepted. Recently a new tecnique
has been proposed, based on the development of a hand-held gamma detecting
probe for intraoperative use. We report our experience using radioimmunoguided
surgery (RIGS) for resection of liver metastases from colorectal carcinoma. Since
1989, 54 patients with primary or recurrent colorectal carcinoma received
preoperative intravenous injection ofMAb B72.3, a mudne IgG-1 that reacts with
the high molecular weight glycoprotein antigen TAG 72 associated to colorectal
cancer. It was radiolabelled with I-125. A total of24 patients with liver metastases
(13 synchronous and 11 metachronous) were considered eligible for resection at
preoperative diagnosis. At surgery the whole abdominal cavity and its viscuses
were explored by the probe, in order to confirm lesions preoperatively assessed
and detect possible occult tumour deposits. Intraoperative ultrasonografic scans
were routinely performed and compared. Probe assisted liver resection permitted
to locate accurately liver metastases, to exclude lymphnode involvement, to
delineate margins before resection, to control margins during non anatomical
resection and to verify clear margins after resection. Five of 24 patients (19%)
were found to have a large bilateral metastatic spread not previously detected;
major procedures were avoided and a catheter for locoregional chemotherapy was
placed in the hepatic artery via the gastroduodenal artery. Thirteen of 20 (65%)
synchronous metastases and 20 of 25 (80%) metachronous metastases were
correctly localized by the probe. Twelve metastases (7 synchronous and 5
metachronous) were unrecognized. Factors influencingMAb binding to colorectal
cancer cells (MAb pharmacokinetics and physiological factors within the tumor)
negatively affect the radiolabelling of turnout metastases. The smaller lesion
identified was 5 mm in diameter. Compared to intraopemtive US-scan RIGS
shows a lower sensitivity (75%) and a higher specificity (100%). In 6 of 54
patients US-scan diagnosed suspicious or benign lesions (2 angiomas, 1 serosal
cyst, 3 isoechogenic lesions). Correct diagnosis of metastases was allowed by
RIGS. New highly selective MAbs, fragments ofMAbs and humanMAbs against
different cancer cell lines would improve availability of the radioimmunoguided
surgery technique.
91FP092 Determinants of the Natural History of
Colorectal Uver Metastases
R. Stangl, A. Altendorf-Hoffmann, C. $chmidt,
D. Mowbray, O. Wiesinger, J. Scheele
Surgical Department,
University Hospital Edangen, FRG
Between Jan. 1, 1980 and Dec. 31, 1990 data from 1099 patients
with colorectal liver metastases were recorded at the University Hospi-
tal Erlangen. Excluding all patients, who received any kind of treatment,
489 patients remained for the univariate (log-rank) and multivariate
(BMDP 2L) analysis of the determinants of the natural history of colo-
rectal liver metastases. All patients were followed up to June 1, 1992
or death. At the closing date of the study only 11 patients were still
alive.
Univadate analysis yielded the following highly significant factors: me-
senteric lymph node involvement (MLNA)0 grading of the primary tu-
mor, treatment of the primary tumor, radicality at the primary tumor
site, hepatomegaly, percent liver volume replaced by tumor (%-LVRT),
number of liver metastases, distribution of liver metastases, alkaline
phosphatase, LDH, WBC-counting, CEA, Karnofsky-index and extrahe-
patic tumor. With multivariate stepwise regression analysis (Cox) 6
independent significant factors were selected" %-LVRT, grading of the
primary tumor, MLNA, extrahepatic tumor and diameter of metastases.
Subsequent combination of the multivariate significant factors resulted
in a factor adapted prognostic assesment (FAPA). This prognostic
"tree" demonstrates the heterogenity of this patient sample with medi-
an survival times ranging from 3.1 months to 20.3 months, dependent
on the presence or absence of the multivariate, relevant factors.
Because of the extreme differences between the group consisting of
less than 25%-LVRT and the group with more than 25%-LVRT we also
carried out a multivariate stepwise regression 1analysis, selectively for
each of these groups. For patients with < 25% LVRT mesenteric
lymph node involvement was replaced by LDH as a significant variable
allowing a more adequate definition of prognosis. In patients with > 25
%-LVRT only grading of the primary tumor and diameter of metastases
were proved independently significant.
In view of the lack of detailed knowledge on the natural history of colo-
rectal liver metastases the prognostic "tree" presented may improve the
assesment of palliative therapeutic approaches, with respect to progno-
sis compared to the natural history of colorectal liver metastases.
92FP093 A PILOT STUDY OF PERCUTANEOUS
INTRALESlONAL LASER HYPERTHERMIA (ILH)
FOR HEPATIC MALIGNANCIES.
Mclnnes*, C Christophi, P Jones, C ODonnell,
M. Scelwyn, F Dudley.
Departments of Surgery, Gastroenterology, Radiology
& Pathology, Alfred Hospital, Commercial Road,
Victoria, 3181, AUSTRALIA
The AIM of this study was to prospectively evaluate the clinical, radiological
and histological effects of ILH in a series of patients with primary and
secondary hepatic malignancies. Seven women and 6 men, median age 56
(range 39-77) were referred for ILH. Nine patients had colorectal liver
metastases, 2 had primary liver cell carcinoma with cirrhosis, 1 had
metastatic haemangiopericytoma and 1 had sarcoma. The hepatic lesions were
characterised at entry by CT scanning and ultrasound and the size and number
of intrahepatic lesions noted.
METHODS The patients were considered suitable for treatment if their
lesion(s) was >5cm and <15cms in size, <10 in number and accessible to
percutaneous puncture. A 19 gauge needle was inserted into the centre of the
tumour under ultrasound control, a naked laser fibre was then inserted into
the core and the needle withdrawn. Laser therapy was then administered by
continuous firing until the lesion became echogenic. Patients were assessed
clinically and by ultrasound imaging during and for the first 24 hours after
therapy and again at 2 weeks. CT was performed at 8 and 24 weeks.
RESULTS A mean 5000 Watts (range 1449-9449) dose was administered
per session and each lesion received between 1 and 3 treatments (mean 1.8).
Median follow up was 31 weeks (range 7-46). There were 2 deaths during
this time and 1 patient refused follow up. Six patients had completed 6 month
follow up, in 3 the size of the tumour(s) decreased but 1 developed
extrahepatic metastatic disease and in the other 3 progression of local disease
was apparent. Two specimens (1 post mortem and 1 resection) were
examined. Treated areas showed more haemorrhage and possibly greater
necrosis than untreated areas. Seven patients required opiate analgesia post
procedure for 12 hours and 3 patients required extended hospital stay for
pain control. Other side effects included macroscopic haematuria (2),
massive abdominal wall bruising (1), biliary leak (1), jaundice (1).
CONCLUSIONS This study indicates that ILH is a feasible option for the
treatment of hepatic malignacy. Cell necrosis and decreased tumour mass can
be achieved despite the significant procedure related morbidity and therapy
can be easily monitored by ultrasound. The value of ILH as an adjuvant to
other therapeutic options in the management of patients with hepatic
malignancy is worthy of study in a randomised clinical trial setting.
93FP094 ZAL TRANSVERSE HEPA
M Steves and P Sugarbaker
Washington Hospital Center
Washington, D.C. USA
With recent advances in liver surgery, liver resections with cura-
tive intent are being performed at a growing rate. However, there
is a group of patients with lesions at the confluence of the hepa-
tic veins who pose a problem for the hepatic surgeon. Extended re-
sections for these lesions have a highr morbidity and mortality
than lesser procedures (segmental resection). The use of the trans-
verse hepatic plane to resect $5 and S6 has been previously report-
ed. This surgically created plane can also be used to resect those
lesions at the hepatic vein confluence. We report two cases of
right and middle hepatic vein sacrifice with segmental liver resec-
tion of S7, S8, and S4A (cranial transverse hepatectomy).
In the last three years and seventy liver resections, our institu-
tion has seen several challenging lesions at the hepatic vein con-
fluence. Two patients underwent cranial transverse hepatectomy for
metastatic colon cancer. Each patient had a solitary lesion located
at the junction of the IVC, RHV, aD MHV. There were no intraopera-
tive or postoperative complications. One patient received no blood
transfusion and the other 6 units. Discharge was at 14 and 12 days
postoperatively. Peak bilirubin was 3.7 and 3.3. Bilirubin at POD
10 was 2.9 and I .6. Both patients are alive at 10 and 22 months.
Cranial transverse hepatectomy is a safe and useful segmental resec-
tion for lesions located at the hepatic vein confluence. The abil-
ity of the liver to develop collateral venous drainage to the lower
segments (S5, S6, and S4B) is remarkable.FP095 PROBLEMS IN DIFFERENTIAL DIAGNOSIS OF
CYSTIC TUMOURS OF THE PANCREAS
C Sperti, C Pasquali, F Capellazzo, *R Polverosi,
S Pedrazzoli
Semeiotica Chirurgica- University of Padua,
*Radiology- Montebelluna, Italy
From 1970 to 1991 we observed 156 patients with suspected pancreatic cystic
lesions: pre-operative diagnosis suggested a cystic neoplasm in 16 cases.
Histologically, a pancreatic cystic tumour was found in 24/156 patients (15%),
including 3 microcystic adenomas, 9 cystadenomas, 10 cystadenocarcinomas,
1 solid and papillary epithelial neoplasm, and 1 neuro-endocdne cystic tumour.
A correct pre-operative diagnosis was made in 14 patients. US and CT showed
a multilocular cyst in only 3/14 cases, while angiography showed a
hypovascular lesion. Serum amylase levels were high in 3 patients (2
cystadenocarcinomas and 1 papillary-epithelial). Amylase in cystic fluid
performed in 6 cases, was low in 4 (2 benign and 2 malignant) and high in 2
cases. CEA and CA 19-9 in aspirated cystic fluid were within normal range in
3 cystadenomas and high in 1 cystadenocarcinoma.
CT guided fine-neeAle cytology revealed epithelial lining in 8 mucinous tumours
(1 benign and 7 malignant). Excluding 2 casional surgical findings the other
7 patients had a pre-olrative diagnosis ofpseudyst (4), carcinoma (2), biliary
neoplasm (1). In 1 patient intra-operative frozen section of cyst wall was
consistent with pancreatic pseudyst and internal drainage was performed.
In our series a single technique or investigation was not able to give us a correct
diagnosis, however fine-needle cytology and fluid determination of tumoural
markers may help to reduce misdiagnosis of pancreatic cystic tumours. Caution
is needed in evaluating cystic amylase content fr differential diagnosis with
pseudocysts.
95FP096 EXPRESSION OF PANCREATIC MARKERS AND SURVIVAL
IN RESECTED PANCREATIC CANCER
L.Colombo, G.Carcano, L.Dominioni, A.Benevento,
V.Di Carlo*, R.Dionigi.
Department of Surgery, University of Pavia-Vare-
se, Ospedale Multizonale di Varese,Italy
*Clin. Chir., Univ. Milan, H.S.Raffaele, Italy
Recent immunohistochemical and ultrastructuml studies (1) have demonstrated
that exocrine pancreatic tumors represent a heterogeneous cytological population
with different immunophenotypic expressions.
Histologic heterogeneity might be responsible for their different biological
behaviour; that could justify the local recurrent disease in cases treated by radical
exeresis and expected to have a better prognosis according toTNM staging.
PATIENTS AND METHODS. The expression of gastrointestinal antigens DU-
PAN-2, M 1 glycoproteic antigen, cathepsin E, pepsinogen II (PG II) and CAR-5
antigen, has been retrospectively assayed by immunohistochemical methods in 70
cases of pancreatic cancer (66 ductal carcinoma and 4 cystoadenocarcinoma)
radically operated. The antigenic expression has been correlated with tumour
grading and survival.
RESULTS. Statistical evaluation was possible only for CAR-5 and PG II
antigens. CAR-5 antigen was never found in cystoadenocarcinoma, and was
expressed more frequently in G 3 (63%) than in G 1 and G 2 carcinoma (40%).
PG II was expressed in all the cases of cystoadenocarcinoma, and was present in
43% of ductal carcinoma. Mean survival correlated to antigen expression was:
17.7 months in ductal carcinoma PG II POS and 10.3 months in ductal carcinoma
PG II NEG (p < 0.01).
CONCLUSIONS.The data show that patients undergoing surgery for resection of
ductal pancreatic carcinoma expressing PG II antigen have a more favoumble
prognosis. This information could be ofvalue in planning treatment ofpancreatic
cancer.
(1) Sessa F. et al." Ductal cancers of the pancreas frequently express markers of
gastrointestinal epithelial cells. Gastroenterology (1990), 98" 1655-1665.
96FP097 MORBIDITY AND MORTALITY OF TRADITIONAL AND
EXTENDED LYMPHO-ADENECTOMY IN RESECTION OF
PANCREATIC HEAD CANCER (PK)
S Pedrazzoli*, V Di Carlo, R Dionigi#, F Michdassi@
F Mosca", P Pedorzo’li
Departments of Surgery, University of Padova*,
Milano, Vareseg, Pisa", Verona", Italy. Chicago@, USA
Extended lymphadenectomy (L) is reported to improve local recurrence rate and
5-year survival after curative resection ofPK in two retrospective studies (1,2).
In March 1991 we started a prospective, randomized, multi-centric study aimed
at comparing the short and long term results of a pancreatoduodenectomy (PD)
with conventional (R1) L or extended (R2) L in the treatment of PK. We now
report on the short term results obtained in our first 48 pts (33 m, 15f, mean
age 59.9 _+ 10.6 years) operated on between March 1 1991 and October 31
1992.
Extent of lymphadenectomy
Age (years)
Intra-op blood transf. (U)
Post-op abd drainage (ml)
Post-op day drains removed
Post-op day diet started
Length p o hospital stay
Post-op mortal./major morbid
Pancreatic fistula
Haemorrhage
Cardiognic shock
Subphrenic abscess, pulm. embol.
Acute pancreatitis, hemobilia
Renal insufficiency, pneumonia
Peptic ulcer
RI (n=24) R2 (n=24)
mean +/- SD mean + SD
60.2 :!: 12.4 59.7 _+ 8.6
2.3 +/- 1.5 2.0 + 1.0
2196 _
1520 2636 _
4361
11.3 5:4.7 10.1 4.3
10.4 +/- 4.4 8.9 + 2.8
22.9 +/- 9.8 18.6 5:6.3
2/11 1/ 6**
4
2 2 (1)
1 (1)
1 2
1 (1)
2 1
1
( ) Patients who died; ** Chi square = 2.28 0.3 > P < 0.1. Only post-op
major morbidity was statistically slightly better after 112 L; the amount of lSt
op abdominal drainage may be greater after the extended L; n other difference
was statistically significant. Operative time was about 30’ 60’ longer in R2
L, although lal pancreatic conditions interfered greatly with it. We conclude
that extended L can be performed at least as safely as a conventional L in
association with a PD fr hopefully curative resection of PK. The retmrted
effect (1, 2) on long term survival will be assessable in the next years.
1) Ishikawa Ann Surg 208,1988 2) Manabe Cancer N, 1989.
Suplrted by CNR, ntract n. 92.02236.PF39
97FP098 CANCER OF THE EXOCRINE PANCREAS.
RESULTS OF 787 RESECTIONS.
H Baumel, M Huguier, JC Manderscheid
Departments of Surgery and
Biostatistics, Montpellier, Paris.
This retrospective multicentric study was carried
out in patients operated on from 1982 to 1989.
Overall postoperative mortality was 10%. A
multivariate analysis showed that age > 70 years
and visceral failure influenced postoperative
mortality (P<0.05) In patients surviving more
than 30 days, the median survival time was 12.3
months, and the 5-year actuarial survival rate was
12%. This rate was lower (P=0. 001) in patients
with lymph node involvement (4%) than without
(20%) According to the type of procedure,
operative mortality was higher (P=0.01) after
total pancreatectomy (n=l12) than after Whipple
procedure (n=555) 17% and 8%, respectively.
Median survival times and 5-year actuarial
survival rate after total pancreatectomy and
Whipple procedure were ii months and 14 months,
and 3% versus 15%, respectively. The site of the
tumour on the left pancreas, and left
pancreatectomies (n=120) were related to a poor
prognosis without
Whipple procedure,
9% of cases with
(n=366), in none
(n=16), and in
obturation (n=24)
any 4-year survivors. After
a pancreatic fitulae occured in
pancreaticojejunal anastomosis
after pancreaticogastrostomy
21% of cases after ductal
These results suggest that resection must be
avoided in patients over 70 years old with
visceral failure. The Whipple resection remains
the gold standard type of resection. Total
pancreatectomy is
tumours, and if a
safely constructed.
of the corpus or
considered as a
Whipple procedure,
be
only indicated in multicentric
pancreatic anastomosis cannot be
Left pancreatectomy for cancer
tail of the pancreas may be
palliative procedure. After
pancreaticogastrostomy seems to
a safer procedure than pancreaticojejunostomy.
98FP099 CANCER OF THE EXOCRINE PANCREAS.
RESULTS OF PALLIATIVE PROCEDURE
IN 2493 PATIENTS
H Baumel, M Huguier, JC Manderscheid
Departments of Surgery and
Biostatistics, Montpellier, Paris.
Opinions are still divided regarding the optimal
palliative procedures in patients with cancer of
the pancreas. This retrospective, multicentric
study, was carreid out in patients operated on
from January 1982 to December 1988 to compare the
results of various procedures aimed at palliation
for pancreatic cancer.
Cholecystoenteric bypasses (n=237 in comparison
to choledochoenteric bypasses (n=1770) were
associated with a higher postoperative mortality
(20% vs 14%), a lower long-term morbidity (26% vs
35%) and a lower survival rate (means: 13.2
versus 5.2 months) Choledochoduodenostomy
(n=i159) and choledochoj ejunostomy (n=611) had
similar rates of postoperative mortality (14% vs
13%) ," morbidity (26% vs 27%) incidence of
recurrent jaundice (8% vs 7%) and median survival
(5.4 vs 5.0 months) Surgically placed biliary
stents (n=l14) were followed by the highest
postoperative mortality (27%) morbidity (46%)
rate of recurrent jaundice (14%), and the shortest
median survival (2.6 months) Postoperative
mortality in patients undergoing a
choledochoenteric bypass and a gastroj ejunostomy
(n=I134) was similar to that observed in patients
who had only a biliary bypass (n=636) (16% and
12%) but among the patients who had a biliary
bypass alone, 16% developed a gastric obstruction.
For the relief of pancreatic pain, radiotherapy
was more effective
treatments (p=0. O2)
These results suggest
obstructive j aundice
choiedochoduodenostomy
bypasses, 2) a
gastrojejunostomy to
obstruction, 3 and
pain
than other symptomatic
the need i) in patients with
to perform a
rather than other biliary
routine prophylactic
prevent gastric outlet
for the relief of pancreatic
to perform radiotherapy or splanchnicectomy.
99FP100 ROLE OF OCTREOTIDE COMBINED WITH TPN AND
ANTIBIOTICS IN THE TREATMENT OF PANCREAT-
IC DISEASES AND PREVENTION OF POSTOPERA-
TIVE COMPLICATIONS FOLLOWING PANCREATIC
RESECTION
BM Wang, Y Tang, XG Hu, R Liu, QF Liu
Department of Surgery,Chang Hai Hospital
Shanghai 200433,PR of China
Pancreatic exocrine secretion decreased significantly from the
stent drainage tube inserted into the pancreatic duct stump
during a Whipple procedure for patients with periampullary
cancer (n-----10)after receiving a 7--day treatment of 100g oc-
treotide (Sandostatin) subcutaneously Q8h, as compared with
the control group (n---- 8) (P%0. 01).
Octreotide was given I. V. in saline with a dosage of 5/g/Kg/h
for a hours in rats with acute hemorrhagic pancreatitis estab-
lished by the iniection of 5M sodium taurocholate into the
pancreatic duct. The results showed that octreotide could de-
crease the serum levels of amylase and lipase effectively, re-
duce lung index and extravascular lung water significantly, as
well as ameliorate the pathologic changes in lung and pancreas
of rats, as compared with the control group (p0. 01).
During a period of 1 year (Dec. 1991--Nov. 1992), a cases of
pancreatic fistula and 5 cases of acute hemorrhagic pancreati-
tis were treated non--operatively with octreotide, TPN plus
antibiotics, and recovered uneventfully. During the same pe-
riod, no pancreatic fistula was observed in any of the 1 con-
secutive patients folllowing a difficult Whipple procedure after
receiving octreotide in coniunction with TPN and antibiotics
perioperatively, as compared with the historical control. It is
concluded that octreotide is an invaluable drug in conjunction
with TPN and antibiotics for the treatment of certain pancre-
atic diseases and prevention of postoperative complications
following pancreatic resection.
100FPI01 PERCUTANEOUS US-GUIDED HNE NEEDLE ASPIRATION
CYTOLOGY IN THE DIFFEREN’HAL DIAGNOSIS OF
PANCREATIC AND PERIPANCREATIC MASSES
A Campatelli, F Farina, G Sartoni, P C Giulianotti,
G Di Candio, U Boggi, F Mosea
T stituto di Chirurlia Generale e Slaerimentale
Pisa Universify Medical Sehoo’l, Italy
Although recent improvements in imaging techniques (US, CT and ERCP), the differential diagnosis
of a pancreatic mass still remains a challenging problem. In some eases fine needle aspiration
cytology (FNAC) has been proposed as a helpful diagnostic tool.
Out of 186 patients admitted to PISA University Hospital with a diagnosis of pancreatic or
peripanereatie mass, in the period between November 1987 and July 1992, forty-one (22%) (22 males;
19 females; mean age 59 9.3),who had already had a routine diagnostic work-up (i.e. US, CT and
ERCP), underwent US-guided FNAC to define diagnosis and treatment.
Patients were retrospectively divided into 2 groups on the basis of whether or not the clinical
judgement suggested a surgical approach regardless of FNAC results: Group A (surgery group)
(n=36) and Group B (no surgery group) (n=5).
Twenty-three lesions were located in the head ofthe gland, 9 in the body and 9 in the tail; thirty-five
were solid and six cystic masses. Mean US diameterwas 37mm (range 10 80ram).A 22-gauge spinal
needle was inserted under US guide. Sufficient material for cytology was available after the first
sampling in thirty-eight patients (92.68%) and in three a second or third attempt was required.
GROUP A (n=36)
FNAC diagnosis
18 AdenoCa
4 possible Ca
1 Careinoid tumour
2 Cystoadenoma
9 Panereatitis
1 Adenoma
1 Lymphoadenitis
Operative Specimen
18 AdenoCa
4 AdenoCa
1 Carcinoid tumour
2 Cystoadenoma
3 Panereatitis
6 AdenoCa
1 AdenoCa
1 Lymphoadenitis
Hodgkin lymphoma
AdenoCa
AdenoCa
Metastasis ofHHC
Chronic panereatitis
7 False negative: Sensitivity 80%
GROUP B (n=5)
FNAC diagnosis Notes
Previous positive lymph node biopsy
Recurrence after PPPD*
Dead from carcinosis
Dead from HHC
Alive
*PPPD: pylorus preserving panereatoduodeneetomy
No procedure (FNAC) related complication was recorded. Neither local nor diffuse peritoneal
metastatic spread was observed (samples ofperitoneal lavage cytologywere routinely examined after
surgery).
In conclusion in Group A, patients in whom surgery is indicated after a standard diagnostic work-up,
FNAC does not add any further element in treatment decision making. Findings suggestive for
chronic panereatitis do not actually exclude the presence of an underlying cancer and resection
should be performed whenever the clinicaljudgement suggests to do so. On the otherhand a positive
cytology (specificity 100%)maybe ofhelp in planning therapy (i.e. combined antibalstiepre-operative
neo-adjuvant treatment).
In Group BFNACmaybe useful in clarifying diagnosis (specificity 100%), guiding follow-up therapy.
101FP102 153 PYLORUS PRFERVING
PANCREATODUODENECTOMIES"
A CLINICAL AND PHYSIOLOGICAL SURVEY.
F Mosca, P C Giulianotti, U Boggi, G Sartoni.
F D’Elia, G Di Candio, T Balestracci, M Olegg{ni
Istituto di Chirur.gia Generale e Sperimentale
Pisa University Medical School, Italy
FromJanuary 1982 toNovember 1992 153 pylorus preserving panereatoduodenectomies (PPPD)
(94 m, 59 f),ineluding 10 total panereatectomies, were performed at the Department of General
and Experimental Surgery of Pisa University. 20 patients had chronic panereatitis, 73 ductal
adenocarcinoma (including 3 patients who had a synchronous neoplasm: two of the papilla of
Vater and one of the kidney), 28 papillary cancer, 13 common bile duct cancer, 4 duodenal
cancer, 4 eystadenocarcinoma, 2 cystadenoma, 2 non-functioning endocrine tumour, I carcinoid
mmour, 1 squamous carcinoma, 1 inslet cell carcinoma, 1 duodenal leiomyosarcoma, 1
lymphoma, 1 papillary-cystic neoplasm and one benign tumour of papilla of Vater.
Mean age was 63.41 +/_ 12.9 yrs. and 48.85 +/_ 12.03 yrs. in the neoplastic and in the chronic
panereatitis group respectively. Operative mortality (overall rate 7.18% [11/153]) has shown a
significant decrease while gaining further surgical experience and is now 2.6% (2 deaths out of
75 operations in the last 4 yrs.). Half of the deaths occurred from cardiovascular diseases.
Morbidity rate was 41.8% [64/153] and 6 patients required re-operation. Postoperative naso-
gastric suction maintained for an average of 12.3 days (range 5-27) and for more than two
weeks ( delayed gastric emptying) in the 26% of eases (36/146). Food re-introduction was
satisfactorily accomplished in the majority of the patients. The weight gain average, six months
after surgery (excluding those who had an early neoplastic recurrence) was 3.8 kg (some
patients gained as much as 7-10 kg). Specific late complications were observed in 5 patients:
2 perforated gastric ulcers requiring emergency surgery (one due to chemotherapy for lymphoma
and the other to aspirin abuse 5 months following surgery), 1 duodenal bleeding (42 months
after surgery) and 2 antral gastritis with mild bleeAing. The latter three were successfully treated
with medical therapy.
All the patients operated on for chronic panereatitis but one, who died of laryngeal cancer, are
still alive. Late complications in this group were: 1 stricture of hepaticojejunostomy
(successfully treated by pereutaneous balloon dilation) and one small intestinal obstruction due
to adhesions, which was relieved by medical therapy. A satisfactory pain control was obtained
in every case.
Out of 73 patients operated on for pancreatic cancer 14 are still alive (with three surviving
longer than three yrs.). The overall three yrs. survival rate is 25.64% (10/.39). 47 patients died
of cancer recurrence: the mean survival time in this group was 14.19’/. 12.9 months. A
retrospective analysis comparing two homogeneous groups of patients who underwent PPPD
(n 41) or Whipple procure (n 16) did not show significant differences in the survival time
(median survival time: PPPD 14+/. 1.9 months; Whipple 13+/. 3 months) (Life table and
survival function [Breslow and Mantel-Cox test] and Cox proportional regress hazard model).
102FP103 LIVER TRANSPLANTATION FOR VIRAL HEPATITIS
A REVIEW OF 31 CASES
S Bhattacharya, G Dusheiko, A Burroughs
B Davidson, K Rolles
Royal Free Hospital and School of Medicine
London NW3 2QG, U.K.
From October 1988, 32 liver transplantations were performed on 31 adults
with acute or chronic viral hepatitis.
Two were transplanted for fulminant viral hepatitis B. Both are alive 8
to 12 months later, with no evidence of reinfection.
Of 11 patients with chronic hepatitis B, 2 died of early post-operative
complications. Three have had their HBsAg eradicated, and remain well at
10, 26 and 43 months. Six suffered HBV reinfection of the graft. Return
of HBsAg and HBV DNA in serum was followed by clinically apparent graft
dysfunction. All six have died of liver failure, with a mean post-operative
survival of 9 months.
Two patients had chronic hepatitis B and D. Both are now HBsAg negative,
though one suffered an episode of acute HBV graft infection. Two patients
had chronic hepatitis B and C, and both succumbed to HBV graft reinfection
at 3 and 7 months respectively.
All but one patient with HBV infection received prophylactic hepatitis B immune
globulin (HBIG). Of the 8 patients who died of HBV reinfection, 4 were negative
for HBV DNA and HBeAg when transplanted.
Of 14 patients transplanted for chronic hepatitis C, there was one early
mortality. Two were cleared of HCV RNA, though one died later from unrelated
causes. The remaining 11 all developed viral reinfection (positive HCV RNA).
One died of liver failure at 23 months, and 3 have liver dysfunction
attributed to HCV reinfection of the graft. The mean follow-up of the 10 HCV
RNA positive survivors is 9 months.
Excluding early mortalities, 9 out of 10 deaths were due to viral reinfection
of the graft. In chronic hepatitis B, despite careful patient selection
and attempted prophylaxis with HBIG, graft failure from HBV reinfection
remains the major cause for late morbidity and mortality. In patients with
chronic hepatitis C, reinfection with HCV is common, but it does not have as
damaging an effect on graft function.
103FPI04 A PROSPECTIVE SERIES OF
LIVER TRANSPLANTATION (OLT) FOR
SMALL HEPATOCELLULAR CARCINOMA (HCC)
IN CIRRHOSIS
V.Mazzaferro, E.Regalia, G. Colella,
R. Doci, F. Bozzetti and L. Gennari
Istituto Nazionale Tumori Milan-Italy
From January 1991 to December 1992 24 LT were
performed in 22 patients affected by HCC in cirrhosis.
The acceptance criteria chosen for the prospective
accrual of such patients were:l) non resectable single
nodule < 5 cm or multifocal HCC (< 3 nodules, < 3 cm )
2) pre-operative T1-2,No,Mo 3) histologically proven
cirrhosis. 12 cirrhosis were HCVAb+, 7 had a
HBsAg+/HBV DNA- status and in 3 cases B and C viruses
were associated. Pre-operative Child-Pugh stage was
A=5 pts, B=7 pts, C=I0 pts.
In 15 pts (68%) pre-transplant chemoembolization (CE)
with Lipiodol, Gelfoam and Doxorubicin, Mitoxantrone
or Mitomycin C was feasible. Although a necrosis of
> 50% was observed in 41% of the HCC-nodules,the exact
role of CE on pts-survival is not clear since no tumor
recurrence was detected neither in the CE-pts nor in
untreated OLT.
Two pts (9%) underwent re-OLT (primary non-function
and fulminant HBV reinfection) while complex arterial
reconstruction (iliac graft) occurred in 41% of cases.
Perioperative mortality (1st month) was 18%, median
stay in ICU was 10 days (4-62). Post-transplant HCC
stage was pTx=2, pTI-T2=I3, pT3=6, pT4=l. Lymphnodes
were free of tumor in all cases. Six out of 15 pts
(40%) had a mild form of HCV recurrence and 2 out of
10 pts (20%) had a severe HBV recurrence.
One-year survival of the present series is 78% and up
to now ali deaths are due either to post-OLT
complications (ARDS, GvHD, multiple organ failure and
sepsis) or to HBV recurrence. No tumor recurrence has
been observed after a median follow-up of 12 months.
OLT for HCC in cirrhosis seems to be justified in
early tumor stages.
104FP105 ARTERIAL CHEMOEMBOLIZATION (CE)
BEFORE LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA IN CIRRHOSIS
E.Regalia, G.Colella, C.Spreafico,
A.Marchiano’ S Andreola,F.Montalto,
R.Doci, F.Bozzetti, L.Gennari and
V.Mazzaferro.
Istituto Nazionale Tumori Milan-Italy
From November 1990 to December 1992, 24 orthotopic
liver transplants (OLT) were performed on 22 patients
with small unresectable hepatocellular carcinoma (HCC)
in cirrhosis. 15 out of 22 pts (68%) were treated
pre-operatively with CE with Lipiodol, Gelfoam and
different drugs schedule- Doxorubicin(30 mg/m2) =9pts;
Mitoxantrone (14 mg/m2) =4pts and Mitomycin-C (20 mg/m2)
=2pts. A total number of 33 cycles were given with a
mean of 2.2 for patient (range 1-4). CE was not
performed in 7 pts either for advanced Child stage or
for technical problems.
Complication rate was 40% medullary aplasia-2 pts;
fulminant liver failure requiring emergency OLT:3 pts;
hepatic artery intimal dissection-4 pts but no
pts died from the procedure.
Hystological response in terms of % of tumor necrosis
after total hepatectomy was evaluated on 22 nodules
of HCC (mean diameter 1.9 cm range 0.8-5.1).
Necrosis >50% was observed in 9 nodules (41%), partial
response (<50% necrosis) in 7(32%) and 5 nodules (23%)
were unaffected by CE. Number and diameter of nodules,
presence of capsule, type of drug and number of cycles
were not significantly associated with response to CE
while the hypervascolar aspect on the angiogram
was significantly associated with necrosis > 50%
(p=0.004). The pT stage of the tumor was correlated
with response to CE ( necrosis >50% in 57% of TI-T2
nodules vs 12% of the T3 p=0.05).
Longer follow-up is needed to assess the influence of
CE on patients-survival since no tumor recurrence was
detected after OLT at a median follow-up of 12 months.
105FP106 LIVER TRANSPLANTATION IN CHILDREN
WITH CIRRHOSIS AND SEVERE HYPOXEMIA
J HOBEIKA*,D HOUSSIN*,O BERNARD,D DEVICTOR,
G GRIMON, Y CHAPUIS*
Clinique chirurgicale,H6pital Cochin,PARIS FRANCE
Dpartement d’hpatologie pdiatrique Hbpital
Kremlin-bictre,le Krem/in-Bictre.FRANCE
Liver transplantation has been considered until recently as an
absolute contraindication in hypoxemic patients with intrapulmonary
shunting (IPS)because of a high mortality. We report our experience
of orthotopic liver transplantation (OLT) in nine patients with
cirrhosis-related hypoxemia.
Pa.t.ients and methods: Nine patients with a median age of 9 years (28
months-17 years) having cirrhosis-related hypoxemia had orthotopic
liver transplantation (OLT) between June 86 and June 92. The arterial
blood oxygen pressure (Pat2) at room air ranged from 47 to 78 mm Hg.
Hypoxemia was related to intrapulmonary shunting(IPS) in all cases
as documented by technetium 99-m macroaggregated albumin
scintigraphy (MAA* scintigraphy) and pulmonary angiogram. OLT
was performed 9 years (2-15 years) after the first symptom of liver
disease and 36 months (4-108 months after the first respiratory
symptom. As a mean,operation time and cold ischemia time were 11
hours (6-19 hours) and 10 hours (4.5-22 hours) ,respectively. Two
patients had vent-venous by-pass during OLT.
R.sults.:Four patients who had preoperative Pat2 at air level lower
than 60 mmHg died between the second and the 37th post-operative
day ,three from worsening hypoxemia requiring 100% oxygen
ventilation and leading to cardiopulmonary failure and one from
primary graft non-function. Five patients survived.Two of them had
preoperative Pat2 level lower than 60 mmHg. Two patients had acute
graft rejection successfully treated by corticosteroids on the 12th and
the 21th post-operative day. One patient required reoperation for
biliary anastomotic stricture. Two patients had symptomatic
cytomegalovirus infection without pulmonary infection successfully
treated by DHPG. The median hospitalization time in intensive care
unit was 9 days (4-22 days). Median endotracheal tubing time was 6.8
days(2-19 days) All patients demonstrated normal blood gas analysis 3
months after OLT with closure of IPS, as documented by
MAA*scintigraphy.
Conclusion: Severe hypoxemia is no longer a contraindication to liver
transplantation .Patients having PaO2 levels higher than 60 mm Hg
should have OLT as soon as possible before reaching lower levels of
PaO2. Because of the high operative risk of liver transplantation,
combined lung-liver transplantation should be considered in patients
with more severe hypoxemia(PaO2<60 mm Hg).
106FP107 VALUE OF DONOR MEGX LEVELS AND
HISTOLOGY IN PREDICTING GRAFT OUTCOME
K Karayalcin, D Mirza, R Harrison,
R DaSilva, S Hubscher, AD Mayer,
JAC Buckels, P McMaster.
The Liver and Hepatobiliary Unit, Queen
Elizabeth Hospital, Birmingham, U.K.
Despite their limitations, conventional tests of
liver function and macroscopic appearance of the
donor liver have been the mainstay in selection of
donor livers for transplantation. The use of donor
liver biopsies and the cytochrome P-450 mediated
formation of lignocaine metabolite mono ethyl
glycine xylidide (MEGX) has been reported to be
useful in predicting early graft function.
This prospective study included 63 consecutive
livers harvested and transplanted over a six month
period. Serum MEGX levels were assessed 15 minutes
after an intravenous bolus of 1 mg/kg lignocaine.
Preperfusion liver biopsies were obtained at
harvesting prior to any dissection and postperfusion
liver biopsies after completion of vascular and
biliary anastomoses, and these were examined for
features of pre-existing disease and effects of
preservation injury. No grafts were discarded on the
basis of MEGX levels or histology, and all harvested
livers were transplanted.
The median MEGX level was 89 #g/L (16-250); 15 had
MEGX levels < 50 #g/L, 17 between 50 and 90 g/L, and
31 > 90 #g/L. There ware no significant differences
in early graft function and outcome in the three
groups. Preperfusion biopsies were reported as
normal (n=33), mild steatosis (n=17), moderate/
severe steatosis (n=ll). All grafts showed good
function, including those with moderate/ severe
steatosis. There was no case of primary nonfunction.
MEGX levels failed to correlate with donor
histology. Examination of postperfusion biopsies for
effects of preservation injury (minimal, mild,
moderate) revealed no difference in graft outcome,
although the livers with moderate/ severe steatosis
showed a significantly greater degree of
preservation injury (p<0.01).
I07FPI08 LIVER TRANSPLANTATION IN PATIENTS WITH POSITIVE
T LYMPHOCYTOTOXIC CROSSMATCH
T. R. Kurzawinski, Z. Varghese, S. Hardy, J. Bed, G. Shirling,
A. Burroughs, K. Rolles.
Hepatobiliary & Liver Transplantation Unit, Tissue Typing
Laboratory, Royal Free Hospital, London, U.K.
The effect of a positive T lymphocyte crossmatch on the outcome of orthotopic liver
transplantation (OLT) is conflicting.
The aim of this study is to evaluate the influence of a positiveT cell crossmatch on the outcome
of orthotopic liver transplants performed in the Royal Free Hospital between 1988 and 1992.
One hundred and forty-two patients undergoing OLT had a T cell crossmatch performed
retrospectively by the cytotoxicity method. The results of the crossmatch did not influence
recipient selection, which was based on medical indications for transplantation only.
Eight patients (6%) (four males, four females, median age 46 years, range 31-64) had
circulating cytotoxic antibodies to donor T cells detected in serum taken hours before
transplantation. Indications for transplantation in these patients were Hepatitis B (1), Hepatitis
C (2), alcoholic cirrhosis (1), epithelioid haemangioendothelioma (1), primary biliary cirrhosis
(1), chronic liver graft rejection (1) and cryptogenic cirrhosis (1). The past medical history of
these patients included pregnancy (4/4) and blood transfusion (6/8) before transplantation. Five
patients were treated with Cyclosporin A, Methylprednisoloneand Azathioprine post-operatively
and three patients with anti-thymocyte globulin, Cyclosporin A and Methylprednisolone.
Cytotoxic antibodies against donor T cells disappeared from the circulation within the first 48
hours after liver transplantation. All patients experienced one to four episodes of biopsy proven
moderate to severe acute cellular rejection. Rejection episodes were treated with 1 gram of
Methylprednisolone per day for three days. Additional OKT3 therapy was given to three
patients following an unsatisfactory steroid response. No case of primary graft non-function
or graft loss for any reason were seen. The earliest episode of acute cellular rejection was seen
on the fifth post-operative day. A single patient developed chronic rejection of the liver graft
at 12 months. Thrce of the eight patients died; one chronic rejection at 17 months, one tumour
recurrence at 4 months, one infection at 5 months. Five out of eight patients are currently alive
with normal liver function. No radiological or histological evidence of vanishing bile duct
syndrome has been seen in any of the patients. Actuarial one year survival in this group is
69%.
We conclude that a positiveT cell lymphocytotoxic crossmatch has not significantly effected the
outcome of transplantation in our small series.
108FP109 ZOLLINGER ELLISON SYNDROME. SURGICAL
TREATMENT FOR "CURE" OR LONG TERM
PALLIATION?
C Pasquali, C Sperti, D Miotto*, A Alfano D
C Filipponi, S Pedrazzoli
’Andrea,
Semei_otica Chirurgica & Radiology*,
University of Padua, Italy
Since 1970 we observed 51 patients with Zollinger-Ellison syndrome; 11 had
a MEN type 1 with two or more endocrine glands involved. 24 patients had a
Portal Venous Sampling (PVS) before surgery for tumour localization and
evaluation of resectability. 28/50 patients underwent surgery; 11 had only a total
gastrectomy because the tumour was not found. 17 patients underwent surgery
with resective purpose; 13/17 had a PVS performed before surgery which in 8
cases showed only a single source of gastrin release, then hopefully "curable".
All these 8 cases became normogastrinemic after operation (follow-up 5 to 16
years). Only 1/5 cases in which PVS was not localizing a single tumour was
cured by surgery. Only 1/4 patients who underwent surgery without prior PVS
was made normogastrinemic by resection of a large liver tumour involving the
fight lobe.Then in 10 out of 28 patients surgically treated,gastrin fell to
normal,but in two cases a late recurrence of hypergastrinemia was found after
5 and 14 years.All the patients in which gastrin did not fall to normal after
surgery were treated with antisecretory drugs (if not gastrectomized) as well as
those who had no surgery at all.Out of 26 patients who had medical treatment
3 escaped and needed emergency surgery later (3 mo.-3 yrs.) while 9 required
omeprazol for long term failure of H2 blockers (3-14 yrs.)
5 patients had liver metastases at the time of diagnosis; 2 died within 12 months.
Two cases (1 total gastrectomy and 1 who had only medical treatment)
developed liver metastases 21 and 15 years later respectively. PVS greatly
enhanced the chance for tumour resection and gastrin normalization after
surgery; late recurrence may occur even after 5 years due to slow growing
tumour. So, despite gastrin falling to normal, tumour resection may represent
a long term palliation; careful and lifelong follow-up is mandatory even in
"cured" and total gastrectomized patients.It is strongly advisable not to leave
patients in chronic medical treatment without periodical re-evaluation for
possible resective surgery.
109FP110 PREOPERATIVE LOCALIZATION OF
INSULINOMAS BY ENDOSCOPIC
ULTRASONOGRAPHY.
J Pitre, O Soubrane, L Palazzo, Y Chapuis
Clinique Chirurgicale, H5pital Cochin, Paris,
France
Pre-operative radiological localization of insulinomas often fails because
of the small size of these tumors. However, the tumor localization is of
great interest before surgery in order to avoid any blind pancreatic
resection. Thus, the aim of this study was to assess the value of
endoscopic ultrasonography (US) in preoperative localization of
insulinomas.
Between 1983 and 1992, 14 patients with hyperinsulinism were
evaluated for tumor localization before surgical resection. Radiological
assessment included: abdominal US (n=13), CT-scan (n=13),
angiography (n=5), magnetic resonance imaging (n--5), portal venous
sampling (n=l), and endoscopic US for the last 7 patients. All patients
underwent laparotomy with intra-operative US.
During surgery, the association of palpation and US localized 12 solitary
tumors and 2 multiple tumors (including a case of multiendocrinopathy
type I), confirmed at histological examination. Four tumors were found
malignant because of lymph node involvement and/or liver metastasis.
The mean size of the tumors was 19+11 ram. The sensitivity of
conventionnal preoperative methods of localization was 6114 cases
whereas the sensitivity of endoscopic US was 617 cases with no false
positive case. No blind pancreatic resection was done. The surgical
procedures were: 5 enucleations, 8 distal pancreatectomies (4 without
splenectomy) and one total pancreatectomy. No postoperative death
occurred.
We conclude that because of its high sensitivity and safety, endoscopic
US is the best method for preoperative localization of insulinomas
whereas the conventional methods are of limited interest and should be
abandoned.
110FPII1 LOCALIZATION AND SURGICAL MANAGEMENT
OF INSULINOMAS
C Pasquali, C Sperti, G Liessi , A Alfano D’Andrea,
C Filipponi, M Guido*, $ Pedrazzoli
Semeiotica Chirurgiea -_University of Padua,
Radiology- Castelfranco * Pathology- Cittadella, Italy.
From 1966 to 1992, in our Department 65 cases with organic hyperinsulinism
were observed. A single case had a MEN type 1. 58 patients underwent
surgery; 5 of them had a second operation because the first failed to find the
tumour. Pre-operative investigations included: arteriography in 56 cases, a CT
scan in 32, US scan in 21, portal venous sampling in 28, NMR in 12. 23
patients had also a pre-operative US scan. Arteriography was positive in 20/60
performed, (33 %), with 10 false positive (10 %). Only 12/33 CT (36 %) and
9/21 (43 %) US scan were positive; false positives were 9 % and 5 %
respectively. NMR was positive in 7/12 cases. Portal venous sampling (PVS)
was positive in 23/28 cases (82 %). Operative US localized the tumour in 17/23
(74 %) cases, including 4 cases in which pre-operative US was negative and 2
cases of "occult" insulinoma. In the last 9 year period (22 patients) the positivity
rate for imaging techniques rose to 50 % for angiography, 56% for CT scan and
64% for US in patients with adenoma, but three patients underwent surgery
having only a positive PVS.
In 63 operations performed, 18 cases (29%) had a negative surgical exploration
and at least I adenoma was missed by palpation and occasionally found in three
more cases. Multiple tumours were found in 5 while in 5 were found a
nesidioblastosis or Beta cell hyperplasia. Only 2 cases had liver metastases at
surgery. An explorative laparotomy was performed in 4 cases, a pancreatico-
duodenectomy in 2, a left pancreatectomy in 34 (in 15 the spleen was
preserved), a tumour excision in 18, and an atypical pancreatic resection in 3.
53/58 patients (91%) became euglycaemic after surgery, 2/58 died from tumour
progression and in 2 cases the tumour was not found (3.4 %). Morbidity was
23% and mortality was 6%, however only one death, unrelated to surgery
occurred in the last 45 cases.
111FPII2 NON-FUNCTIONING ISLET CELLTUMOURS OF
THE PANCREAS.
R.C.N. Williamson, S. Cheslyn-Curtis
Department of Surgery, Royal Postgraduate Medical
School and Hammersmith Hospital, London
Pancreatic neuroendocrine tumours are rare and most produce a clinical
syndrome due to the excess production of a single hormone. Between 15-
41% appear to be non-functioning producing neither a clinical syndrome nor
an excess of any active peptide. We have reviewed the natural history and
management of non-functioning tumours diagnosed between 1982 and 1991.
There were 20 patients of median age 44 yr (22-75 yr). Presenting features
were obstructive jaundice (7), abdominal pain (7), weight loss (6),
abdominal mass (6), and severe haemorrhage (4). Gut hormone profiles
were normal except in one patient with a raised pancreatic polypeptide level.
Contrast-enhanced computed tomography localised the tumour in 17 patients
and visceral angiography in 14 of 15 patients; all but three tumours were
highly vascular. Ten patients underwent curative resection and the remainder
were managed palliatively by resection, bypass procedures or biopsy alone.
There were two postoperative deaths and 7 early complications. Seven of
the remaining 18 patients have died of their disease at a median 16 months
(4-30 months) following presentation. The 11 survivors, 8 of whom had
"curative" resections have been followed for a median 42 months (7-72
months). Ten patients are asymptomatic although only 5 are free of disease.
These tumours are seldom curable by radical surgery but patients may remain
free of symptoms for many years.
112FPl13 The use of an isotope labeled somato-
statin analog in the visualization of
pancreatic tumors enlarges the indica-
tion for operative therapy.
C.H.J. van Eijck, S.W.J. Lamberts,
E.P. Krenning, J. Jeekel.
Ac. Hosp. Dijkzigt,
Dr. Molewate_rplein 40, 3015 GD Rotter-
dam, The Netherlands.
Since palliative surgery in patients with islet
cell tumors is not only of value to relief clinical
symptoms but also to decrease tumor burden, which
facilitates the effect of causal medical treatment, pre-
operative differentiation between pancreatic adeno-
carcinomas and "non-functioning" islet cell tumors is
essential.
We recently developed a new technique for visuali-
zation of "non-functioning" islet cell tumors pre-
operatively. We tested this new technique in 25 patients
with islet cell neoplasms after the intravenous admini-
stration of the isotope labeled somatostatin analog
IIIIn-Octreotide.
The primary tumors, as well as previously often un-
recognized distant metastases were visualized in 20 of
these 25 patients (80%) with islet cell tumors.
All 6 "non-functioning" islet cell tumors could be
visualized. In contrast in 20 patients with primary
pancreatic adenocarcinomas the tumor could not be seen.
This new technique of in vivo localisation of somatosta-
tin receptor positive tumors may select more candidates
preoperatively for palliative surgery, especially
patients with "non-functioning" islet cell tumors which
by other means cloudn’t be recognized and the detection
of somatostatin receptors on these tumors in vivo pre-
dicted a good suppressive effect on hormonal hyper-
secretion by these tumors and may help to predict and
monitor the growth inhibitoiry effect of octreotide.
113FPll4 PANCRF_TIC MICROCYSTIC ADENOMAS
(GLYCOGEN-RICH CYSTADENOMAS).
A CLINICOPATHOLOGIC STUDY OF 20 CASES.
D. BRASSIER- L. De CALAN
Association de Recherche en Chirurgie
Association Universitaire de Recherche en Chirurgie
Hopital R. Ballanger Service de Chirurgie Viscrale
93600 AULNAY SOUS BOIS
Pancreatic microcystic adenoma is a rare cystic neoplasm which is benign. This
retrospective multicentric study (from january 1978 to december 1987) reports the
clinicopathologic features and results of treatment of 20 patients with microcystic
adenoma of the pancreas.
There were 4 men and 16 women. The median age was 62 years (31-82). The tumour
was found incidentally in 10 patients (3 times during an operation for other disease, 7
times during abdominal investigation for other disease); 10 patients had a palpable
abdominal mass with or without abdominal pain. One patient has two tumours, 19
patients had a single tumour with a mean size of 7cm, which was located in the head (6
patients), the body (5 patients) or the tail of the pancreas (8 patients). Two patients had
only a biopsy of their tumour, 18 patients underwent a complete excision of their
tumour 4 Whipple procedures, 12 distal pancreatectomies, 2 tumorectomies. Them
were two post-operative deaths (one patient operated on for a carcinoma of the colon,
one patient operated on for a carcinoma of the rectum). One patient was lost to follow-
up. The remaining 17 were alive and well, without evidence of recurrence, with a
median follow-up of 16 months.
This results confirm that microcystic adenoma of the pancreas is benign and can be
managed conservatively. When the tumour occurs in the body or tail of the pancras a
distal resection can be carried out. On the other hand, when the tumour occurs in the
head of the pancreas, surgical removal may not be necessary if the diagnosis can be
made by biopsy with frozen section, especially in the elderly. If there is a
gastrointestinal or biliary obstruction a bypass can be performed.
114FPII5 RISK FACTORS AND OUTCOME OF GUT
PERFORATION AFTER LIVER TRANSPLANTATION
FOR BILIARY ATRESIA.
O $oubrane, M El Meteini, D Houssin, O Bernard,
Y Chapuis.
Clinique Chirurgicale, HSpital Cochin, Paris
FRANCE
The incidence of gut perforation after liver transplantation (LT) for
uncorrectable biliary atresia (BA) ranges from 5 to 30 %. Because it is a
potentially lethal complication in immunosuppressed patients, the present
study aimed at evaluating the risk factors and prognosis of such gut
perforations.
From april 86 to february 92, 61 LT were performed in 51 children with
uncorrectable BA. Gut perforation occurred in 20 % of the patients. Two
groups of patients were therefore individualized: group A of 10 patients with
19 episodes of gut perforation arising 5 to 68 days after 14 LT and group B
of 41 patients without gut perforation after 47 LT. These two groups were
compared in order to identify risk factors and a stepwise regression analysis
about 12 factors possibly associated with the occurrence of digestive
perforations was carried out.
The recipients’ age and body weight, the number of cholangitis episodes
after Kasai operation, pre-transplant liver biological tests and the number of
reduced-size grafts used were not different between the two groups. On the
contrary, the amount of red blood cells transfused during the recipient
hepatectomy and the duration of LT were significantly greater in group A.
The incidence of severe fungal infections was 65 % in group A vs 2.5 % in
group B (p<0.001). There was no difference between the two groups
regarding early occurrence of acute rejection episodes and subsequent use
of steroid pulses, as well as early CMV infections. The stepwise regression
analysis identified 3 factors significantly and independently associated with
the occurrence of gut perforation: duration of LT, post-transplant
intraperitoneal bleeding requiring reoperation and post-transplant portal
vein thrombosis. The survival rate was not different between the two groups:
70 vs 80 %, respectively after a median follow-up of 32 months.
In conclusion, the occurrence of gut perforations seemed especially related
to the technical difficulty of the recipient’s hepatectomy whereas the
influence of steroids and CMV infections was not significant. This type of
complication, formerly known to bear a poor prognosis in organ transplant
recipients, led in this series to a survival rate as high as 70 % despite the
immunosuppression and high incidence of fungal infections.
115FP116 CORRELATION BETWEEN INFLAMMATORY
CYTOKINES, ENDOTOXIN, AND ISCHEMIA IN
PATIENTS DURING AND AFTER ORTHOTOPIC
LIVER TRANSPLANTATION
S Tange, Y H6fer, W Ertel, M Welte*, E Pratschke, K Jauch,
E Faist, F-W Schildberg,
DPucmhent
of Surgery, K)inikum Grosshadem, LMU
* Department of Anaesthesiology, Klinikum
Grosshhdem, LMU Munich, Germany
Inflammatory mediators released by residual liver macrophages (Kupffer cells)
regulate metabolism and synthesis of hepatocytes. Although ischemia activates
Kupffer cells to produce and secrete cytokines, a potential correlation between
ischemia and cytokine release into blood remains to be determined. Moreover,
as a result of veno-venous bypass during liver transplantation, the effect of gut
ischemia with bacterial translocation and endotoxemia on cytokine release is
unclear. It was the objective of this study to investigate, whether duration of
liver ischemia correlates with cytokine and endotoxin serum levels in the early
post operative course. Forty patients undergoing liver transplantation were
studied. Arterial blood samples were taken before laparotomy, at the beginning
of the anhepatic phase, 10 minutes before reperfusion,5,15,30,60,90,120 and
240 minutes after reperfusion. TNF- and IL-6 serum levels were determined
using bioassays (WEHT 164 cytotoxicity assay (TNF); 7TDI-proliferations assay
(IL-6)), and endotoxin plasma levels with a turbidimetric limulus amoebocyte
assay. The duration of ischemia varied from 270 up to 1050 rain with a mean
of 5665:20% min. Peaks for circulating TNF were observed 5 rain(18.7__+ 10.5
U/ml) and 30 min (20.0+ 17.7 U/ml) after reperfusion compared with 8.1 +2.4
U/ml before operation and 4.5 5:1.9 U/ml 4 hrs after surgery. Serum levels of
circulating IL-6 raised from 54.6-t-27.3 U/ml before surgery to 842.0-1-177
U/ml during reperfusion (5-120 minutes)and decreased to 376.8+217.8 U/ml
4 hrs after surgery. Increased endotoxin levels (with a range from 6-150 pg/ml)
were detected in 23 patients. Duration of ischemia did not correlate with
TNF(r=0.15), IL-6 (r=0.05), and endotoxin serum levels (r=0.15) using the
Bravais-Pearson regression analysis. Moreover, no correlation was detected
between serum levels of TNF-, IL-6 and endotoxin. Orthotopic liver
transplantation resulted in detectable cytokine and endotoxin levels during
reperfusion. Cytokine levels did neither correlate with endotoxin levels nor with
the ischemic time of the transplant. Increased cytokine serum levels may
predominantly be due to activation of Kupffer cells. Duration of liver ischemia
does not seem to represent a major factor for induction of the inflammatory
response by residual liver macrophages.
116FPl17 EXPERIENCE WITH COMBINED LIVER AND
PANCREAS-FOR-ISLETS PROCUREMENT.
V.Mazzaferro,E.Regalia,C.Socci,
G.Colella,V.Sansalone,F.Romani,
G.Rossi,M.Colledan,F.Bertuzzi,
V.Di Carlo,G.Pozza and L.Gennari
Istituto Naz.Tumori,Ist. Sci. S.Raffaele,
H.Niguarda,H.Policlinico Milan-Italy
Transplantation of the liver and pancreas are accepted
clinical procedures; nevertheless some questions
regarding the combined procurement of both organs from
the same donor are still pending. During 1992, with
respect to islet preparation 40 pancreas were procured
in combination with the liver. At the time of the
procurement 3 main surgical steps were followed:
i) Arterial (aortic) perfusion of < 2000 ml of UW-
Solution (i.e. avoid pancreas overperfusion) ,2) Decom-
pression of portal system after the first 200 ml of
arterial perfusion (i. e. early vent of the splenic
vein), 3) Injection of collagenase in the pancreatic
duct within 45 from the aortic cross-clamp. -
Xnerlor Nesenterlc Vei -
Superior Nesenterlc Vein -
Portal Vein
(. cc)
Islet function was tested by in vitro perfusion of two
samples of 150 islet/equivalent from each preparation.
209.473 179. 250 purified islets were sepagated from
69.64 19.95 gr. of pancreas. Insulin release in
response to glucose increased significantly (- AVC =
81.31 18.49 g/islet/min indicating the functional
integrity of the isolated islets.
A primary non-function of the liver graft was observed
only in 2 out of 37 cases (5.4%).
Reproducible surgical recommendations allow good
quality liver and pancreas grafts.
]]7FPll8 ISLET ALLOTRANSPLANTATION IN COMBINATION
WITH LIVER REPLACEMENT FOR METASTATIC
NEUROENDOCRINE PANCREATIC TUMOR.
C Socci, V Mazzafen’o, E Regalia, F Bertuzzi, S Andreola,
G Colella, P Magistretti, F Gavazzi, L Piemonti,P De Nittis,
Doci R, Bozzetti F, Di Carlo V, PozzaG and Gennari L.
Istituto Scientifico San Raffaele, Universit degli Studi di
Milano; Liver Transplant Unit, Ist. Nazionale dei Tumori,
Milano, Italy.
Islet transplantation is a new procedure for the replacement of pancreatic endocrine
secretion in type I diabetic patient. In this study a patient with a carcinoid of the
pancreas and multiple metastasisis of the liver underwent to medical and surgical
treatment. After 7 cicles of chemotherapy (5FU + DTIC + EPIADH) the tail, the
body of the pancreas and the spleen were removed. Further 4 cicles of
chemotherapy were performed during the following six months. Then the liver and
the head of the pancreas were removed with a subsequent liver islet allograft. The
patient received 485,000 (Absolute Number) fresh islets from three pancreases plus
700,000 cryopreserved islets from one gland. The islets were separated using a
modification of the automated method for isolation of human islets and purificated
by centrifugation on EuroFicoll gradients. All the organs were compatible with the
recipient for blood group without regarding HLA matching. The islets were injected
in the portal vein immediatly after the liver revascularization. Serum C- peptide
increased from < 0.15 to 3.92 ng/ml but the liver function quickly worsened (AST
6390, ALT 5040, PT < 15%). Two days later, another liver transplantation had to
be performed. The organ came from a 26 years old donor. The pancreas allowed to
obtain 190,000 fresh islets. The day after another gland compatible with the
recipient was processed and 620,000 islets were separated. The islets were injected
in the portal vein by a percutaneous trans hepatic approach. Immunosuppression
consisted in cyclosporine and prednisone. Due to a transitory renal failure
cyclosporine had to be stopped between the 5th and the 9th days p.o. During this
period a short course of anti lymphocyte serum was administrated. However no
significant decrease in the blood lymphocytes count occurred. Four days after the
transplantation, a biopsy of the liver allowed to identify two islets well shaped with
1] cells.
Three weeks after the transplant the liver and the islet grafts showed a good
function (AST 30, ALT 79, PT 54%, Serum C-Peptide between 3 and 6.95 ng/ml).
Insulin requirement is about 50 units/day but with 20 mg of prednisone for
immunosuppressive purpose and a parenteral administration of 1250 calories in
glucose. No side effects related to the percutaneous islet transplant occurred.
In conclusion, the high levels of serum C-peptide indicate the integrity of islet graft
making islet transplantation an alternative to pancreas transplant in total
pancreasectomized patients.
118FPl19 THE INFLUENCE OF COLD ISCHEMIA TIME
ON BILIARY COMPLICATIONS FOLLOWING
LIVER TRANSPLANTATION
B Dousset,M Scotte, Y Calmus, Conti, D Houssin, Y Chapuis.
Clinique Chirurgicale, H6pital Cochin, Paris, France.
The aim of this study was to determine whether cold ischemia time and
preservation injury judged on early liver function tests were acting upon the
incidence and the type of biliary complications (BC) following orthotopic liver
transplantation (OLT).
Patients and methods: 92 adult patients, who received 100 full-size liver
allograts between 87 and 91 were analyzed. All grats were ABO-compatible and
preserved in UW solution. 18 patients (24 grafts) died within 7 days following
OLT or urgent retransplantation without BC, leaving 74 patients (76 grats)
eligible for statistical analysis. The methods used for biliary reconstruction were
end-to-end choledochocholedochostomy (n=26) over a T-tube in most cases
(19/26) and Roux-en-Y choledochojejunostomy (n=50). Mean cold ischemia time
was 10.2 +/- 0.5 hours (range 3.6-19). The numbers of graft preserved beyond 13
and 15 hours were 21 and 14, respectively.
Results: 18 patients (19.6%) developed 25 biliary complications: 8 anastomotic
leakages (AL), 8 anastomotic strictures (AS), 6 non-anastomotic strictures (NAS),
2 cystic duct mucoceles and 1 biliary fistula following T-tube removal. Despite a
high rate of reoperative surgery (70%), there was no death related to BC. Cold
ischemia time was not significantly shorter in patients without BC (10.3+/-0.6 h)
than in those with BC (10.1+/-1.1h), biliary strictures only (10.5+/-1.3 h) or NAS
only (12.0+/-1.8 h). Biochemical parameters of early graR function including
highest value of AST, serum bilirubin and prothrombin rate during the first 3 days
did not significantly differ in these 4 groups of patients. An univariate analysis of
several features including initial liver disease, age, sex, pre-transplant steroid
therapy, previous surgery, volume of blood transfusion, type of biliary
reconstruction, acute rejection and CMV infection failed to identify predisposing
factors for BC or strictures. Despite a small number of patients, chronic rejection
appears to be the only significant risk factor for NAS (p=0.05).
Conclusions: (1) Prolonged cold ischemia time up to 19 hours is not affecting the
rate or the type of biliary complications aider OLT. (2) In view of these data, there
is no warrant for reconsidering prolonged cold ischemia up to 15 hours in UW
solution, as it has transformed liver transplantation from an emergency operation to
a semi-elective procedure and allows longer back-table preparation for graft
reduction or splitting.
119FPI20 CHOLANGIOCELLULAR CARCINOMA-
RESECTION AND TRANSPLANTATION
P.Lamesch, B.Rlnge, A.Welmann, J.Klempnauer,
R.Pichlmayr
Medizinische Hochschule Hannover
KIInik for Abdominal- und Transplantatlonschlmegle
Konstanty Gutschow Str.8
3000 Itannover 61 FRG
INTRODUCTION
Cholangiocellular caminoma(CCC) can be defined as intrahepatic cholan-
giocaminoma and must be distinguished from hilar or proximal bile duct car-
cinoma. In comparison with hepatocellular carcinoma (HCC), CCC repre-
sents the second most common primary hepatic malignancy accounting
10% of all primary liver cancer. The rarity of this malignancy becomes evi-
dent in the relative small number of experiences that can be drawn from the
literature. In the present retrospective stu6y 40 consecutive patients tmted
for CCC by resection and transplantation were reviewed.
PATIENTS AND METHODS
40 patients (15 m, 25 f, age 32-81 years, mean 52 years) were treated for
CCC between 6/1979 and 12/91. According to UICC, pathologic tumor
classification and stage grouping was applied. 23 patients (group 1) under-
went partial liver resection (LR), 17 patients (group 2) were treated by re-
moval of the liver and subsequent transplantation (LTX). The postoperative
course was analysed with regard to survival and tumor stage.
RESULTS
In group 1 (LR) 57% of the patients had an advanced tumor stage III, IV (I
n--l; II n--9; III n=6; IVA n--7; IV B n--0) compared to group 2 (L’I’X) 82% (I
n=0; II n=2; III n=2; IVA n--11, IV B n--2). The mean survival after hepatic
resection was 15 months compared to 5 months following transplantation
(p<0,01). After transplantation all patients died, the majority within 1 year
after LTX of tumor recurrence, the longest survival was 25 months after
transplantation. Actually there are 4 resected patients surviving between 27
and 46 months without tumor.
CONCLUSIONS
These results show that prognosis of CCC is more unfavorable as compared
to HCC and proximal bile duct cancer. Whereas curative partial resection
allows prolonged survival, hepatic transplantation from our experience does
not seem justified.
120FP121 LIVER TRANSPLANTATION WITH
COMBINED ADJUVANT TREATMENT
IN HEPATOCELLULAR CARCINOMA
D Cherqui, P Piedbois, D Vavasseur,JY Pierga, C Duvoux,
F Charlotte, D Mathieu, M Julien, D Dhumeaux, PL Fagniez
H6pital Henri Mondor 94010 Cr6teil, France
The results of liver transplantation in the treatment of hepatocellular carcinoma
(HCC) have been poor because of a high rate of local and distant recurrences with
survival rates below 30% in most series. In order to reduce the risk of relapse, we
initiated a protocol of adjuvant treatment including preoperative hepatic arterial
chemoembolization (HACE), radiotherapy (RT) and postoperative chemotherapy
(CT).
Methods HACE consisted of injection of adriamycin, spongel and lipiodol in the
hepatic artery during angiography. It was performed after inclusion of the patient in
the protocol and repeated if the transplantation was not performed within 2 months.
RT was performed in the immediate preoperative period at a dose of 5 Gy in one
fraction on the liver volume. CT consisted of weekly doses of mitoxanthrone (5mg/m2)
for 4 months, starting on postoperative day I if the patient condition allowed it.
Results From 1989 to 1992, 10 patients (9 men, I woman, 27-56 year-old) were included
in this study. HCC was developed in all cases in a cirrhotic liver. The tumor was
solitary in 4 cases (4-9 cm) and multifocal in 6 cases (2-9 nodules, 2-7 cm). Eight
patients had 1 to 4 courses of HACE (mean 2), and 2 did not have it because of portal
vein thrombosis in one case and reversed portal flow in the other. One patient with
Child’s class C cirrhosis and HCC died of liver failure after HACE. Seven patients
received RT while it was not done in 2 for technical reasons. Standard liver
transplantation was performed in 9 patients. Ciclosporine, steroids and azathioprine
were given for immunosuppression. One patient died at day 5 of heart failure without
receiving CT. The other 8 patients survived and received CT (4-12 courses, mean 9). The
first dose was administered at day I in 6 cases and delayed to day 8 and 15 in 2 cases
because of renal failure and pulmonary edema respectively. Morbidity included
mainly hematologic toxicity of CT with leucopenia which led to suppress
azathioprine from the immunosuppression regimen in the last patients. Two patients
relapsed and died 7 and 11 months after transplantation, and 6 (60%) are alive and
free of disease (mean follow-up 17 months, 6-34 months).
Conclusions These results show the feasibility of an aggressive adjuvant therapy in
patients transplanted for HCC and suggest a possible effect of such a protocol in the
prevention of tumor recurrence.
121FP122 RESECTION VERSUS TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA ASSOCIATED
WITH LIVER DISEASE
B Launois, F Siriser, E Bardaxoglou, B Chareton,
B Meunier G G Jamieson, M Messner
Department of Digestive Surgery and Transplantaion
Unit, Pontchallou Hospital, Rennes-France
Management of hepatocellular carcinoma associated with liver cirrhosis remains
controversial. Liver transplantation appears particularly indicated because it
allows treatment of the liver malignancy as well as the underlying liver
condition. Long term results are however poor. Thus, liver resection is
considered by many to be the treatment of choice, even though recurrences in
the remaining liver parenchyma are frequent. The aim of this study was to
compare these treatment modalities.
Between April 1978 and February 1992, 74 patients underwent surgery for
hepatocellular carcinoma associated with liver cirrhosis (70 males, 4 females,
mean age 60 + 9 years, range 31-80 years). Fifty-seven patients were rated
Child A (77%) and 17 were rated Child B (23%). The etiology of cirrhosis was
alcoholic (58%), hepatitic (30%) and hemochromatosis (12%). Tumour staging
was the following: T1, 6.7 %, T2, 39.2 %, T3, 44.6 %, T4, 9.5 %. Sixty
patients underwent liver resections and 14 patients underwent liver
transplantation. Total operative mortality was 15 %; 10 % following liver
resection and 35.7 % following liver transplantation (p< 0.05). Factors that
were found not to influence survival were: tumour size and number, presence
of a tumour capsule, vascular spread, staging and differentiation of tumour, and
Child rating. Actuarial survival at 3 years (operative mortality included) was
38.6 % following liver resection and 27% following liver transplantation (N.S.).
Liver resection attained similar results to those of liver transplantation when 3
year actuarial survival and tumour recurrence was considered. Thus, we believe
that liver transplantation should be considered only when liver resection is
contra-indicated.
122FP123 MANAGEMENT AND PROGNOSIS
IN PROXIMAL CHOLANGIOCARCINOMA
A Principe, R Golfieri, ML Lugaresi,F
Ruberto, A Colangelo, A Frena, G
Gozzetti
2 Dpt. of Surgery, Univ. of Bologna,
S. Orsola Hospital, Bologna, ITALY
Proximal cholangiocarcinoma is a rare lethal disease and
associate with a poor prognosis. They are often invasive
of the intraepatic bile ducts along the wall and so we
have been performing preoperatively percutaneous
transhepatic cholangiography to this patients for the
diagnosis of this neoplastic invasion. A review of our
experience revealed the only those patients undergoing
resection had an opportunity for long survival. PATIENTS
AND METHODS During on eleven years period 43 patients
were assessed for treatment of hilar cholangiocarcinoma.
The patients selection for a correct management stems
from an accurate preoperative work-up. In all patients,
percutaneous transhepatic cholangial drenaige was done.
Operative ultrasonography aids the decision making and
engineers, radical surgery. We classified tumours
according to Bismuth classification. RESULTS Two
patients died before the operation. Radical surgery was
carried out in II patients (27 %). In type I and II the
tumor with the bile duct bifurcation was resected in 3
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123FP124 RADICAL RESECTION FOR AMPULLARY
CARCINOMA. LONG-TERM RESULTS.
C Sperti, C Pasquali, # A Piecoli,
* CSemagiotto and S Pedrazzoli.
Semeiotica Chirurgica, # Medicina Intema, University
of Padua, * Surgery, C.H. Montebelluna, italy
Cancers arising from the region of the ampulla of Vater have a better prognosis
than other tumours originating from the peri- ampullary area. Several factors
are known to affect survival after radical resection for ampullary carcinoma, but
conflicting results have been reported. We reviewed our experience with
ampullary carcinoma in order to identify pathological factors influencing
survival and long-term follow-up after resection. From 1970 to 1990, 30
patients underwent potentially curative resection for adenocarcinoma ofampulla
of Vater (25 duodenopancreatectomy, 1 total pancreatectomy and 4 local
excisions). According to UICC staging system 19 patients were in stage I-II and
11 in stage III-IV. Tumour size ranged from 1.1 to 5.2 cm; 7 patients had
lymph-node metastases, 9 had pancreatic invasion. The tumour was well
differentiated in 19 cases, moderately-poorly differentiated in 11 cases. One
patient died in the peri-operative period (3 %). Overall 5-year actuarial survival
rate was 37%, 45% in the absence of lymph- node involvement versus 0% of
patients with nodal metastases (p=0.03). Estimated 5-year survival rate was
51% for well-differentiated turnouts (p=0.0001) versus 0% for moderately-
poorly differentiated tumours.Survival was significantly better (p=0.0002) in
patients with tumour stage I-II than in III-IV. Tumour size, pancreas invasion
and jaundice, did not correlate with survival. After local excision, 2 patients
developed local recurrence after 6 months and 3 years respectively. Among the
patients (15) without nodal metastases and treated with duodenopancreatectomy,
local and hepatic recurrence were found after 3,3,4,5,9 years respectively.
In conclusion, long-term survival may be obtained by radical resection in
patients with ampullary carcinoma, but late tumour recurrence requires a long
and careful follow-up. Lymph-node involvement, tumour differentiation and
stage, are the most important factors influencing long-term survival.
124FP125 GASTRIC EMPTYING AND GASTROINTESTINAL
MOTILITY ARE DISTURBED IN PANCREATIC AND
PERIAMPULLARY CANCER PATIENTS WITH
BILIARY OBSTRUCTION.
W.A.J.J.M. Haagh, L.M.A. Akkermans,
K.J. van Erpecum, H. Obertop.
Depts. of Surgery and Gastroenterology, University
Hospital Utrecht, Utrecht, The Netherlands.
Pancreatic and periampullary (PP) cancer patients can present with jaundice,
anorexia and symptoms of indigestion. These symptoms may be related to
disturbances in gastrointestinal (GI) function, in conjunction with the presence of
biliary obstruction. The aim of this study was to assess GI function in PP cancer
patients in relation to the degree of biliary obstruction.
We studied gastric emptying (GE) of a liquid nutrient-rich meal in 28 preoperative
PP cancer patients using Applied Potential Tomography, a technique measuring
changes in resistivity in a thick cross-section through the abdomen at the level of
the stomach. All patients had undergone endoscopic biliary drainage before the
study with variable response as assesed by the serum bilirubin level. No duodenal
obstruction was present in any of the patients as evidenced by endoscopy. Normal
values of GE were determined with the same method in 25 sex and age-matched
healthy controls. T1/2 in these controls was 109 + 34 min (mean + SD). Delayed
gastric emptying was defined as t1/2 > 180 min (mean + 2 SD). Also six channel
24-hour ambulatory antroduodenal manometry was carried out in obstructive
jaundice patients before biliary drainage to assess interdigestive GI motility (n =4).
Gastric emptying was delayed in 8 PP cancer patients (29 %), two of whom had
external biliary drainage. The bilirubin level was 70 + 90 mol/1 (mean SD)
in these patients versus 20 + 20 mol/1 in patients with a normal gastric emptying
rate (p < 0.05). There was a significant correlation between gastric emptying and
a bilirubin level above normal (> 17 /zmol/1) (r 0.5273; p 0.043).
Ambulatory antroduodenal manometry showed gross disturbances of normal
interdigestive motility in all patients. There was predominant irregular contractile
activity with some clusters of contractions. Phase III of the migrating motor
complex was absent or occured very infrequently and was not propagated.
Conclusion" Biliary obstruction has adverse effects on both GE and interdigestive
GI motility. These effects may be related to diminution or absence of intraluminal
bile in the GI tract.
125FP126 PROGNOSTIC SIGNIFICANCE OF TUMOR
DNA CONTENT IN CARCINOMA OF THE
HEPATIC DUCT CONFLUENCE
Y Sato, TM van Gulik, A Bosma, NJ Lygidakis,
K.Koyama, MN van der Heyde.
Dept.of Surgery and Pathology, Academic Medical
Center, Amsterdam, The Netherlands.
Introduction. In an attempt to identify prognostic factors in carcinoma of
the hepatic duct confluence, the value of tumor DNA content was studied in
58 cases of this type of malignancy.
Methods. Of 58 patients (age 26-74 years) surgically treated for carcinoma
of the hepatic duct confluence, tumor DNA content was assessed in relation
with clinical-pathological characteristics and patient survival. The resected
specimens were analyzed for nuclear DNA content of the tumor by flow
cytometry. 33 patients underwent additive radiotherapy.
Results. Resection was radical in only 3 patients with negative surgical
resection margins, as well as dissection (cleavage) margins. 28 patients
(48%) had diploid tumors and 30 patients (52%) aneuploid tumors. No
significant correlation was found between tumor DNA ploidy, degree of
tumor differentiation, lymph node status, and hepatic infiltration. Aneuploid
tumors were significantly associated with neural invasion. The median over-
all survival was 18 months. Survival of patients with a diploid tumor was
significantly (p<0.0003) longer than those with aneuploid tumors (median
survival 26 months and 11 months, resp.). Additive radiotherapy improved
survival significantly only in patients with aneuploid tumors. When tested by
univariate survival analysis, DNA ploidy, additive radiotherapy and the state
of the surgical resection margins were significant prognostic factors. With
multivariate survival analysis, only DNA ploidy, age, hepatic infltration and
lymph node status were significantly related to prognosis.
Conclusion. This survival analysis shows that DNA ploidy is a powerful
prognostic determinant of carcinoma of the hepatic duct confluence.
126FPI27 LONG TERM RESULTS OF THE MUCOSAL
GRAFT OPERATION FOR BENIGN BILE
DUCT STRICTURES.
T.Kakavouiis, A.E.Ziros
A"Surgical Unit., "Agia Olga"
General District Hospital
Athens., Greece.
From 1979 through 1992, fifteen patients aged 40
to 70 years old, with benign strictures of the
axtrahepatic ducts were treated. Percutaneous
transhepatic cholangiography was optimal
preoperative diagnost
site of strictures.
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127FP128 SURGICAL TREATMENT OF INTRAHEPATIC
BILIARY STONE AND STRICTURE
Yang Sen-hua, Yang Yi-eun
Department of Su(gery, Chengdu Third People’ s
Hospital, Cfiengdu, Sichuan, China
Intrahepatic stone (IHS) and intrahepatic duct stricture (IHDS) are common in
China. Due to prolonged biliary obstruction and repeated infection, IHS and
IHDS might result in liver and biliary lesions widely. Their treatment might be
very difficult and there are various kinds of operations for managing them.
Lately, in this hospital, elective operations for 63 cases were as follows. In 19
cases of choledocotomy and drainage with T tube stones were retained in 16
(84.21%). Bilio-enteric drainage in 29 cases without treating the co-existing
lesions only gave fair results in 8 cases, and this procedure, if abusively
adopted, might result in more trouble such as reflux cholangitis. 17 cases
(58.62%), developed mild or severe recurrences and 2 deaths resulted from
intrahepatic infection. Typical hepatic lobectomy alone was rarely indicated, 3
cases had been operated on. 11 cases were treated with combined operations
including thoroughly removing stones, properly relieving the IHDS, resecting
the severely damaged liver and establishing synthetically the external and the
internal biliary drainage. Post operatively 10 (90.91%) remained fair for 4.88
years on average. Above results seem to suggest in treating hepatolithiasis, the
liver and biliary system should be considered as a whole, for delayed patients
the operation should be performed directly against various lesions.
128FP129 BENIGN STRICTURES OF THE LOBAR HEPATIC
DUCTS AND THE REGION OF THEIR JUNCTION
E I Galperin, N F Kuzovlev, K M Khubiev.
I.M. Sechenov Medical Academy, Moscow, Russia
The report presents the experience of 230 operations performed in patients with
cicatricial stenosing of the lobar hepatic ducts and the region of their junction.
(Type 3,4,5 after H.Bismuth) from 1973 through 1991, 75% of patients having
a restricture.
When restoring the passage of bile from the liver into the intestine two basic
operative techniques were used: 170 patients (Group 1) the biliodigestive
anastomosis was created using a O-ring transhepatic drain which was left in
place for a period of no less than 2 years; in 60 patients (Group 2) no drain was
used at all. The post-operative complication rate in Group 1 was 11.7%, in the
majority of cases this being due to the use of a transhepatic drain (hemobilia,
collection of bile in the subphrenic space, subphrenic abscess), that in Group 2
was 6.7%. Of 170 Group 1 patients 11(6.4%) died. The main cause of death
was endotoxemia due to unresolved suppurative cholangitis and liver cholangific
abscesses. There were no fatal outcomes among Group 1 patients.
Long-term results were evaluated in 219 patients followed up from 1 to 17
years. The O-ring transhepatic drain was removed in 136 Group 1 patients.
Among 118 Group 1 patients in whom no less than 2 years had elapsed after
removal of their transhepatic drain the recurrence of hepatic duct strictures
occurred in 3 patients (2.5%) and in group 2 only in 1 patient (1.7%).
In our view, both techniques should not be opposed one against the other. Each
has its own indications for use and if there is no avoiding the incorporation of
the scarred tissues into the biliodigestive anastomosis it is expedient to use the
transhepatic drain.
129FP130 CONGENITAL DILATATION OF COMDN BILE DUCT IN ADULTS
A MULTICENTRIC STUDY OF 41 CASES.
LENRIOT J.P., OTrE J.B., ADLOFF M., A.U.R.C.
178, rue des Renouillers 92700 COES FRANCE
Congenital Dilatation of Common Bile Duct (CDCBD) in adults are rare in European
countries and few cases have been reported. The purposes of this multicentric
study were to assess the frequency of abnormal pancreaticobiliary junction,
evaluate the risk of cholangiocarcincm (CC) associated with CDCBD, and analyse the
results of surgical treatment.
Patients and methods. From 1975 to 1990, 41 patients with CDCBD, 32 women and
9 men were operated in 17 Centers members of AURC or ARC their mean age was
36,6 +/- 19 years. Patients with Caroli’s disease were excluded. Jaundice with
(n=16) or without (n=6) cholangitis, abdominal pain (n=13), and acute pancreatitis
(n=3) were the main presenting symptoms. Six patients (15 7) had undergone
previous drainage procedures. According to Todani’s classification, there were
14 type I, 3 type II, I type III, 22 type IVA and I type IV B CDCBD.
Results. Anomalies of pancreaticobiliary junction were classified according to
Kimura. Of the 36 patients with type I or IV A CDCBD, 29 were corectly opacified
27 had the C-P type and 2 had the P-C type. Of the 3 patients with type II CDCBD, 2
had the P-C type. Five patients (12 7) experienced CC associated with CDCBD one
CC of the gallbladder, 3 intra-cystic CC, and i CC arising from ductal bifurcation.
Thirty two patients underwent cystic excision with hepaticojejunostomy and chole-
cystectomy, associated with Whipple resection (n=2), or left hepatic lobectomy (n=2).
Four patients had internal drainage. Two patients with type II CDCBD had elective
cyst resection and one with type III CDCBD had transduodenal sphincteroplasty.
There were one palliative biliary drainage for unresectable CC and one hepatic
transplantation for CC of the ductal bifurcation.
Postoperatively, one patient died (2,4 7) and 7 (16 7) experienced abdominal
complications. None was reoperated. There were 6 later deaths, from unrelated
disease (n=l), and from recurrences of OS, 3 to 24 months after surgery (n=5).
After cyst excision with hepaticojejunostomy 23/27 patients (85 7) followed more
than 2 years have had excellent results 4 experienced recurrent abdominal pain
or cholangitis and 2 (type IV A) have been reoperated for intra-hepatic lithiasis.
After internal drainage, poor results occured in 3/4 patientes with one death
(unrelated disease) and 2 reoperations.
Conclusions. I) Anamalies of pancreaticobiliary junction are very frequent in
patients with type I or IV A CDCBD. 2) Incidence of carcinama associated with
CIX]BD seems to be similar in European and in Eastern countries. 3) Cyst excision
with hepaticojejunostomy is the best treatment for adults but does not eliminate
risk of intra-hepatic lithiasis.FP131 DYNAMIC GALLBLADDER SCINTIGRAPHY IN
ACALCULOUS BILIARY PAIN CHRONIC
CHOLECYSTITIS VS CHOLESTEROLOSIS
W Kmiot, I Donovan, R Wolverson, M Lee,
E Perry, K Harding, J Neoptolemos
Depts of Surgery & Nuclear Medicine,
Dudley Road Hospital, Birmingham, UK
The management of patients with chronic acalculous
biliary pain is difficult. One of the promising
approaches is the use of computerised dynamic chole-
scintigraphy following gallbladder stimulation with
cholecystokinin (CCK-PZ).
We evaluated 55 patients with ’acalculous biliary
pain’ whose median (range) symptom duration was 24
(12-120) months. The patients were assessed by a
Visick score (l=no symptoms; 2=mild pain; 3=moderate
pain; 4=severe pain) and were followed up 3-6 monthly
for a median (range) of 24 (12-60) months. The
patients were divided into three groups according to
the gallbladder ejection fraction (EF): low EF (<35%),
N=29; normal EF (35-50%), N=I0; high EF (>50%), N=I6.
35 patients with Visick scores of 3 or 4 underwent
cholecystectomy because of persisting symptoms; 20 did
not have surgery because of symptomatic improvement
(N=4) or an alternative diagnosis (N=I6). 22 cases
with a low EF had surgery, of whom 21 (96%) improved
with Visick scores of 1 or 2 (p<0.01) compared to only
4 out of 9 (44%) with a high EF (NS). All 4 patients
with a normal EF improved after cholecystectomy and
all had EF values of <39%. Histology, which was
available in 32 cases, revealed chronic cholecystitis
in 32 (100%) and cholesterolosis in 20 (63%) of whom
i0 also had microlithiasis. Only 7 out of 12 (58%)
patients with chronic cholecystitis alone improved
after cholecystectomy compared to in 19 out of 20
(95%) patients with cholesterolosis (p=O.03). ERCP and
duodenal bile collection was performed in the first 12
patients: the ERCPs were all normal and only 7
patients were positive for bile crystals. None of the
US examinations were diagnostic of cholesterolosis.
This study supports the use of dynamic CCK-stimulated
gallbladder scintigraphy in patients with acalculous
biliary pain, cholecystectomy being particularly
indicated in those with a low EF.
131FP132 PAPILLARY ADENOCARCINOMAAND SQUAMOUS CELL
CARCINOMA OF THE GALLBLADDER ARE LIKELYTO BE
ASSOCIATED WITH DIFFERENT FACTORS ORCONDmONS
F Cetta, *A Cariati, F Lombardo,M Giubbolini, A Cappelli
Institute of Surgical Clinics, University of Siena and
*University ofGenoa Italy
Fify-one consecutive patients with gallbladder carcinoma (GBC) [11 men (M) and
40 women (W); mean age, 69.4 years] were found during the study of2750 patients
who underwent surgery for biliary tract diseases (GBC 1.85% of all operations).
Forty-eight had gallstones, which were symptomatic in 23 cases and asymptomatic
in 25. In particular, 21 of these patients (4 M, 17 W, mean age 68.7) who had
complete removal of the gallbladder, isolated or as a part of a more radical
operation, had systematic bile (pH, culture, trypsin) and stone analysis. Data in
patients with GBC were compared with clinical and laboratory findings, histologic
examination, stone and bile analysis in 1000 consecutive patients with non
malignant bile tract diseases, who were analyzed in the course of a prospective
study. Patients with non squamous GBC (n=16) (13 adenocarcinoma (ADC), 1
papillary, 2 poorly differentiated) had cholesterol or combination stones in 14
cases, black mud in 1 case and no stone in the patient with papillary ADC. Stones
were larger than 15 mm in 9 cases and smaller in 6 cases. The mean time lapse
(TL) between documented lithiasis and operation was 16.3 years (n=7). Bile
culture was positive in 24% of patients, pancreaticobiliary reflux (PBR) was
evident in 3 of 18 patients (16.6%). Patients with squamous cell carcinoma (SQC)
(n=5 patients, I squamous, 4 adenosquamous), always had cholesterol stones larger
than 15 mm. Time lapse was 31.6 years (10.002). Bile culture was negative.
Evident PBR was not detectable. On the basis of present data and of the literature
review concerning GBC and premalignant lesions or conditions it is suggested that
adenocarcinoma (ADC) (in particular papillary ADC) and SQC seem to be
associated with different factors and conditions. ADC, the most frequent histologic
type, is sometimes associated with PBR, but less frequently than SQC with
gallstones of large size and long duration. Papillary ADC can be found in the
absence of gallstones. On the contrary, SQC is more closely related to longstanding
cholesterol or combination stones and to risk factors affecting their formation
(female sex, parity, obesity). Instead of classifying GBC as a unique entity, it is
suggested to separate carcinomas associated with or related to gallstones from
those without gallstones. Distinction between these 2 groups as well as between
ADC and SQC could be of importance for both epidemiologic and clinical
purposes, i.e., for a proper recognition ofthe risk factors, a better knowledge of the
natural history ofthe illness and a correct evaluation ofthe therapeutic options.
132FP133 PROSPECTIVE RANDOMIZED TRIAL OF
ELECTROSURGERY VS ULTRASONICALLY ACTIVATED
SCALPEL FOR LAPAROSCOPIC CHOLECYSTECTOMY
J Amaral
Department of Surgery, Rhode Island Hospital
Brown University, Providence RI U.S.A.
The ultrasonically activated scalpel (UAS) is composed of a blade
that vibrates axially 55,500 x per second resulting in cutting and
simultaneous coagulation. Animal studies have shown little lateral
thermal damage (imm), no smoke, no grounding needed and minimal
tissue injury. The purpose of this study was to compare the UAS
to conventional electrosurgery (ES) for human laparoscopic
cholecystectomy. Thirty-five patients were randomized to either
ES or UAS by choice of their surgeon. All patients had normal
preoperative liver function tests. Preoperatively there was no
difference between ES and UAS for hemoglobin, white blood cell,
LDH, SGOT, SGPT, alkaline phosphatase and bilirubin. These values
were obtained preop and 24 hours postop. (*=p 0.05)
Postop N Hgb WBC Bill Alk LDH SGOT SGPT
UAS 15 12.7 8.71 0.7 75.6 559* 62* 89*
ES 20 12.2 8.17 0.7 68.0 375 40 55
There was no difference in length of hospital stay or operative
tissue. There were more gallbladder perforations with ES (3)
than UAS (0). These data are consistent with the hypothesis that
there is less tissue damage with UAS thqn ES since postoperative
LDH, SGOT and SGPT were significantly greater for ES than UAS.
Despite the reduced tissue damage UAS was as hemostatic as ES as
reflected in hemoglobin. In conclusion, UAS is as effective as
ES with less tissue damage and greater safety.
133FP134 COMPARATIVE EVALUATION OF EARLY
CHOLECYSTECTOMY VERSUS INTERVAL
CHOLECYSTECTOMY IN ACUTE CHOLECYSTITIS
T.K. Malik, S.Madaan, R. Malik
Deptt. of Surgery, Maulana Azad Medical
College, New Delhi.
A total of 224 patients with a provisional clinical diagnosis
of acute cholecystitis were taken up for study. All the
patients were subjected to ultrasonographic examination
and/or DISIDA scanning for the confirmation of diagnosis.
Initial clinical diagnosis proved to be wrong in 11.6 (26)
of patients. The remaining 198 patients were randomly
allocated into early (n=98) and delayed (n=100) surgery
group. Those taken up for delayed surgery were continued
on conservative management till acute symptoms subsided
and were discharged to be readmitted for elective surgery
3 months later. The patients undergoing early surgery
were operated on within 7 days of the onset of acute symptoms
under antibiotic cover. Per-operative saline biliary manometry
was done in all cases to detect any unsuspected CBD stones
and CBD explored whenever necessary.
In delayed surgery group 8 of patients had to be operated
early due to failed conservative management and 25 of
patients had to be readmitted due to recurrence of symptoms
before the planned date of surgery. Incidence of CBD stones
was similar in two groups (Early surgery 8.16; Delayed
surgery 8). No undue technical difficulty was encountered
during early surgery with operating time being similar
in two groups. The morbidity and mortality was comparable
in two operative roups. Total duration of hospital stay
was 6.3 days fewer in the early surgery than in the delayed
surgery group, thereby reducing hospital costs. On the
basis of this study we recommend early cholecystectomy
as a routine in the management of patients with acute chole-
cystitis.
134FPI35 ASSF_SMENT OF SECRETED MUCOPROTEINS
IN THE GALL-BLADDER WITH CALCULOUS
Alvarez J, Lobato R, Carabias A, Maillo,
Jover J, Lucia P, Moreno Azcoita M.
Hospital Universitario de Getafe.
Madrid, Spain
Different substances like cholesterol, calcium carbonate and proteins are
consolidated upon mucoproteins secreted by the gall-bladder forming a lithiasis.
Mucoproteins play an essential role in lithogenesis.
OBJECTIVE:
mucoproteins.
Determine pattern and amount of secretion of gallbladder
PATIENTS AND METHODS" Prospective study in cholecystectomy
specimens. By means ofdifferent histochemical analyses every mucoprotein was
determined, and the intensity of the colour showing the amount.
RF_ULTS" Overall mucoprotein was 1-24 (11.6 5.2). In mucous membrane
was 1-9 (3.7 + 1.8), and in glands 0-9 (4.7 + 2.1). Neutral mucine showed a
mean intensity graduation of 0-12 (4.4 + 1.9), and acid low sulphated 0-9 (2.4
2.4).
CONCLUSION: Mucoproteins are produced in secretory grains by distal pole
of the cell, with a larger intensity in the glands than in epithelial cells. In
cholelithiasis an unspecific secretion of mucoproteins is produced.
135FP136 OPEN CHOLECYSTECTOMY IN THE ’90s
STILL A COMPETITIVE OPTION
PG SFIKAKIS, SB KONTOSTOLIS, NL LECOS
2rid Surgical Unit, Tzanion General Hospital,
Piraeus, Greece
Open surgery remains the most prominent treatment for gallstone di-
sease although recently, the laparoscopic option was the breakthrough
which established minimal access surgery with minimum postoperative
discomfort and accelerated recovery with early return to full acti-
vity or work. We have been persuaded that mini-laparotomy for cho-
lecystectomy, has similar results with the laparoscopic one with
significant cost savings.
All 81 patients admitted for elective cholecystectomy had cholelithi-
asis diagnosed preoperatively by ultrasound and confirmed at surgery.
All had a mini subcostal incision. Dissection of the gallbladder,
was from above downward. Complete hemostasis of the liver bed was
achieved with a sheet of absorbable collagen hemostatic sponge (HE-
LISTAT) in the liver bed. A closed system drainage was employed in
only 6% and was removed within 24 hours. The abdominal wall was be-
ing closed in routine fashion with two layers of 2 vicryl, after the
cut surfaces of peritoneum, fascia, subcutis and skin were infiltra-
ted with 200 to 250mgr (40 to 5Oral) of 0.5% bupivacaine hydrochlori-
de (Marcaine). The skin was closed with 3/0 subcuticular continuous
plain cat gut. Nasogastric decompression was used in 12 of pati-
ents and the tube was removed within the first 12 to 24 hours.
Perioperative antibiotics prior and 2 doses after the operation were
used. The patients were instructed intensivelly about the need for
early ambulation and pulmonaz toillet and 93 of them were dismis-
sed the 3d postoperative day. No complication developed, was aggra-
vated, or went unrecognized because of early discharge. Two subjects
had superficial hematomas treated on an outpatient basis.
We conclude that concerning the financial point of view, mini-lapa-
rotomy remains the gold standard for patients undergoing elective
cholecystectomy. On the other hand, concerning the patients’ com-
fort, it remains still competitive to laparoscopic cholecystectomy.
Patients can be discharged soon after major operations and such pro-
grams have demonstrated the safety of outpatient surveillance.-
136FP137 CHOLEDOCHODUODENOSTOMY(CDD) IN THE MANAGEMENT
OF CHOLEDOCHOLITHIASIS LONGTERM RESULTS
A.M.Almeida, NoM.Santos, F.J.Aldeia
Surgical Unit I,University Hospital Sta Maria
Lisbon,Portugal
Reported as a more efficient approach to choledocholithiasis,as com
pared to T-tube drainage(l,2),CDD is regarded as a last resort mea-
sure due to fears of higher operative morbidity,cholangitis,sump syn
drome and liver dysfunction.We aimed to assess the aforementioned i-
ssues analyzing prospectively our experience(1973-Dec 91).METHODS-
CDD was performed in 89 F/36 M,60.2+/-8.7(m+/-sd)yrs old,26 as resurge-
ry,for CBD stones 94(75%),papillary dysfunction 23(18%),pancreatic
nodule 8(6%).Peroperative liver bx was obtained,upon written conse
in 44 pts.The follow-up schedule(>2.5 yrs in llO)included clinical
interview and liver biochemistry profile every 4 months for the Ist
year and once a year thereafter and USG every 1-2 yrs.ERCP was obtai
ned in i0 symptomatic pts plus 25 others for academic purposes,upon
written consent.Liver bx’s were obtained,upon consent,4-9 yrs postop,
in ii pts(5 at relaparotomy for unrelated pathology,6 fine needle).
Duct mucosa bx was obtained in one pt,at endoscopy.The anastomotic
technical details were previously described(3).Longterm results were
classified as previously defined(3),poor meaning the need for fur
ther invasive therapy.RESULTS-The operative mortality rate was 1.6%o.
The postoperative hospital stay was of 8.2+/-2.3(m+/-sd)days.The long-
term results(123 survivors)were considered as excellent 89(72%),od
22(18%),fair 9(8%),poor 3(2%).Three pts died from unrelated causes
and 8 others ceased the follow-up evaluation 3-5 yrs postsurgery,all
of them classified as excellent or good result at the end point.A
widely patent anastomosis(2.5 cms)was documented in every patient
assessed via ERCP,without duodenal or duct mucosal inflammatory chan
ges,including those classified as poor result.Food "debris" were de
tected in the distal "cul-de-sac" of 4 pts,easily floating and flu-
shed through the stoma.In none of the longterm liver bx’s could We
observe histological abnormalities,although definite cholestatic
changes had been demonstrated on peroperative tissue exams.CONCLU-
SIONS-I)CDD is a highly efficient short and longterm treatment of
choledocholithiasis,without the alleged long run morbidity such as
bacterial or "chemical" cholangitis,sump syndrome or hepatic dysfun
ction,provided a technically correct and wide anastomosis(25 mms)
is accomplished,2)The longterm efficiency,in terms of retained and/
or recurrent calculi,of the recent laparoendoscopic approaches shou]d
be matched to what is achievable by a suitable and correct CDD.
REFERENCES’I)Br.J.Surg,1985;72"428, 2)Br.J.Surg,1987;74"1095,
3)Am.J.Surg,1984;147"253
137FP138 SYMPTOM SCORING OF RIGHT UPPER QUADRANT PAIN
M Harper, IS Bailey, C D Johnson
University Surgical Unit, Southampton
General Hospital, Southampton, UK
Many patients complain of right upper quadrant (RVQ) pain, but
only a small proportion of these will have gallstones. Ultra-
sonography (US)is the most accurate diagnostic test for gallstones,
but to submit all patients with RUQ pain to US is wasteful of
resources. We have investigated symptoms in patients referred for
US for this indication, in an attempt to identify symptoms which
can indicate the presence or absence of gallstones.
174 patients were asked to complete a detailed symptom questionnaire
and the US findings were recorded. Questionnaires were then
analysed by univariate and multivatiate analysis to identify
symptoms associated with the presence or absence of stones.
Six features were identified which could predict the absence of
gallstones: pain not severe; pain not relieved by vomiting; sharp
pain; age<60 years; oesophageal reflux; and absence of jaundice.
If all six features were present, there is a 92% likelihood that
the patient will not have gallstones. All six features were
absent in 62% of those who had stones. Predictive values for
stones were presence: 74%: absence:88%.
This analysis has given promising results in the search for a
symptom score which will predict the absence of gallstones. With
a high negative predictive value, it is possible to exclude from
investigation patients who are unlikely to have stones. The
positive predictive value is lower, but this is less important
clinically, as US will be necessary for all patients in whom
stones cannot be excluded.
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